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Abstract
Microfluidic biochips have now come of age, with applications to biomolecular recog-
nition for high-throughput DNA sequencing, immunoassays, and point-of-care clini-
cal diagnostics. In particular, digital microfluidic biochips, which use electrowetting-
on-dielectric to manipulate discrete droplets (or “packets of biochemical payload”)
of picoliter volumes under clock control, are especially promising. The potential
applications of biochips include real-time analysis for biochemical reagents, clinical
diagnostics, flash chemistry, and on-chip DNA sequencing. The ease of reconfigura-
bility and software-based control in digital microfluidics has motivated research on
various aspects of automated chip design and optimization.
This thesis research is focused on facilitating advances in on-chip bioassays, en-
hancing the automated use of digital microfluidic biochips, and developing an “in-
telligent” microfluidic system that has the capability of making on-line re-synthesis
while a bioassay is being executed. This thesis includes the concept of a “cyberphys-
ical microfluidic biochip” based on the digital microfluidics hardware platform and
on-chip sensing technique. In such a biochip, the control software, on-chip sensing,
and the microfluidic operations are tightly coupled. The status of the droplets is dy-
namically monitored by on-chip sensors. If an error is detected, the control software
performs dynamic re-synthesis procedure and error recovery.
In order to minimize the size and cost of the system, a hardware-assisted error-
recovery method, which relies on an error dictionary for rapid error recovery, is also
iv
presented. The error-recovery procedure is controlled by a finite-state-machine im-
plemented on a field-programmable gate array (FPGA) instead of a software running
on a separate computer. Each state of the FSM represents a possible error that may
occur on the biochip; for each of these errors, the corresponding sequence of error-
recovery signals is stored inside the memory of the FPGA before the bioassay is
conducted. When an error occurs, the FSM transitions from one state to another,
and the corresponding control signals are updated. Therefore, by using inexpensive
FPGA, a portable cyberphysical system can be implemented.
In addition to errors in fluid-handling operations, bioassay outcomes can also be
erroneous due the uncertainty in the completion time for fluidic operations. Due to
the inherent randomness of biochemical reactions, the time required to complete each
step of the bioassay is a random variable. To address this issue, a new “operation-
interdependence-aware” synthesis algorithm is proposed in this thesis. The start
and stop time of each operation are dynamically determined based on feedback from
the on-chip sensors. Unlike previous synthesis algorithms that execute bioassays
based on pre-determined start and end times of each operation, the proposed method
facilitates “self-adaptive” bioassays on cyberphysical microfluidic biochips.
Another design problem addressed in this thesis is the development of a layout-
design algorithm that can minimize the interference between devices on a biochip.
A probabilistic model for the polymerase chain reaction (PCR) has been developed;
based on the model, the control software can make on-line decisions regarding the
number of thermal cycles that must be performed during PCR. Therefore, PCR can
be controlled more precisely using cyberphysical integration.
To reduce the fabrication cost of biochips, yet maintain application flexibility, the
concept of a “general-purpose pin-limited biochip” is proposed. Using a graph model
for pin-assignment, we develop the theoretical basis and a heuristic algorithm to gen-
erate optimized pin-assignment configurations. The associated scheduling algorithm
v
for on-chip biochemistry synthesis has also been developed. Based on the theoretical
framework, a complete design flow for pin-limited cyberphysical microfluidic biochips
is presented.
In summary, this thesis research has led to an algorithmic infrastructure and
optimization tools for cyberphysical system design and technology demonstrations.
The results of this thesis research are expected to enable the hardware/software co-
design of a new class of digital microfluidic biochips with tight coupling between
microfluidics, sensors, and control software.
vi
Dedicated to my beloved grandfather and grandmother, Junyi Luo and Fangzhen
Wang
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1Introduction
Microfluidic biochips have emerged as powerful and reliable toolkits for biotechnology
applications, such as chemical synthesis, the diagnosis of diseases, and the develop-
ment of new drugs [1][2][3]. Nanoliter and picoliter volumes of biological samples can
be manipulated on microfluidic devices under software control. Compared to conven-
tional devices and analyzers, microfluidic devices offer many unique advantages. The
low volume of samples and reagents manipulated on microfluidic devices can signifi-
cantly reduce the costs associated with conducting experiments; the precise control
of reactions on microfluidic devices can enhance the accuracy of the experiments;
the time required for the chemical reactions to occur at the nanoliter scale can be
greatly reduced due to the high surface-to-volume ratios. Based on to the methods
used to manipulate the liquid on the chip, microfluidic biochips are categorized as
“flow-based chips” or “digital (droplet-based) chips” [4][5][6].
In continuous-flow chips, liquid flow on the biochip is achieved through micro-
fabricated channels, pumps, and valves [7][8]. To overcome fluidic resistance, liquid
in the channels is driven by external pressure sources. Such sources include external
mechanical pumps and integrated, mechanical micropumps. The pressure required
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for liquid flow also can be provided by combinations of capillary forces and electroki-
netic mechanisms [7]. In recent years, the development of flow-based microfluidic
devices has been accelerated by innovations in fabrication techniques, including the
application of polydimethylsiloxane (PDMS) and the dense integration of active mi-
crovalves. From the early days, when flow-based biochips had simple topologies and
only a few channels, commercial flow-based microfluidic devices today have large-
scale networks of channels, and they can be used in various real-world applications.
For example, a product from Fluidigm [9], a biotechnology company that focuses
on flow-based microfluidic biochips, can perform a series of gene analyses, including
enrichment for target DNA sequences, sample barcoding for multiplexed sequencing,
and preparation of the sequencing library.
However, flow-based biochips have several inherent limitations and drawbacks.
First, flow-based chips are difficult to integrate and scale down, as the scale of each
component in the device may have a decisive impact on the performance of the entire
system [5]. The second problem is that these chips cannot be reconfigured after they
are fabricated because the channels are etched in the substrate [4]. Thus, the paths
for liquid flow and all of the operations implemented by the chip are pre-determined,
and no software-based differentiation is possible. The third problem is that these
chips lack fault tolerance, hence the entire chip ceases to be functional if any channel
or other on-chip element is defective [4].
Digital (droplet-based) microfluidic biochips have been proposed as an alternative
to flow-based microfluidics [4][6]. On the droplet-based microfluidic platform, liquid
droplets and all of the fluid-handling operations are manipulated using an array of
discrete electrodes [1][3]. Since each droplet is analogous to “a bit of information”
and operates under clock control, this device is referred to as a “digital microfluidic
biochip” [3].
In digital microfluidic biochips, all molecular processes and biochemical reac-
2
tions are conducted using discrete droplets (or “packets of biochemical payload”)
that have nanoliter/picoliter volumes, which allows a very significant reduction in
reagent/sample volume and reaction time. Since microfluidic droplet platforms have
the capability of conducting fast and efficient mixing inside droplets, high through-
put can be achieved for experiments. The droplets on digital microfluidic biochips
have no contact with any of the solid walls of the flow channels because they are
surrounded by silicone oil and manipulated on the surface of the electrode array.
Thus, as a benefit of this structure, the risk of cross contamination in experiments
and the adsorption of reagents/samples by the walls of the channels are minimized.
Therefore, the quality of the product droplet as well as the reliability of the biochip
is improved.
Since discrete droplets are manipulated independently on the biochip, the droplet-
based microfluidic biochip is especially suitable for researchers to closely monitor var-
ious reactions over time. For example, researchers have developed a droplet-based
process for the identification and enumeration of foodborne pathogens [10]. In this
process, each water-in-oil droplet acts as a microreactor for the encapsulation of the
cell. By observing the metabolic activity of single bacteria cell that is confined by a
picoliter-scale droplet, the detection and enumeration of bacteria can be performed
quickly and precisely. The oil that surrounds each droplet acts as a carrier of droplets
and a barrier against cross contamination. Compared with the conventional methods
used to detect pathogens, in which researchers have to incubate the specimens for
several hours or even days before the pathogens can be detected by conventional in-
struments, the method based on digital microfluidic biochips can significantly reduce
detection time and improve the reliability of the measurement results.
Given all these advantages, digital microfluidics is now seeing increasing accep-
tance in biotechnology applications that require high-precision control of fluid flow
during experiments [1][2][3]. The complexity of such systems and the integration level
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of digital microfluidic biochips has increased markedly in the last few years. For ex-
ample, a commercially-available droplet-based microfluidic system embeds more than
300, 000 electrodes with integrated optical detectors [11]. The system is developed
and optimized for single-cell gene expression, single nucleotide polymorphism (SNP)
genotyping, protein expression, and the quantification of samples of DNA strands.
As the applications of digital microfluidic biochips grow, greater demands are
likely to be placed on the quality of product droplets and the accuracy of fluid-
handling operations. At the same time, the risk of errors during the execution of a
bioassay is likely to increase due to the greater number of on-chip operations. For
example, if a larger droplet that is to be split is not placed at the center of the
splitter, unbalanced splitting may occur, and the resulting smaller droplets will have
erroneous volumes.
Unlike the detection of defects involving the electrodes and the breakdown of the
insulation layer, operational errors are difficult to predict or detect before the bioas-
say is conducted. For a biochip that does not have any hardware defects, operational
errors are the main cause for the failure of bioassays. In order to improve the yield
of bioassays and the automation of digital microfluidic biochips, it is necessary to
develop an “intelligent” microfluidic system that has the capability of making on-line
re-synthesis while a bioassay is being conducted.
Based on the existing hardware platform of biochips and emerging on-chip sensing
techniques, the concept of a cyberphysical microfluidic biochip is proposed in this
thesis work. In such a biochip, the control software and the hardware platform are
tightly coupled. The status of the droplets is monitored in real-time by on-chip
sensors. If an error is detected, the control software performs dynamic resynthesis
to determine how to recover from the error. The dynamic re-synthesis procedure
reschedules operations and reallocates on-chip resources to operations in order to
minimize the completion time of the bioassay, while guaranteeing that there is no
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conflict in resource sharing. By applying the control signal sequences derived by the
re-synthesis procedure, the biochip discards the faulty droplets immediately to stop
the propagation of the error. The operation that generated the faulty droplet(s) will
be repeated. In this way, the biochip recovers from the effects of the operational
error.
In order to minimize the size and cost of the system, a hardware-assisted error
recovery method is also proposed in this thesis. Instead of the control software
running on a computer, a finite-state-machine implemented on a field-programmable
gate array (FPGA) is used to control the error-recovery procedure. Each state of
the FSM represents one possible error that may occur on the biochip; for each of
these errors, the corresponding sequence of error-recovery signals is stored in the
memory of the FPGA before the bioassay is conducted. When an error occurs, the
FSM transitions from one state to another, and the corresponding control signal
is updated. Therefore, by using simple and inexpensive hardware (the FPGA), a
portable, cyberphysical system can be implemented. This design is particularly
convenient for handheld or portable devices that may emerge with future advances
in technology.
In addition to errors in fluid-handling operations, another possible cause for the
failure of a bioassay is the uncertainty in the completion time of fluid-handling oper-
ations. Due to the inherent randomness of biochemical reactions, the time required
to complete each step of the bioassay can be viewed as a random variable. To address
this issue, a new “operation-interdependence-aware” synthesis algorithm is proposed
in this thesis. The start and stop time of each operation are determined by feedback
from the on-chip sensor. Bioassays can therefore be carried out in a self-adaptive
fashion on cyberphysical microfluidic biochips. With such a synthesis approach,
the reliability and flexibility of the biochips are improved, and the applications of
biochips can be extended beyond well-calibrated bioassays to the exploration of new
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biochemical protocols.
To reduce the cost of fabricating biochips while maintaining flexibility with re-
spect to potential applications, the concept of a general-purpose pin-limited biochip is
introduced in this thesis. Using a graph model for pin-assignment, we have developed
the theoretical basis and a heuristic algorithm to generate optimized pin-assignment
configurations. The associated scheduling algorithm for on-chip biochemistry synthe-
sis is also presented. A complete design flow for pin-limited cyberphysical microfluidic
biochips is presented on the basis of these results.
Another design problem addressed in this thesis is a layout-design algorithm that
can minimize the interference between the devices on a biochip. A probabilistic model
for the polymerase chain reaction (PCR) process is considered; based on the model,
the control software can make on-line decisions regarding the number of thermal
cycles that must be performed in the PCR procedure. Therefore, the duration of the
PCR can be controlled precisely.
The rest of this chapter is organized as follows. Section 1.1 presents an overview
of digital microfluidics. Section 1.2 introduces the design automation aspects of
digital microfluidic biochips. Section 1.3 presents a chapter-by-chapter outline for
this thesis.
1.1 Overview of digital microfluidics
In this section, we present an overview of digital microfluidics, including the hardware
platform and sensing techniques.
1.1.1 Hardware platform
A digital microfluidic biochip consists of a two-dimensional electrode array and on-
chip reservoirs [13]. By utilizing the effect of electrowetting, nanoliter droplets con-
taining biological/chemical samples and reagents can be manipulated on the chip
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Figure 1.1: Schematic cross-section of a unit cell on the microfluidic biochip [12].
without curved channels or external pressure sources [4][12].
Figure 1.1 [12] shows the structure of a unit cell on a digital microfluidic biochip.
The upper plate is a large electrode which covers all cells on the array and serves as
the ground electrode for all unit cells [12][13]. When the biochip is used, the upper
plate is applied a common voltage, thus all the unit cells in the array have the same
voltage on their upper electrodes [12][13]. The lower plate of the unit cell consists
of an array of discrete control electrodes. During chip operation, the unit cells in
the array may have different voltages on their lower electrodes. The movements of
droplets are determined by signals applied on the discrete electrodes. In the literature
on microfluidic biochips, the term “control voltages applied to electrodes” usually
refers to the voltages applied to the lower electrodes of the unit cells on the chip.
As shown in Figure 1.1 [12], droplets manipulated by the digital microfluidic
biochip are confined between the upper and lower electrodes [12]. To move a droplet,
a high voltage should be applied to a unit cell adjacent to the droplet, and at the
same time, a low voltage must be applied to the cell under the droplet [12]. The
voltages applied to the electrodes can influence the surface characteristics of the
hydrophobic coating on the lower electrodes. In this way, the different voltages
applied to the electrodes result in different levels of interfacial tension on the surface
of the biochip [12]. Due to this effect, the droplet is moved from the low-voltage
electrode to the high-voltage electrode[12]. This is the basic operating principle of
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Figure 1.2: Several generations of fabricated and packaged digital microfluidic
biochips [14].
digital microfluidic biochips. All microfluidic functions, such as droplet merging,
splitting, mixing, and dispensing can be reduced to a set of basic operations [12].
Concurrent manipulation of multiple discrete droplets can be coordinated by control
software and by voltages applied to the electrodes, without the use of mechanical
devices, such as tubes, pumps, and valves [4].
Figure 1.2 [14] shows several generations of fabricated and packaged digital mi-
crofluidic biochips. The electrodes in these devices are fabricated on printed circuit
boards (PCBs). Similar biochips have been fabricated on glass and silicon, and
demonstrated for a wide variety of biomedical assays, including on-chip chemistry
for DNA sequencing [1], multiplexed real-time polymerase chain reaction [15], protein
crystallization for drug discovery [16], and cytotoxicity assays [17].
The process of fabricating microfluidic biochips on silicon wafers is described in
[18]. In this process, the wafer is coated with a layer of SiO2, which is used as the
bulk insulation layer. Figure 1.3(a) shows electrodes fabricated on a silicon wafer.
Two metal layers are deposited to form the interconnects. A cross-sectional view of
a silicon-based biochip is shown in Figure 1.3(b) [18].
The silicon-based microfluidic biochip in [18] can be used to generate and manip-
ulate droplets that have volumes of 300 pl, and the actuation voltages required for
dispensing and transporting a droplet are 11.4 V and 7.2 V, respectively.
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(a)
(b)
Figure 1.3: (a) Electrodes of a silicon-based biochip [18]; (b) side view [18].
1.1.2 Sensing systems
The development of integrated biomedical analysis systems requires miniaturized,
integrated, and robust sensing systems [19]. Sensing systems on biochips can be
divided into three categories based on their working principle, i.e., droplet visual-
ization monitoring system, on-chip capacitative sensor, and on-chip photodetector.
More details about each of these systems are provided below.
Droplet visualization system
Cameras can be used to record the movements of multiple droplets on the biochip
simultaneously. The setup of the droplet visualization system is shown in Figure 1.4
[20]. By analyzing the images captured by the cameras, droplet dispensing, trans-
portation, and mixing can be monitored. An example is shown in Figure 1.5 [20].
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Figure 1.4: Setup of droplet visualization system: two CCD cameras are fixed on
the biochip platform to get top view and side view of droplets [20].
One KCl droplet and one fluorescein droplet are mixed by repeating the splitting
and merging operations. The time-lapsed images obtained from the top view show
the procedure by which the fluorescein is diffused inside the droplet. Finally, the
fluorescein will be distributed homogeneously inside the merged droplet.
When the bioassay is being conducted, the control software compares the images
of the droplets in each intermediate step with the reference image of a fully-mixed
droplet. In this way, the control software can determine the extent to which the
mixing operation has approached completion [21]. In Chapter 2, we will show that
the droplet visualization system also can be used for automatic tracking of droplets
on biochips and for error detection.
Capacitive sensors
The upper and lower electrodes in each unit cell of the microfluidic biochip form
a parallel-plate capacitor. The capacitance associated with the pair of electrodes can
be measured by the resistor-capacitor (RC) circuit shown in Figure 1.6 [22]. Since
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Figure 1.5: Mixing of fluorescein and KCl droplets [21].
Figure 1.6: Circuit for capacitive sensing of biochip [22].
the droplet’s permittivity is different from that of the filler medium of the biochip,
the capacitance of a unit cell will change when a droplet is moved to it. In this way,
the movement of a droplet can be monitored.
Capacitive sensors can also be used to detect whether the droplet is contaminated
by particles. As shown in Figure 1.7 [23], a droplet may be contaminated by dust
particles or by another small droplet that contains a different reagent. A contaminat-
ing particle changes the capacitance of the droplet. This difference can be detected
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Figure 1.7: A droplet with particle contamination [23].
by capacitive sensors. The minimum radius of a contaminating particle that can be
detected by the capacitive sensor has been derived using theoretical calculations in
[23].
By using the experimental setup shown in Figure 1.8 [24], the relationship be-
tween the volume of droplet and the capacitance of a unit cell can be measured.
During the measurement procedure, liquid is injected from the top of an electrode
of the digital microfluidic biochip via a hole using a syringe pump. The flow rate
of injected liquid is set as a constant, hence the volume of the droplet can be cal-
culated based on the pumping time. By repeating the measurement procedures, the
relationship about the volume of the droplet and the capacitance of electrode pair
can be determined. Using this relationship and calibrated curve, during bioassay
execution, the precise location and volume of each droplet can be estimated based
on the feedback from capacitive sensors.
Photodetectors and optical sensing
Photodetectors can be used for sensing because they convert the intensity of
fluorescence of droplet on chip into electrical signals [25][26][27]. These electrical
signals can subsequently be used as the feedback to the control software of the
biochip.
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Figure 1.8: Experimental setup for measuring the relationship between the volume
of droplet and the capacitance of the unit cell [24].
1.2 Computer-aided design and optimization
In recent years, design automation methods for digital microfluidics have received
much attention [28][29][30][31]. In order to map an abstract representation of the
desired bioassay protocol, e.g., a sequencing graph, into a design implementation in
terms of fluidic handling operations, a unified synthesis tool for digital microfluidic-
based biochips is described in [32]. The inputs of the synthesis tool are the bioassay
protocol, constraints on the available resources on the biochip, and a library of
module that can implement fluidic operations; the outputs are a mapping of assay
operation to on-chip resources and a schedule for the fluidic steps.
The synthesis procedure proposed in [32] includes architectural-level synthesis and
geometry-level synthesis. Architectural-level synthesis can be viewed as the problem
of scheduling fluidic handling operations and binding them to a given number of
resources. On the other hand, geometry-level synthesis addresses the placement of
resources to satisfy area constraints. In order to get an optimized solution, the
parallel recombinative simulated annealing (PRSA) algorithm forms the core of the
synthesis procedure in [32].
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The PRSA-based algorithm for digital microfluidic biochips includes two parts:
(1) the random generation of a large number of feasible synthesis configurations for
the microfluidic biochips that satisfy all the resource and utilization constraints and
dependency between operations; (2) the use of the PRSA algorithm to select an opti-
mized synthesis configuration from these candidates. In this way, the tool can derive,
from a high-level specification, synthesis results that satisfy all the constraints related
to on-chip resources and minimize a given cost function under resource constraints.
Figure 1.9 illustrates the high-level synthesis flow.
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Figure 1.9: The high-level synthesis procedure [32].
A drawback of the synthesis procedure of [32] is that it does not consider droplet
routing. In some cases, the droplet transportation paths may all be blocked by other
modules on the biochip, and no feasible routing solution can be derived. To solve
this problem, the authors of [33] propose an improved PRSA-based synthesis algo-
rithm that considers the time of droplet transportation as a criterion during design
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optimization. This approach can improve the routability of the synthesis results,
even though it does not generate routing paths of droplets nor does it guarantee the
existence of a routing solution.
Several algorithms for determining optimized droplet routing paths are proposed
in [28][31][34][35]. In [28], droplet routing is modeled as a motion-planning problem
for multiple robots, and the A search technique is used to determine the shortest
routing path.
The electrical I/O interface for digital microfluidics poses challenges. If each
electrode is controlled by an independent pin and each pin has an input pad fabricated
on the chip, the area required for the biochip will be extremely large. Hence, the
fabrication cost will be high. In order to reduce the number of control pins and
to control the digital microfluidic array without significantly affecting concurrent
droplet operations, several design optimization techniques have been proposed and
analyzed in the literature [34; 36; 37; 38]. These methods reduce the number of
pins in two different ways. One way is to reduce the number of pins by designing
the biochip with some special structures. For example, in the n-bus-phase scheme,
every nth electrode is connected to the same control pin [36]. Another example is the
cross-referencing biochip proposed in [37]. For the cross-referencing (row-column)
scheme, the upper electrodes of all of the unit cells in the same row are connected
to the same control pin, and the lower electrodes of all of the unit cells in the same
column are connected to the same control pin. A different approach for reducing the
number of control pins is to exploit knowledge about the target bioassay and divide
the set of electrodes into groups based on the control signals that are applied on
them. Electrodes that have compatible signal sequences are connected to the same
pin [34; 38].
The above discussion has highlighted the design flow for digital microfluidic
biochips. This design flow includes four stages, namely 1) high-level synthesis, 2)
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Figure 1.10: Comparison between the conventional design flow and the chip-level
biochip design flow [39].
droplet routing, 3) the derivation of pin-assignment configuration, and 4) the deriva-
tion of the wire-routing solution. Figure 1.10(a) illustrates the overall design flow
[39]. “Fluidic-level synthesis” (which includes Stages 1 and 2), and “physical design”
(which includes Stages 3 and 4), are optimized separately.
An integrated design flow of a biochip, which aims at filling the gap between
fluidic-level synthesis and chip-level design, is proposed in [39]. The conventional and
proposed design flows in [39] are compared in Figure 1.10. In the synthesis stage,
the concepts of “synchronous reaction” and “device count aware scheduling” are in-
troduced. The reusability of modules can be improved and the number of control
pins required can be minimized [39]. Next, the modules that correspond to these
scheduled operations are placed on the biochip. Based on the device-count-aware
scheduling algorithm, the number of modules and the shapes of the modules are de-
termined. The placement of modules and the assignment of resources are determined
to minimize the transportation distances for the droplets. Electrodes are classified
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into three categories, i.e., bus, branch and device electrodes. The pin-assignment
methods and wire routing strategies for these three categories are different. For ex-
ample, the same types of devices that are used to implement synchronous operations
will share the same group of control pins. In this way, co-optimization for the syn-
thesis result of the bioassay, pin assignment configuration of the biochip, and metal
wire routing solution is achieved.
For biomedical applications such as clinical diagnostics, it is necessary to ensure
the accuracy of on-chip fluidic operations. The accuracy of fluid-handling operations
can be monitored by examining parameters such as the volume and concentration
of product droplets. If an error occurs during the execution of the bioassay, for
instance, the volume of an intermediate product droplet exceeds the normal value, the
assay outcomes can be incorrect and the whole experiment needs to be re-executed.
Therefore, it is important to detect such errors as early as possible and re-execute
the corresponding fluid-handling operations to obtain correct bioassay outcomes.
In [40], the authors proposed a conceptual mechanism to monitor the interme-
diate products of bioassay and implement error-recovery operations to minimize the
influence of error operations. A sequence of checkpoints is inserted into the initial
protocol of the bioassay. At these checkpoints, sensors are used to check the quality
of intermediate droplets. If the droplets fail to meet the quality requirements, the de-
tector sends an interrupt to the control software, and some fluid-handling operations
are re-executed. In this way, error recovery can be carried out automatically.
1.3 Thesis outline
This thesis research addresses a number of optimization problems related to cyber-
physical microfluidic biochips. The reminder of the thesis is organized as follows.
Chapter 2 presents a transformative cyberphysical approach towards achieving
closed-loop and sensor feedback-driven biochip operation under the program control.
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Section 2.1 presents the motivation for developing a “physical-aware” system recon-
figuration technique that uses sensor data at intermediate checkpoints to dynamically
reconfigure the biochip. Section 2.2 develops an algorithm for the measurement and
tracking of droplets based on real-time imaging data from a charge-coupled device
(CCD) camera. Section 2.3 introduces a reliability-driven error recovery strategy.
Section 2.4 presents the parallel recombinative simulated annealing (PRSA)-based
and greedy algorithms for reliability-driven synthesis. In Section 2.5, simulation re-
sults for three representative bioassays are discussed. Finally, conclusions are drawn
in Section 2.6.
A hardware-assisted error-recovery method that relies on an error dictionary for
rapid error recovery is presented in Chapter 3. The research motivation for the
hardware-assisted cyberphysical biochip is introduced in Section 3.1. The proposed
algorithm for creation of the error dictionary is presented in Section 3.2. Section 3.3
introduces the generation of actuation matrices corresponding to synthesis solutions
in the error dictionary. Section 3.4 describes the procedures for compaction of the
error dictionary. The implementation of dictionary-based error recovery on FPGA is
introduced in Section 3.5. A fault simulation method with consideration of parameter
variation in the fabrication process is discussed in Section 3.6. Simulation results are
shown in Section 3.7, and conclusions are presented in Section 3.8.
Chapter 4 presents the optimization algorithms for PCR on a cyberphysical dig-
ital microfluidic biochip. The working principle of the PCR biochip is introduced
in Section 4.1. Section 4.2 describes the statistical model for the amplification of
DNA strands and the on-line decision making method during an actual experiment.
Section 4.3 presents the layout design algorithm with the consideration of device
interferences. It also describes an application-specific reservoir allocation method.
Simulation results for three widely used bioassays are presented in Section 4.4. Sec-
tion 4.5 concludes the chapter.
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Chapter 5 describes the synthesis algorithm for bioassays under completion-time
uncertainties in fluidic operations. Section 5.1 discusses the drawbacks of previ-
ous uncertainty-oblivious methods of biochip design. Section 5.2 presents the de-
sign of microfluidic biochips with multiple clock frequencies. Section 5.3 introduces
the framework of operation-dependency-aware synthesis. Based on results derived
from the proposed synthesis algorithm, integrated on-line decision-making for droplet
transportation path is presented in Section 5.4. Simulation results are presented in
Section 5.5. Section 5.6 concludes the chapter.
The design procedure for a general-purpose microfluidic biochip is presented in
Chapter 6. Section 6.1 describes previously published pin-assignment algorithms
and their limitations. Section 6.2 presents an analysis of pin-actuation conflicts, and
derives the necessary and sufficient conditions for control-pin sharing to ensure high
flexibility in the concurrent movement of two droplets. Section 6.3 introduces an
integer linear programming model for designing a pin-assignment with the small-
est number of pins. Section 6.4 presents a graph-theoretic method to formulate an
acceptance test for a pin-assignment configuration and a lower bound on the num-
ber of pins. A heuristic algorithm that generates a pin-assignment configuration for
biochips is proposed in Section 6.4. Extension of the study from 1 volume droplets
to 2 and even larger droplets is presented in Section 6.5. Section 6.6 presents the
scheduling algorithm that can be applied to biochips with pin-constraints. Simula-
tion results for commercial biochips and experimental prototypes are discussed in
Section 6.7. Finally, conclusions are drawn in Section 6.8.
Based on the work discussed in Chapters 2-4 and Chapter 6, the concept of
pin-limited cyberphysical microfluidic biochip is proposed in Chapter 7. The struc-
ture and layout design of two-metal-layer biochips are introduced in Section 7.1. In
Section 7.2 the wire-routing solution for general-purpose pin-limited biochips is pro-
posed. The specific design flow for pin-limited cyberphysical biochips is discussed in
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Section 7.3. Results for several experimental bioassays are discussed in Section 7.4.
Finally, conclusions are drawn in Section 7.5.
Finally, Chapter 8 summarizes the contributions of the thesis and identifies di-
rections for future work.
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2Error Recovery in Cyberphysical Biochips
In this chapter, by exploiting recent advances in the integration of sensing system
in a digital microfluidics biochip, we present a “physical-aware” system reconfigu-
ration technique that uses sensor data at intermediate checkpoints to dynamically
reconfigure the biochip. A cyberphysical re-synthesis technique is used to recompute
electrode-actuation sequences, thereby deriving new schedules, module placement,
and droplet routing pathways, with minimum impact on the time-to-response.
The key contributions of this chapter are as follows:
• A charge-coupled device (CCD)-based sensing system for digital microfluidic
biochips (Section 2.2).
• An algorithm for the measurement and tracking of droplets based on real-time
imaging data from a CCD camera (Section 2.2).
• A reliability-driven error recovery strategy (Section 2.3).
• Parallel recombinative simulated annealing (PRSA)-based and greedy algo-
rithms for reliability-driven synthesis (Section 2.4).
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• Simulation results for three representative bioassays (Section 2.5).
2.1 Motivation and related prior work
The ease of reconfigurability and software-based control in digital microfluidics has
motivated research on various aspects of automated chip design and chip applica-
tion. A number of techniques have been published for architectural-level synthesis
[32], module placement, and droplet routing [31][41][42]. However, these techniques
ignore domain-specific constraints or practical realities that arise from attempting
to carry out biochemical reactions and microfluidic operations on an electronic chip.
Due to the randomness and complex component interactions that are ubiquitous in
biological/chemical processes, predictive modeling and accuracy control are difficult
[43; 44].
In addition to manufacturing defects and imperfections, faults may also arise
during bioassay execution. For example, excessive actuation voltage applied to an
electrode may lead to breakdown of electrodes and charge trapping, and DNA foul-
ing may lead to malfunction of multiple electrodes in the biochip [45][46][47]. These
faults are hard to detect a priori, but they occur often during bioassays [47]. Yet,
despite such inherent variability, many biomedical experiments, such as drug devel-
opment and clinical diagnostics, require fluid-handling operations that are highly
accurate and precise. Each step in the protocol of a biochemical experiment has
an “acceptance range” for the volume and concentration of droplets. For example,
in the preparation of samples of plasmid DNA, the pH of the solution must be less
than 8.0 to avoid a significant reduction in the efficiency of the lysozyme [48]. If an
unexpected error occurs during the experiment and the requirements of the bioas-
say protocol are violated, the outcome of the entire experiment will be incorrect.
When this occurs, all the steps of the experiment must be repeated to correct the
error [40][49]. Repetition of experiments leads to wastage of expensive reagents and
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hard-to-obtain samples.
The repetitive execution of on-chip laboratory experiments leads to the following
problems: (i) wastage of samples that are difficult to obtain or prepare, and the
wastage of expensive reagents; (ii) an increase in the time-to-result for a bioassay,
which is detrimental to real-time detection and rapid response. Therefore, it is
necessary to develop techniques for monitoring assay outcomes at intermediate stages
and design an efficient error-recovery mechanism.
Error recovery in digital microfluidics has received relatively little attention in the
literature. The only reported work is [40], which proposed intermediate stage mon-
itoring and rollback error-recovery for a microfluidic biochip. The key idea in this
work is to use sensing system to verify the correctness of immediate product droplets
at various steps in the on-chip experiment. Sensors has been integrated with digital
microfluidics to evaluate the concentration and volume of product droplets [1]. In
the recent approach described in [40], error recovery is carried out as follows. During
bioassay execution, intermediate product droplets are sent to sensors. When an error
is detected at a sensor, i.e., the volume or concentration of the droplet is below or
above the acceptable calibrated range, the corresponding droplet is discarded. The
operations whose outputs fail to meet the quality requirements based on sensor cali-
bration are re-executed to generate a new product droplet to replace the unqualified
droplet.
Figure 2.1 shows an example of rollback error-recovery. The initial sequencing
graph of a bioassay is shown in Figure 2.1(a). Here we assume that the outputs of
each dispensing, mixing and splitting operation are evaluated by a sensor. When an
error occurs at operation 9, the system will re-execute the corresponding dispensing
and mixing operations. The new sequencing graph for error recovery is shown in
Figure 2.1(b). Operations 12, 13, and 14 are added for error recovery.
In the absence of “physical-aware” control software, the error recovery method
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(a) (b)
Figure 2.1: (a) Initial sequencing graph; (b) operations 12, 13, and 14 are added
for error recovery.
in [40] suffers from following drawbacks:
1. The first drawback is the over-simplification of fault detection and the asso-
ciated assumptions. Using a uniform “expected value” for the calibration of
each detection operation is not practical. Note that at various stages during
bioassay execution, the concentration of intermediate product droplets vary in
a dynamic manner, hence the calibration also needs to be repeated and carried
out dynamically.
2. In [40], all recovery operations are carried out in a stand-alone manner. When
an error is detected, all other ongoing bioassay-related fluidic operations are in-
terrupted. The potential long waiting times introduced by recovery operations
can lead to sample degradation and erroneous assay outcomes [50]. Some oper-
ations, such as colorimetric enzyme-kinetic reactions, require precise durations
as specified by the reaction protocol, and they cannot be extended without
introducing unpredictability in the experiment outcome [26].
3. The error recovery approach in [40] cannot handle situations when multiple
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Figure 2.2: The schematic of the cyberphysical digital microfluidic system.
errors occur during a bioassay. For example, it assumes that all error recovery
operations will be executed successfully and it does not consider the likelihood
that errors can also occur during recovery.
4. The error recovery strategy in [40] does not consider reliability issues. Errors
such as the generation of droplets with abnormal volumes are usually caused by
the accumulation of charge on the surface of certain electrodes [45][46]. If the
use of such electrodes is continued, it is likely that they will introduce more
errors [45][46]. Thus, in order to ensure the reliability of biochips, we must
minimize the utilization of these electrodes.
To overcome the above drawbacks, we take a transformative “cyberphysical” ap-
proach towards achieving closed-loop and sensor feedback-driven biochip operation
under program control. By exploiting recent advances in the integration of sensing
system in a digital microfluidics biochip [27], we present a “physical-aware” sys-
tem reconfiguration technique that uses sensor data at intermediate checkpoints to
dynamically reconfigure the biochip [51].
2.2 Overview of cyberphysical biochips
In this section, we introduce propose cyberphysical system on microfluidic biochips
and introduce each component of the system. With the availability of sensing sys-
tem for biochips, “physical-aware” control software becomes feasible. By “physical-
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Figure 2.3: Illustration of a digital microfluidics-based image processing system
[52].
aware”, we refer to the fact that the software can receive information about the
outcome (error-free/erroneous) of fluid-handling operations based on feedback from
the sensing system. Depending on sensor feedback, the control software can appro-
priately reconfigure the microfluidic biochip. In this way, the various steps in the
bioassay are executed based upon real-time sensing of intermediate results.
Figure 2.2 depicts each component of a cyberphysical system on the microfluidic
platform. The control software sends a control signal to the microfluidic biochip,
and the on-chip sensing system monitors the outcomes of fluidic operations. The
outcomes are compared with the “expected values”, i.e., the pre-determined thresh-
olds. If the results of the comparison indicate that an error has occurred, the control
software receives a “repeat request”, and the corresponding operation in which the
error occurred can be executed again, thereby correcting the error.
2.2.1 Sensing systems
As described in Chapter 1, CCD cameras can be used in experiments to view the
top sides of droplets simultaneously. An example of the CCD monitoring system is
shown in Figure 2.3.
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Based on images captured by the CCD camera, droplets can be automatically lo-
cated by the control software. The procedure of automatically searching for droplets
can be described as a “template matching” problem. Here a pattern can be repre-
sented as the image of a “typical” droplet. During the matching process, we move
the template image to all possible positions in the image of the entire array and crop
a sub-image that has the same size as the template image. Then the control software
computes the correlation index, which indicates the similarity between the template
and the “cropped image”. This process is shown in Figure 2.4(a) and the correlation
factor is calculated on a pixel-by-pixel basis.
In the control software, all images are stored in grayscale form, which can be
encoded as matrices or vectors. Suppose the template image is represented in a 1-D
array: ~x = px1, x2, ...xNq. Here xi represents the gravel level of a pixel and N is the
total number of pixels in the template image. Similarly, the cropped sub-image to
be compared with the template image can be written as ~y = py1, y2, ...yNq. Thus the
correlation factor between these two images is defined as:
cor 
N°
i1
pxi  x¯q  pyi  y¯qd
N°
i1
pxi  x¯q2 
N°
i1
pyi  y¯q2
,
where x¯ and y¯ are the average gray level in the template image and cropped sub-
image, respectively. The range of correlation factor cor is a real number between
1 and  1. According to the definition of correlation, a larger value represents a
stronger relationship between two images.
After deriving the correlation factors for all possible positions in the image for
the complete biochip, we obtain the correlation map between the template and the
original input image. Suppose there are κ droplets on the biochip. By searching
for the largest κ correlation factors in the correlation map, the locations of droplets
can be determined. An example is shown in Figure 2.4(b) and (c) [53]. Part (b)
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Figure 2.4: (a) The matching process moves the template image to all possible
positions in a larger source image and computes a numerical index that indicates how
well the template matches the sub-image in that position; (b) the image of the whole
biochip [53] and the pattern we selected; (c) the correlation map between image
of the whole array and the pattern. The positions of droplets can be determined
by finding κ maximum elements (κ is the number of droplets on the chip) in the
correlation map.
shows the original input image of the whole chip and the pattern image, and (c) is
the correlation map, where the best matching locations, i.e. the coordinations of
droplets derived by the control software are (77, 107), (77, 147) and (76, 208). Thus
the control software automatically locates the droplets, and it can further analyze
the sizes and colors of droplets according to the image. In this manner, the volumes
and concentrations of droplets can be acquired after processing the image taken by
the CCD camera.
Instead of searching for droplets in the complete image, we use imaging to check
whether the droplets have been moved to the expected positions. This is implemented
using the following steps:
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First, we do some calibration before the experiment. We choose a large number of
sub-images with (or without) droplets, and calculate their correlation with the tem-
plate. Based on this calculation, we find an appropriate threshold for the correlation
index (Cth): if the correlation is larger than Cth, we conclude that there is a droplet
in the cropped sub-image; otherwise, there is no droplet in the sub-image. When the
bioassay is running, we only need to crop the sub-images near the expected positions
of droplets, and calculate their corresponding correlation indices to determine the
absence/presence of droplets.
The advantages of the CCD camera-based sensing system are: (i) the detection of
errors immediately after they occur and (ii) the identification of the precise locations
of the errors. A disadvantage of this system is that extra instruments, such as CCD
cameras, are required to observe the cyberphysical system.
2.2.2 “Physical-aware” software
The availability of on-chip sensors provides digital microfluidic biochips with the
capability of using sensor data at intermediate checkpoints to detect errors, thereby
minimizing the impact of errors that occur during bioassay execution. The work
in [40] proposed intermediate stage monitoring and rollback error-recovery for a
microfluidic biochip. The key idea in this work is using the sensing system on-chip to
verify the correctness of output droplets at various steps in the on-chip experiment.
In this approach, error recovery is carried out as follows. When an error is detected
at a checkpoint, operations whose outputs failed to meet the quality requirements
based on sensor calibration are re-executed to recover from the error. Additional
intermediate product droplets must be stored in specially designated locations of
the chips to facilitate recovery. Additional droplets of samples and reagents must
also be dispensed from reservoirs for error recovery. The details of the strategy for
reliability-driven error recovery are presented in Section 2.3, and the algorithm for
dynamic re-synthesis of error recovery is described in Section 2.4.
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Figure 2.5: The schematic of the cyberphysical digital microfluidic system. Soft-
ware running on the computer and the biochip are coupled by a field-programmable
gate array (or a single-board microcontroller) and peripheral circuit.
2.2.3 Interfaces between biochip and control software
We next describe the cyberphysical coupling between the control software and the
hardware of the microfluidic platform. There are two interfaces needed for cyber-
physical coupling. The first interface converts the output signals from the sensing
system to the inputs of the desktop computer that the control software can interpret.
The second interface converts the output data generated by the control software to
voltage signals that can be directly applied to the electrodes of the biochip.
A schematic representation of the cyberphysical system is shown in Figure 2.5.
The system consists of a computer, a single-board microcontroller, a peripheral cir-
cuit, and the biochip. During the execution of a bioassay, the software running on
the computer sends control signals to the biochip. At the same time, the software
receives feedback from the sensing system on the biochip through the single-board
microcontroller. The control software recomputes the schedule of fluidic operations,
module placement, and droplet pathways depending on sensor feedback. This pro-
cess is referred to as reconfiguration and the key idea is to use an on-chip sensing
system for concurrent monitoring of experiments. When an error is detected by
on-chip sensors, error propagation is prevented by the immediate discarding of the
abnormal droplet. The biochip implements error-recovery operations in subsequent
30
cycles.
The closed-loop integration in cyberphysical microfluidics can also be used to
control the completion time of bioassays. For example, in the measurement of glu-
cose in blood, serum samples need to be well-mixed with an enzymatic reagent [54].
During the mixing procedure, the status of the droplet is monitored by an image sen-
sor. The extent to which mixing has been completed can be quantified by analyzing
images for the droplet. Therefore, the control software will force the biochip to con-
tinue mixing until the feedback information shows that the droplets are sufficiently
well-mixed. Hence the mixing operation can be precisely controlled without knowing
the precise mixer execution time in advance, and the on-chip measurement results
for glucose concentration can be as precise as the results derived by a traditional
bench-top analyzer used by a laboratory technician [54].
2.3 Reliability-driven error recovery
2.3.1 Error recovery strategies
In this subsection, we formulate the principles underlying error recovery. For the
given bioassay protocol, we use the sensing system on-chip to evaluate the quality of
output droplets of each dispensing, mixing, dilution and splitting operation. Accord-
ing to the data provided by [1], the response time of on-chip sensors are in the scale
of picoseconds or nanoseconds. Thus the time cost for adding detection operations
is negligible.
For a microfluidic biochip, fluid-handling operations can be divided into two
categories: reversible and nonreversible operations. Reversible operations include
dispensing and splitting operations; nonreversible operations include mixing and
dilution operations. For errors that occur at reversible operations, their recovery
processes are relative simple. In a splitting operation, if two droplets with unbal-
anced volumes are generated, then the biochip will first merge the two abnormal
droplets to a larger one and then split the larger droplet again. For errors that oc-
cur at a dispensing operation, the chip can send the abnormal droplet back to the
corresponding reservoir and dispense another droplet. Thus for errors that occur at
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(a) (b)
Figure 2.6: (a) An example of a sequencing graph corresponding to a bioassay
protocol; (b) the layout of a biochip with reserved area for error recovery.
reversible operations, the time cost for recovery is small and no additional droplets
need to be consumed.
The error recovery process for nonreversible operations is more involved. To
implement the corresponding nonreversible operations to correct the error, we also
need input droplets from operations whose outputs feed the inputs of the failed
operation. Thus we may need to re-execute all the predecessors of the erroneous
operation. For instance, if an error occurs at operation 7 in Figure 2.6(a), operations
1, 2, 3, 4, 5, and 6 may need to be re-executed. Thus the time cost for executing
error recovery operations can be extremely high. To reduce the incidence of the worst
case, the following strategies are taken in our approach:
 For a splitting operation, if only one of its output droplets is used as the
input for the immediate successors, we store the other (redundant) droplet as a
backup for possible error recovery at a subsequent stage. For example, operation 7
in Figure 2.6(a) is a splitting operation and it generates two output droplets. Only
one of these two droplets is used as the input of operation 9. (Note here each circle in
the sequencing graph stands for a fluid-handling operation. The unused droplets are
not shown in the sequencing graph.) If an error occurs at operation 9, the redundant
droplet will be used as an input for re-execution.
 All dispensing operations are scheduled for execution as early as possible and
their output droplets are stored on the biochip. We also dispense some droplets as
backup for possible error recovery operations. When the bioassay is completed, those
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unused backup droplets are sent back to the corresponding reservoirs.
Thus, when an error occurs at a nonreversible operation, the control software
first checks whether the inputs of this operation can be provided by backup droplets
stored on chip. If the answer is yes, then the time cost for this operation can be
reduced. Otherwise, more operations will be executed during error recovery. Based
on the above discussion, the operations in the sequencing graph can be divided into
three categories according to the number of operations and droplet consumptions in
their error recovery processes, as shown in Figure 2.6(a).
The above operations can be formally categorized as follows:
Category I: This is the set of all reversible operations. They can be simply re-
executed when an error occurs.
Category II: This is the set of nonreversible operations for which immediate pre-
decessors can provide backup droplets.
Category III: This corresponds to the set of nonreversible operations for which
their immediate predecessors cannot provide backup droplets.
In a given sequencing graph, each node represents an operation. We define the
number of input droplets as the in-number of an operation, and the number of output
droplets as the out-number of an operation. As described below, any operation optk
can be categorized based on its in-number and out-number values:
• If in-number of optk is equal to zero, then optk is a dispensing operation. Thus
we have: optk P Category I.
• If in-number of optk is equal to one and the out-number of optk is equal to two,
then optk is a splitting operation. Thus we have: optk P Category I.
• Suppose optj is an immediate predecessor of optk. Then the number of backup
droplets at the output of optj can be calculated as: Boptj  ONjMNj, where
ONj is out-number of optj, and MNj is the number of immediate successors of
optj. If the numbers of backup droplets for optk’s immediate predecessors are
all non-zero, then we have: optk P Category II; otherwise, optk P Category III.
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For an operation opti, the set of its error recovery operations, Ri, can be derived
according to the categorization result for opti. Operations in Category I and II can
be simply re-executed when an error occurs because their input droplets are stored
on chip. However, for operations in Category III, their inputs come from the outputs
of predecessor operations and we do not have backup for these droplets. Thus if
an error occurs in an operation of Category III, we not only need to re-execute the
operation itself but also need to backtrace to its predecessors. Suppose the error
operations is opte and its immediate predecessors are operation optp1 and optp2 . If
these immediate predecessors are operations in Category I or Category II, we can first
re-execute optp1 , optp2 and then opte for error recovery, thus Ri  toptp1 , optp2 , opteu.
If the immediate predecessors optp1 and optp2 are neither in Category I nor Category
II, we have to continue enlarging Ri by adding the immediate predecessors of optp1
and optp2 into Ri. This backtracing and enlargement procedure needs to be repeated
until we reach predecessor operations that can provide backup droplets to feed the
inputs of operations in the set of error operations.
The above procedure of backtracing and enlargement of the set Ri can be de-
scribed as follows. First, we define the mapping predpoptiq to be a mapping from
opti to the set of immediate predecessors of opti in the sequencing graph.
For a set of operations O  topto1 , opto2 , ...optoku, we define the operator Pr as:
Pr : O Ñ
¤
io1,o2,...ok
{opti, optj|optj P predpoptiq, @ j}
where Pr is a backtracing operation. For any operation opti, its set of error recovery
operations Ri can be derived by the procedure presented in Figure 2.7. According to
above discussion, we can derive the set of recovery operations Ri for any operation
opti.
Based on the relationship between operations in the initial sequencing graph, we
can further add edges between operations in the set Ri, and thus derive the error
recovery graph GRei for opti. If an error occurs in opti, we will re-execute operations
in GRei for error recovery.
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1: Classify operations into Category I, Category II and Category
III;
2: Initialization of Ri: Ri  opti;
3: Initialization of intermediate variable Re: Re  PrpRiq;
4: while pReRiq X {Set of operations in Category III}  ø do
5: Update Ri: Ri  PrpRiq;
6: Update Re: Re  PrpRiq;
7: end while
8: Ri  Re;
9: Ri is the set of recovery operation for opti;
Figure 2.7: Pseudocode for determining the recovery operation for opti.
It is important to note that some electrodes on the biochip are intentionally
left unused and reserved for storage of backup droplets. An example is shown in
Figure 2.6(b); all electrodes on the boundary of the chip are used as storage cells.
Thus backup droplets can be easily transported on the biochip.
2.3.2 Reliability consideration in error recovery
When an error is detected during the execution of a bioassay, simply re-executing
the operation for which an error occurred is not efficient to ensure reliable operation.
This is because the errors that occur during the execution of a bioassay usually
are caused by defects involving electrodes; thus, multiple errors may occur in the
same region of the biochip at different times. Two examples are provided below to
illustrate the errors caused by the charge-trapping phenomenon and DNA fouling.
When the electrodes of a digital microfluidic biochip are actuated excessively,
physically-trapped charge and residual charge may lead to reliability problems [46][45].
Charge trapping is a phenomenon in which charge is trapped and concentrated in
the dielectric insulator of the chip. It can lead to a reduction in the electrowetting
force and malfunctions in the execution of the bioassay. An example is shown in
Figure 2.8(a).
Suppose Electrode 1 has a trapped charge in its dielectric insulator layer, while
Electrode 2 and 3 do not suffer from charge sharing. In order to implement a splitting
operation, high voltages are applied on Electrode 1 and Electrode 3. However, the
charge trapped on Electrode 1 will reduce the electrowetting force. The droplet
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(a) (b)
(c)
Figure 2.8: (a) An error caused by the phenomenon of charge trapping; (b) splitting
operation with droplets with unbalanced volumes; (c) an error caused by DNA fouling
on the surface of a biochip.
will be split by unequal forces, and the two resulting droplets may have unequal
volumes; see Figure 2.8(b). If we simply re-execute the splitting operation and
continue to use Electrode 1, additional errors may result. Even worse, the charge-
trapping phenomenon eventually may cause permanent dielectric degradation of the
electrode [46][45]. Thus, once an error is detected, the electrode at which the error
occurred must no longer be used to implement fluid-handling operations in order to
ensure the reliability of the biochip.
When droplets contain macromolecules, such as DNA, they may foul the surface
of the electrodes [55]. As a result, droplet concentration can change in undesirable
ways. If we continue to use these contaminated electrodes, other droplets may also
be contaminated. An example of this is shown in Figure 2.8(c). The region where
DNA fouling occurred is used as part of a mixer, and the concentrations of the output
droplets of the mixing operation may be abnormal.
We use a simple strategy to ensure a reliability-driven error recovery. When an
error is detected, we update the execution of the bioassay as follows:
• The operation with error is re-executed.
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• The electrodes that may lead to errors will not be used in other operations.
Note that for each operation, the on-chip resources occupied by it are all
recorded by the control software. Thus depending on the error droplet, it
is easy to backtrace to the region where error occurs. We consider all elec-
trodes in this region as the possible locations for defects. These electrodes will
therefore be discarded.
2.4 Error recovery and dynamic re-synthesis
With the availability of hardware that can send feedback to the control software, it is
now necessary to design physical-aware software that can analyze sensor data and dy-
namically adapt to it. Adaptations include updates for the schedule of fluid-handling
operations, resource binding, module placement, and droplet routing pathways.
The task of the control software includes two phases: the first phase is off-line
data preparation before the execution of bioassay and the second phase is on-line
monitoring for the fluid-handling operations as well as dynamic re-synthesis of the
bioassay. Details are presented below.
2.4.1 Off-line data preparation before bioassay execution
The first step in data preparation is to convert the sequencing graph of the bioassay
to a directed acyclic graph (DAG) and store it in memory for use by the control
software. In this DAG, the vertices represent microfluidic handling operations and
the edges represent precedence relations between operations. The predecessors and
successors of any operation can be determined by performing depth-first search on
the graph [56].
The second step in data preparation is to assign error thresholds for each op-
eration. These thresholds are determined by the requirement of precision for the
bioassay and they are stored as a table in memory for use by the control software.
During bioassay execution, if a detection result is outside the range of pre-assigned
threshold values, we conclude that an error has occurred at the corresponding oper-
ation.
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Table 2.1: Synthesis results for the bioassay shown in Figure 2.1(a).
Operation Start time Stop time Resource Location
Mix 1 6 12 32 mixer (2, 6)
Mix 2 0 6 23 mixer (2, 5)
Mix 3 0 10 22 mixer (6, 2)
Mix 4 12 15 44 mixer (4, 6)
Mix 5 15 18 42 mixer (4, 6)
The last step in data preparation is the initial synthesis step for the bioassay. In
this procedure, we map the sequencing graph of the bioassay and on-chip resources
to the scheduling, resource binding, module placement, and droplet routing results
for each operation.
For a sequencing graph consisting of n operations, the synthesis result can be
written as the following set:
S  tMopt1 , Mopt2 , ...Moptnu
where Mopti , 1 ¤ i ¤ n, is the synthesis output for the ith operation opti. The
element Mopti can be viewed as an ordered 6-tuple:
Mopti    tspoptiq, tepoptiq, xpoptiq, ypoptiq, colpoptiq, rowpoptiq ¡
where ts and te are the start time and end time of the operation, respectively; x and y
are the x-coordinate and y-coordinate for the module that implements the operation;
col and row are the number of columns and rows occupied by the operation in the
array.
For an arbitrary operation opti, the order of elements in the tuple M

opti
is defined.
Thus we can useMoptiprjq to represent the rjth element in the tupleMopti . For example,
the start time of ith operation can be written as Moptip1q, the x-coordinate of ith
operation can be written as Moptip3q, and the number of columns occupied by opti
can be written as Moptip5q.
For simplicity, we write the set of all operations in the bioassay as P ; and we use
C to refer to the set of constraints that S must satisfy, which include:
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1. For any pair of operations optw and optv, if the two open intervals pMoptwp1q,Moptwp2qq
and pMoptvp1q,Moptvp2qq overlap, i.e.,
pMoptwp1q,Moptwp2qq X pMoptvp1q,Moptvp2qq  H,
which implies that operations optw and optv are implemented concurrently. It
is important to note that multiple operations cannot share on-chip resources
(including electrodes and dispensing ports) at the same time. Thus optw and
optv must satisfy following constraint:
pMoptwp3q,Moptwp3q  Moptwp5qq X pMoptvp3q,Moptvp3q  Moptvp5qq  H,¤
pMoptwp4q,Moptwp4q  Moptwp6qq X pMoptvp4q,Moptvp4q  Moptvp6qq  H,
i.e., their corresponding modules cannot overlap with each other.
2. For any pair of operations optw and optv, if optw is the predecessor of optv, then
optw must be completed earlier than the start time of optv, i.e. M

optvp1q ¥
Moptw(2).
The completion time of the bioassay can be written as:
Cp  Max
optiPP
tMoptip2qu
Thus the synthesis of the biochip can be viewed as an optimization problem.
The inputs are the set of operations P and the set of constraints C. The target
is:
minimize: Max
optiPP
tMoptip2qu
Previously published CAD methods for digital microfluidic biochip have proposed
several algorithms to solve this optimization problem. For example, the PRSA-based
synthesis algorithms can be used to quickly derive optimized synthesis results [57].
After the optimized synthesis results are derived, the off-line data preparation
step is completed. The bioassay is next executed according to the initial synthesis
result, and the next step is the on-line monitoring of droplets.
39
1: Derive the graph Goriginal by deleting edges between the erroneous operation
and its immediate predecessors in original sequencing graph;
2: Derive the error recovery graph GRei for opti;
3: Copy GRei and label the nodes with different names;
4: Derive the union graph for GRei and Goriginal;
Figure 2.9: Pseudocode for adjustment of the sequencing graph.
2.4.2 On-line monitoring of droplets and re-synthesis of the bioassay
During the execution of the bioassay, the control software must implement the fol-
lowing steps.
Step 1: Error Identification
For the CCD camera-based sensing system, the software can carry out a real-time
monitoring of all droplets on the biochip. The colors and diameters of the droplets are
detected simultaneously by the CCD camera and evaluated for comparisons. Thus,
error recovery is triggered as soon as an error occurs.
Step 2: Update of Sequencing Graph
When an error occurs, the control software determines the required recovery
operations. According to the above discussion, if an error occurs during a reversible
operation, the recovery process is simple. For non-reversible operations, the control
software must search the preceding operations until it finds an operation that can
provide backup droplets to feed the inputs of the recovery subroutine. As mentioned
above, when an error occurs during the implementation of operations, the software
will adjust the sequencing of the bioassay according to the category of operation. The
pseudocode for the adjustment of the sequencing graph is shown in Figure 2.9. The
definition of error recovery graphGRei for operation opti can be found in Section 2.3.1.
The update of the sequencing graph for errors that occur during the operations of
Categories I, II, and III are shown in Figure 2.10. The categorization of operations
can be found in Section 2.3.1.
It is important to note that, for some operations, the recovery subroutines may
change depending on the error. For example, operation 7 in Figure 2.6(a) generates
two droplets; one of them is used in the subsequent reaction and the other is stored on
chip as the “backup droplet”. If a single error occurs at operation 14, the biochip will
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Figure 2.10: Update of the sequencing graph corresponding to error operations of
Categories (a) I; (b) II; and (c) III.
re-execute operations 8, 9, 10 and 12. However, if an error occurs at a predecessor of
operation 14, the recovery subroutine for operation 14 will be different. For example,
when an error occurs at operation 9, the backup droplet of operation 7 will be used as
the input for error recovery. If another error occurs afterwards at operation 14, there
is no more backup droplet available at the output of operation 7. Thus the recovery
subroutine of operation 14 has to be expanded and it will now include operation 1,
2, 3, 4, 5, 6, 7, 8, 9, 10, and 12. Therefore the recovery steps are completely different
from the case when an error occurs at operation 14.
After the recovery subroutine of an operation is determined, the control software
will update the sequencing graph and the corresponding DAG, and then the dynamic
re-synthesis step will be implemented.
Step 3: Dynamic Re-synthesis
In the cyberphysical system envisioned here, when an error is detected at a check-
point, it will trigger the generation of a new mapping of the remaining steps (includ-
ing proper handling of intermediate results) of the bioassay. This process is referred
to here as re-synthesis, on the basis of the initial design obtained from the a priori
synthesis step. The requirements for the process of re-synthesis are:
• The interruption of other operations should be avoided. Consider the following
example. For the bioassay with synthesis results shown in Table 2.1, suppose
an error recovery process is triggered by an error in operation Mix 3 at time
instance 10. When the error recovery process is triggered, operation Mix 1 is
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being implemented. In order to avoid the interruption of Mix 1, in the new
synthesis results, the schedule and resource assignment results for Mix 1 should
be the same as in the inial synthesis results.
• The electrodes at which an error has been deemed to have occurred should be
bypassed in the new synthesis results.
• The completion time of the bioassay should be optimized.
To satisfy these requirements, we propose two re-synthesis strategies for dynamic
re-synthesis. The first strategy is based on a local greedy algorithm, and the second
is a PRSA-based, global optimization algorithm [32].
For the greedy algorithm, the first step is to determine all operations that must
be adjusted in the re-synthesis result. These operations include the operations in the
error recovery graph, the erroneous operation, and the set of subsequent operations
that will be implemented on electrodes with defects in the initial synthesis result.
Other operations will be executed based on the initial synthesis result.
Since the synthesis results for part of the operations are fixed, dynamic re-
synthesis on the microfluidic array can be modeled as the module placement with
obstacles problem. Here the operations that are implemented based on the initial
synthesis result are fixed a priori as the “obstacles” while the other operations that
are necessary for recovery are derived through re-synthesis and placed in the re-
maining available chip area in a greedy fashion. The detailed steps are described
below.
First the control software places all operations that need to be re-scheduled in
a priority queue based on topological sort. These operations include error recovery
operations and all successors of the erroneous operation. Then the software assigns
a priority for each operation in the queue. The “deepest” operation in the subrou-
tine (i.e., the operation at the bottom of the list generated by topological sort) is
assigned the lowest priority while the “shallowest” (at the top of the list produced
by topological sort) operation is assigned the highest priority in the queue.
Next the control software needs to allocate on-chip resources to these operations.
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Here our on-chip resource set R changes with time t. The control software will search
for available resources at the current time for the operation with the highest priority.
For example, if the operation with the highest priority is a mixing operation, then
the system will search for an available m  n cell array that is not occupied from
current time t to t+4t. Here4t is the time needed for the operation in the mn cell
array. If suitable idle resources are available, resource binding will be successful and
the start time of the operation will be deemed to be the current time. Otherwise, the
operation has to be delayed until there are available resources. If multiple resources
are available at the same time, the control software will randomly choose one and
bind it to the corresponding operation. After resource binding and start/stop time
of the operation are determined, the operation will be removed from the priority
queue.
Note that the above steps can also be used to generate re-synthesis results, when
multiple errors are detected at the same time. In this situation, multiple recovery
processes are triggered at the same time and the control software generates a priority
queue for each recovery process. After these priority queues merged, the control
software assigns a priority for each element based on topological sort. Finally, the
control software determines new synthesis results for every operation in the merged
priority queue.
For a microfluidic biochip with an M  N electrode array and P dispensing
ports, the computational complexity of searching for available resources (i.e. “the
maximum empty rectangle”) in this re-synthesis algorithm is O(MN   P ). Since
we can view the number of dispensing ports as being constant and we are interested
in algorithm scalability for large arrays, the worst-case complexity is O(MN). This
is because the software will exhaustively search each electrode/dispensing port in
the array and check whether it is available. The computational complexity for other
parts of the algorithm are all O(1). Hence the overall computational complexity of
the re-synthesis algorithm is O(MN). The pseudocode for the re-synthesis procedure
is shown in Figure 2.11.
An example of re-synthesis is shown in Figure 2.12. Figure 2.12(a) shows the
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1: Localize the fault operation according to feedback at checkpoints;
2: Determine the operations which need to be adjusted and store them into a
priority queue Q;
3: Delete all initial synthesis results for operations in Q;
4: while Q  H do
5: Search available resource for operation q0 which has the highest priority in
Q;
6: Remove q0 from Q;
7: end while
Figure 2.11: Pseudocode for dynamic re-synthesis of the bioassay.
schedule corresponding to the sequencing graphs in Figure 2.1(a). Figure 2.12(b)
and Figure 2.12(c) both show the schedules corresponding to the sequencing graph
in Figure 2.1(b). For the sake of clarity, we only show the schedule for mixing
operations. Here Figure 2.12(b) is the schedule obtained using the error-recovery
algorithm of From Figure 2.12(b), we can see that mixing operation Mix 1 is halted
for 10 time slots when error recovery operations are executed. The completion time
of the bioassay shown in Figure 2.12(a) is increased from 18 time slots to 28 time 18
time slots to 28 time slots, which can be unacceptable for many applications. The
dynamic scheduling result corresponding to Figure 2.1(b) is shown in Figure 2.12(c).
When the error is detected at the output of Mix 3 at time 10, the Mix 3 at time 10,
the ongoing operation Mix 1 is executed based on the initial synthesis result. We
assume that the computing time to generate the new synthesis result is 1 time slot.
In practice, computation time is at least an order of magnitude less than the fluidic
operation time. Then at time 11, the control software will generate new synthesis
result based on the updated Figure 2.1(b). As shown in Figure 2.12(c), Mix 1 is
completed at time 12 without being interrupted and the being interrupted and the
experiment is finished at time 18. Thus the bioassay is executed “seamlessly” without
any time penalty or interruption of other operations.
The re-synthesis problem can also be solved using the PRSA-based global opti-
mization method from [32]. The inputs and constraints of the re-synthesis problem
are different from the initial synthesis problem introduced in Section 2.3.1. Suppose
the set of operation for the re-synthesis problem is P 1 and the set of constraints is
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(b)
(c)
Figure 2.12: (a) Scheduling result when no error occurs; (b) scheduling when
an error occurs in Mix 3. Mix 1 is halted when error operations are executed; (c)
scheduling when an error occurs in Mix 3. Here dynamic synthesis strategy is applied
at time 10 and error recovery operations begin at time 11.
C 1. We can derive P 1 and C 1 based on P and C introduced in Section 2.3.
We first define a operator T on the set P . T is a mapping from the set of all
operations to the set of operations that have already started at time instant t.
T ptq : P Ñ Pptq  topti|Moptip1q ¤ tu
When an error is detected at time instant t in operation opti, the set of operations
that need to be re-synthesized can be written as P 1 = PYRiY rOPptq. Here Ri is
the set of recovery operations corresponding to erroneous operation opti, and rO is the
set of subsequently operations which will be implemented on electrodes with defect
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in the initial synthesis result. The method for determining the operations in Ri is
introduced in Section 2.4.1. Then according to the module placement information
included in initial synthesis result, and locations of electrodes with defects, operations
in rO can be determined.
We write the new synthesis results for opti P P 1 as M 1opti . In addition to the set
of constraints C, the new synthesis must satisfy the constraint that the region where
an error has been deemed to have occurred cannot be used any more.
The optimization problem for re-synthesis process can be written as:
minimize: Max
optiPP 1
tM 1optip2qu
The above optimization problem can be solved by using the PRSA-based synthesis
procedure introduced in [32]. Using this method, we can derive globally-optimized
synthesis results with short assay completion time, but the CPU time is high of the
order of 20 minute for a typical bioassay [40]. Thus, this method is not suitable for
on-line computation of re-synthesis results.
2.5 Simulation results
In this section, we evaluate the re-synthesis approach for error recovery on representa-
tive bioassays that are especially prone to fluidic errors. We compare the completion
time for the two sensing schemes; and the re-synthesis results derived by the greedy
algorithm and the PRSA-based global optimization algorithm.
2.5.1 Preparation of plasmid DNA
First, we simulate the bioassay that is called “preparation of plasmid DNA by alka-
linelysis with SDS-minipreparation” [51][58]. During sample preparation, a mixture
of three reagents is required. The three reagents are:
 R1: Alkaline lysis Solution I (50 mM Glucose,25 mM Tris-HCl (pH 8.0), 10 mM
EDTA (pH 8.0)).
 R2: Alkaline lysis Solution II (0.2 N NaOH, 1% SDS (w/v)).
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Figure 2.13: Sequencing graph for sample preparation of plasmid DNA.
 R3: Alkaline lysis Solution III (5 M sodium acetate, glacial acetic acid).
The required concentration of the mixture is 0.22% of R1, 0.44% of R2, and
0.34% of R3, which can be approximated to
28
128
of R1,
56
128
of R2, and
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128
of R3.
The sequencing graph to get the required concentration by mixing R1, R2, and R3
is shown in Figure 2.13. This bioassay is mapped to a 10  10 electrode array and
all electrodes on the boundary of the array are used as storage cells.
The error-recovery capability of the cyberphysical microfluidic system can be
evaluated on the basis of the bioassay completion time when errors are detected.
We inject errors randomly into the chip during the execution of the bioassay and
compare the completion time of the two sensing schemes. The results are shown
in Figure 2.14. Here the completion time is derived from the greedy algorithm in-
troduced in Section 2.4, and the results are the average of the values derived from
repeating the experiments 10 times. For this case (no error recovery), if an error oc-
curs during the bioassay, the final outcome of the entire experiment will be incorrect.
As a result, the biochip has to be discarded, and the experiment must be repeated
on a new biochip in order to correct the error. If we assume that re-execution of
the experiment will be successful, the bioassay completion time will be twice as the
completion time in the fault-free case. Based on these results, we note that error re-
covery can reduce the bioassay completion time, and the consumption of biochemical
reagents/samples can be reduced.
In reliability-driven error recovery, the electrodes where an error is deemed oc-
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Figure 2.14: Completion time for biochip with CCD camera-based sensing system,
and the biochip without error recovery mechanism when errors are injected in the
sample preparation of plasmid DNA.
Figure 2.15: Comparison for the completion time between reliability-driven and
reliability-oblivious error recovery [51] when a 1 4 subarray is defective in the sam-
ple preparation of plasmid DNA. The error bars show the maximum and minimum
completion time for reliability-oblivious error recovery in simulation.
curred will not be used in other operations. On the contrary, for the reliability-
oblivious error recovery process in [51], when an error occurs during execution, the
region where error occurs will continue to be used in subsequent operations. As
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Figure 2.16: Comparison between the completion time of reliability-driven and
reliability-oblivious error recovery when a 2  4 subarray is defective in the sam-
ple preparation of plasmid DNA. The error bars show the maximum and minimum
completion time for reliability-oblivious error recovery in simulation.
discussed in Section 2.3.2, these electrodes with defects may further lead to more
errors.
To compare between the completion time for reliability-oblivious and reliability-
driven error recovery procedures, the following simulation was set up. In the reliability-
oblivious error recovery, we randomly select one operation optfe as the first instance
of error in the execution of bioassay. The electrodes that are used to implement optfe
are referred to “electrodes with defects”. When another operation is implemented
again on these electrodes with defects, we assume that there exists a probability Pfail
that this operation will also fail. For a fixed value of Pfail, we simulate reliability-
oblivious error recovery 15 times, and determine average completion time.
Figure 2.15 compares the completion time of reliability-driven error recovery and
average completion time of reliability-oblivious error recovery for different values of
Pfail. Here the randomly selected optef is a mixing operation implemented on a
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Figure 2.17: Completion time for biochips with CCD camera-based sensing sys-
tems and without error recovery mechanism when errors are injected in the sample
preparation of interpolating mixing.
14 electrode array. As expected, Figure 2.15 shows that the reliability-driven error
recovery leads to shorter assay completion time in the presence of defects.
Next we randomly select another operation as optfe and run the simulation again.
The electrodes that implement optfe now constitute of a 2  4 electrode array. The
simulation results are shown in Figure 2.16. We find that as expected, the average
completion time for reliability-oblivious error recovery is higher when more electrodes
are likely to be defective. On the other hand, the completion time of reliability-
driven error recovery does not depend on the type of defect on the chip and keeps
the minimum completion time.
2.5.2 Protein assays: interpolating mixing and exponential dilution
Next we evaluate re-synthesis and error recovery for two real-life protein assays.
These assays lead to the dilution of a protein sample by using two methods, namely
interpolating mixing and exponential dilution. The protocols and corresponding
sequencing graphs for these two bioassays are described in [40].
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Figure 2.18: Completion time for the bioassay of interpolating mixing (derived
from two re-synthesis algorithms when multiple errors are injected).
When errors are injected in the sample preparation of interpolating mixing, the
completion time of biochips with CCD camera-based sensing systems and without
error recovery mechanism are shown in Figure 2.17. The bioassay is mapped to a
10  10 electrode array.
Figure 2.18 reports the completion time when multiple errors are inserted during
the interpolating mixing protocol. Note that the completion time defined here only
includes time spent on fluid-handling operations, and excludes the CPU time spent
on resynthesis. From Figure 2.18, we see that the completion time achieved by the
PRSA-based algorithm and greedy algorithm are almost the same, but the CPU
times for these two algorithms are different. The simulation was performed on a
2.6-GHz, Intel i5 processor with 6 GB of memory. Both re-synthesis algorithm are
implemented on the basis of the same initial synthesis result. The CPU time needed
was around 33 minutes for computing the re-synthesis results using PRSA, which
was 10 times more than the bioassay completion time; while the CPU time was
less than 5 seconds for the greedy algorithm, which was only 2.5% of the bioassay
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completion time. The bioassay completion time derived by greedy algorithm is only
slightly higher for the PRSA. Nevertheless, the greedy algorithm is more suitable for
on-line re-synthesis because of low CPU time.
While the PRSA-based approach is less attractive for real-time decision making,
it provides a useful calibration point for the greedy algorithm and shows that the
latter’s effective for timely bioassay completion. Moreover, the PRSA-based method
can serve as the basis for future error recovery methods based on precomputation
and preloading of recovery schedules.
For the exponential dilution protocol introduced in [40], we evaluate the comple-
tion time for the reliability-driven and reliability-oblivious error recovery methods
in Figure 2.19. First we randomly select one operation optfe as the first instance of
error in the execution of bioassay, where optfe is a dilution operation implemented
on a 1 4 electrode subarray. Then for subsequent operations that are implemented
on this electrode array with defects, we set Pfail as the probability that the operation
will fail again. Then corresponding to each value of Pfail, we run the simulations 15
times, and derive the average completion time for reliability-oblivious error recovery.
In contrast, the defective electrodes are bypassed in reliability-driven error recovery.
Thus the completion time of reliability-driven error recovery is independent of Pfail.
From the results shown in Figure 2.19, we find that reliability-driven error recovery
reduces the bioassay completion time. At the same time, we avoid the problem that
any given set of defective electrodes can lead to replicated errors, thus the number of
errors in the bioassay is reduced. Hence less reagents/samples are consumed, leading
to lower cost and higher reliability for the experiment.
2.6 Chapter summary and conclusions
In this chapter, we have shown how recent advances in the integration of a sensing
system in a digital microfluidics biochip can be used to make biochips error-resilient.
We have presented a cyberphysical approach for “physical-aware” system reconfigura-
tion that uses sensor data at intermediate checkpoints to dynamically reconfigure the
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Figure 2.19: Comparison between the completion time of reliability-driven and
reliability-oblivious error recovery [51] when a 1 4 defect array is injected in expo-
nential dilution. The error bars show the maximum and minimum completion time
for reliability-oblivious error recovery in the simulation.
biochip. Real-time experiment monitory techniques based CCD camera have been
considered. Two different sensor-driven re-synthesis techniques have been developed
to recompute electrode-actuation sequences, thereby deriving new schedules, module
placements, and droplet routing pathways, with minimum impact on the time-to-
response. These two methods have been compared in terms of bioassay completion
time and CPU time needed for re-synthesis. The coordination between the physical-
aware control software and the microfluidic biochip allows sensor data at intermediate
checkpoints to be used as feedback to make decisions about completed operations,
and dynamically reconfigure the biochip and optimize electrode actuation sequences
for subsequent operations. The proposed approach has been evaluated through sim-
ulation and its effectiveness demonstrated for three representative protein bioassays.
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3Real-Time Error Recovery Using a Compact
Dictionary
In this chapter, we present a hardware-assisted error-recovery method that relies
on an error dictionary for rapid error recovery. The error-recovery procedure and
dynamic re-synthesis of a reaction, which is especially attractive for flash chem-
istry, can be implemented in real-time on a single-board microcontroller. In order to
store the error dictionary in the limited memory available in the low-cost microcon-
troller, we describe two compaction techniques. We use three laboratorial protocols
to demonstrate that, compared to software-based methods, the proposed dictionary-
based error-recovery method has less impact on response time, and requires simple
experimental setup, and only a small amount of memory.
This chapter is organized as follows. The research motivation for the hardware-
assisted cyberphysical biochip is introduced in Section 3.1. The proposed algorithm
for creation of the error dictionary is presented in Section 3.2. Section 3.3 introduces
the generation of actuation matrices corresponding to synthesis solutions in the error
dictionary. Section 3.4 describes the procedures for compaction of the error dictio-
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nary. The implementation of dictionary-based error recovery on FPGA is introduced
in Section 3.5. A fault simulation method with consideration of parameter variation
in the fabrication process is discussed in Section 3.6. Simulation results are shown
in Section 3.7, and conclusions are presented in Section 3.8.
3.1 Motivation and related prior work
Flash chemistry has emerged as a highlight of recent research in chemical synthe-
sis, where reactions are rapidly carried out and carefully controlled in real-time to
produce desired compounds with high selectivity [59]. It can be used as a powerful
tool for drug discovery, clinical diagnosis, and novel material synthesis [59; 60; 61].
However, flash chemistry introduces the following challenges: (i) the underlying fast
reactions (with time scales of less than a second) require highly precise time-control
in each step of chemical synthesis, a requirement that is beyond the capability of
today’s benchtop laboratory instruments; (ii) organic synthesis procedures require
the precise manipulation of liquids in small volumes [59]. These challenges can be
potentially tackled using miniaturized microfluidic biochips.
Digital (droplet-based) microfluidics is an emerging technology that enables the
integration of fluid-handling operations and reaction-outcome detection on a biochip
[23] and it is a potential candidate for the implementation of flash chemistry. Liquid
droplets with picoliter volumes in a digital microfluidic biochip can be manipulated
on an array of discrete unit cells [3]. Fluid-handling operations, such as dilution of
samples and reagents [47], crystallization of protein molecules [62], and transporta-
tion of droplets, can be implemented on the biochip by applying appropriate voltages
to the electrodes [18][23]. The sequence of actuation voltages is pre-determined (i.e.,
before the implementation of the fluid-handling operations), and they are stored
in a microcontroller or in computer memory [63]. Under clock control, the micro-
controller can transfer pre-loaded actuation data to the biochip, thereby making it
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feasible for laboratory researchers to implement chemical experiments automatically
on the biochip. Precise control of the reaction times of each step in the experiment
also can be achieved [23]. Furthermore, operations implemented on the biochip can
be reconfigured dynamically by reprogramming the actuation sequences [23]. The
sequence of actuation voltages can be derived from bioassay protocols using synthesis
methods [29; 34; 63; 64; 65].
To improve the qualify of product droplets, a cyberphysical system implementa-
tion of a biochip was recently proposed in Chapter 2 [66]. Despite of its novelty and
advantages, the error-recovery method proposed in [66] suffers from the following
shortcomings:
1. It requires on-line re-synthesis, which involves software-based dynamic regen-
eration of electrode actuation sequences. Such a resynthesis step leads to
increased bioassay response times when errors occur [66]. When on-line re-
synthesis is carried out using software, all fluid-handling operations are inter-
rupted. On the other hand, the reaction time for flash chemistry lies in the
range of milliseconds to seconds. For example, in Swern-Moffatt-type oxida-
tion, the reaction time is about 0.01 s at 20 C [60]. For such organic synthesis,
it is essential to precisely control reaction time; these reactions will fail due to
the additional time introduced by re-synthesis [59][61]. Thus the cyberphysical
system in [66] cannot be used for flash chemistry.
2. The error recovery approach in [66] must be implemented by the control soft-
ware running on a computer, which increases the complexity of the cyber-
physical system. The computer-in-loop is not always desirable, e.g., for field
deployment and handheld devices.
3. The complex nature of the coupling between the biochip and the control soft-
ware may introduce reliability problems. The communication between the
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biochip and the software is implemented using three components connected
in series: the peripheral circuit, the microcontroller, and the USB port of the
computer. Each of these components can be a point-of-failure, resulting in
reduced system reliability.
To overcome the above shortcomings, we propose a dictionary-based, hardware-
assisted error-recovery method. The key idea in this method is to precompute and
store recovery actuation sequences for all errors of interest that can occur during a
bioassay. When an error is detected by on-chip sensors during the execution of a
bioassay, the cyberphysical system can simply look up the recovery solution in the
dictionary rather than performing on-line re-synthesis using an in-the-loop computer.
This dictionary-based solution therefore reduces response time and enables flash
chemistry.
The proposed dictionary-based error recovery approach can be implemented using
the finite-state machine (FSM) shown in Figure 3.1. The control signals for the
biochip is determined by the current state of the FSM; the state transition of the
FSM is triggered by the analog feedback indicating that an error has occurred. The
error dictionary plays the role of a precomputed database that links each possible
state to the corresponding outputs. Entries in the dictionary record all possible
errors and the re-synthesis results, which include the corresponding error recovery
operations. When an error occurs, the cyberphysical system can utilize the dictionary
and load the pre-computed synthesis results.
Since no software execution is needed for on-line error recovery, the need for a
computer and the related interfaces can be eliminated. The dynamic adaptation
of the synthesis results can be implemented by a program that executes on the
single-board microcontroller or an FPGA, which integrates components such as the
microprocessor, memory, programmable I/O interfaces, clock circuitry [67]. However,
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Figure 3.1: The proposed finite-state machine control system implementation of
the cyberphysical system. The FSM runs on the microcontroller or the FPGA, and
its current state determines control signals applied on the biochip. A state transition
of the FSM is triggered by the detection of error(s).
since the error dictionary needs to store re-synthesis solutions for errors of interest,
the data volume can be high. Consider a typical protein dilution bioassay with 103
fluidic operations [68]. If we limit ourselves to errors involving at most two operations,
the memory required for storage of the error dictionary without compaction can be
as high as 28.75 MB. However, the memory on a low-cost FPGA is typically limited.
For example, according to the datasheet of several widely-used FPGAs (which cost
less than $50), the capacities of their on-chip memories are less than 1 MB [69].
External memory devices can increase the size of total memory, however, their prices
can be as high as the low-cost FPGAs [70]. According to the current market price
list [70][71], the use of external memory devices may double the cost of the system.
External memory devices will also increase the complexity of the board, and they
require additional circuit-board wiring [72]. Therefore, the above solutions are not
compatible with the goal of low-cost biochip platforms that can be used for field
deployment and point-of-care clinical diagnostics.
In this chapter, we propose a compaction procedure for an error dictionary which
includes re-synthesis solutions for all the possible error combinations in bioassay.
58
Then we compact sets of vectors (i.e., actuation matrices) stored in the dictionary
in a lossless manner. After these two steps, the size of compacted dictionary in the
above example can be reduced to only 0.96 MB.
3.2 Generation of the error dictionary
For any given set of errors that can occur in a bioassay, the error dictionary is
generated using simulation before the execution of experiments. During simulation,
erroneous fluidic operations are considered and the corresponding re-synthesis results
are determined. These resynthesis solutions are stored as entries of the dictionary.
The simulation and dictionary generation are both performed by a computer in the
off-line data-preparation stage.
The error dictionary is stored in controller memory as a decision tree that records
all possible consequences of errors, as shown in Figure 3.2. The dictionary has
multiple levels and the entries at the kth level correspond to all possible cases errors
that can occur involving k operations. Suppose the total number of operations in
the bioassay is N and no errors occur during error recovery. The number of entries
in the kth level of the dictionary can be as high as
 
N
k

. For large N and k, the size of
the error dictionary and the CPU time spent on error-dictionary generation can both
be prohibitively high. Therefore, k must be limited in practice. Here we consider
up to two erroneous operations (k  2) in the bioassay. If more errors occur, the
biochip must be discarded and the experiment repeated on a different biochip.
We next introduce the steps for generating the error dictionary level-by-level.
First we carry out synthesis for the error-free case, which corresponds to Level 0 in
Figure 3.2; next, based on the error-free solution, we insert errors in the simulation
and derive entries in Level 1 and Level 2 of the dictionary.
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Figure 3.2: Tree structure of the error dictionary. Entries at the kth level of
the dictionary correspond to all possible cases of errors that can occur involving k
operations.
3.2.1 Dictionary entry for error-free case
The entry in Level 0 of the error dictionary corresponds to the solution obtained
using high-level synthesis. In this process, the behavioral description of the desired
bioassay protocol, which is modeled as a sequencing graph, is mapped to a design
implementation in terms of a sequence of fluidic operations and the corresponding
actuation sequences.
Published CAD methods for digital microfluidic biochips have proposed inte-
ger linear programming and heuristic algorithms to solve this optimization problem
[68][29][57]. For example, the parallel recombinative simulated annealing (PRSA)-
based synthesis algorithms can be used to derive optimized results [68].
Suppose all the droplets used in the bioassay of Figure 2.1(a) are stored on the
biochip before the execution of the bioassay. The first entry in Table 3.1 shows
the synthesis results derived by PRSA-based synthesis algorithms for all mixing
operations of the bioassay shown in Figure 2.1(a) [68]. The start and end time
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Figure 3.3: Module placement for the bioassay shown in Figure 2.1(a).
of operations are written as ts and te, respectively. Figure 3.3 shows the module
placement corresponding to the synthesis of the error-free case in Table 3.1.
It is important to note that in Table 3.1, “resource” refers to the part of the elec-
trode array occupied by the mixing operation. The location of a mixer is expressed
in terms of the location of the electrode at the upper left corner of the mixer. For
example, the upper left corner of the mixing module M1 is in the sixth row and sec-
ond column; it includes an electrode array with two rows and three columns. Thus
the mixer is described as a 23 mixer at location (6, 2).
In addition, most of the bioassay benchmarks in the literature require that all the
input and output droplets for the mixing/dilution operations are droplets with unit
volume [73][74], i.e., at the end of each mixing/dilution operation, the mixed droplet
with twice the unit volume must be split into two unit droplets. During the synthesis
procedure of bioassays, for each mixing/dilution module, a set of electrodes will be
randomly selected as the “splitter” to split the mixed droplet. The splitter can be
placed in an arbitrarily-chosen place inside the mixing/dilution module. Therefore,
for two operations, even when their corresponding modules are overlapped with each
other (e.g., operations Mix 4 and Mix 5 shown in Figure 3.3), their corresponding
splitters may contain different sets of electrodes.
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Table 3.1: Dictionary entries corresponding to single errors occurred during the
execution of bioassay.
Errors Synthesis result
State 0:
Error-free
case
Operation ts (s) te (s) Resource Location
Mix 1 6 12 23 Mixer (6, 2)
Mix 2 0 6 32 Mixer (5, 2)
Mix 3 0 10 22 Mixer (2, 6)
Mix 4 12 15 24 Mixer (6, 4)
Mix 5 15 18 24 Mixer (6, 4)
State 1: Error
in Mix 1
Operation ts (s) te (s) Resource Location
Re-Mix 1 12 15 24 Mixer (2, 2)
Mix 4 15 18 24 Mixer (2, 2)
Mix 5 18 21 24 Mixer (2, 2)
State 2: Error
in Mix 2
Operation ts (s) te (s) Resource Location
Mix 1 6 12 23 Mixer (6, 2)
Re-Mix 2 6 12 32 Mixer (2, 2)
Mix 3 6 10 22 Mixer (2, 6)
Mix 4 12 15 24 Mixer (6, 4)
Mix 5 15 18 24 Mixer (6, 4)
State 3: Error
in Mix 3
Operation ts (s) te (s) Resource Location
Mix 1 10 12 23 Mixer (6, 2)
Re-Mix 3 10 20 22 Mixer (2, 2)
Mix 4 12 15 24 Mixer (6, 4)
Mix 5 20 23 24 Mixer (6, 4)
State 4: Error
in Mix 4
Operation ts (s) te (s) Resource Location
Re-Mix 4 15 18 24 Mixer (2, 2)
Mix 5 18 21 24 Mixer (2, 2)
State 5: Error
in Mix 5
Operation ts (s) te (s) Resource Location
Re-Mix 5 18 21 24 Mixer (2, 4)
* These operations can be interrupted as part of error recovery.
3.2.2 Dictionary entries for single-operation errors
By inserting an error in the bioassay and recording the corresponding re-synthesis
results, we can get the entries in Level 1 of the error dictionary. The re-synthesis
problem can also be solved using the PRSA-based global-optimization method [68]
while the CPU time is relatively long [66].
In [66], the algorithm for deriving new sequencing graph with error recovery
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operations is proposed. Based on the synthesis result in the error free case, the
newly added operations for error recovery can be “inserted” into the synthesis result
of the error free case in a greedy fashion [66]. Therefore, the re-synthesis results for
error recovery can be generated with short CPU time.
By explicitly analyzing all possible situations corresponding to all the potential
single errors that can occur for a bioassay, we can derive the entries in Level 1 of the
error dictionary. For example, the sequencing graph shown in Figure 2.1(a) has five
mixing operations, and, if we only consider errors in mixing and assume that only
one error occurs during the bioassay, there are five error candidates. We can derive
the error-recovery results for all of the potential errors and store the results during
the “off-line data preparation” stage, as shown in Table 3.1. Suppose Table 3.1 is
loaded into the memory of the FPGA; it determines the state transition of the FSM
running on the FPGA. At time t  0, the FSM comes into State 0, i.e. it begins
to execute the bioassay according to the initial synthesis result. At time ts  6,
operation Mix 2 is completed, the sensing system checks the output of Mix 2. If an
error is deemed to have occurred, the FSM transits to the corresponding state (State
2) and loads the re-synthesis result that is stored in the error dictionary (the third
entry in Table 3.1). It is important to note that the synthesis results for all operations
in the second entry start from time t  6. Since Mix 3 is being implemented when
an error occurs at Mix 2, it will continue to be implemented according to the initial
synthesis result. All operations that may be interrupted by the transition for the
state of the controller are marked by “*” in Table 3.1. In this manner, the controller
can dynamically adapt and do re-synthesis of the on-chip chemistry by looking up
entries in the error dictionary; the computational complexity of on-line re-synthesis
of the bioassay is reduced to O(1).
Note that each entry in the dictionary contains only the re-synthesis result from
the time that the error is detected to the end of the bioassay. For example, the dic-
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tionary entry that corresponds to State 1 shown in Table 3.1 records the re-synthesis
result from the 12th second (i.e., the moment in time that the error occurs in oper-
ation Mix 1 is detected) to the 21st second (i.e., the moment in time that the entire
bioassay is completed). The time span of this dictionary entry is 9 seconds. Based
on the above discussion, we note that there are various time spans for the entries in
Level 1 of the dictionary.
3.2.3 Dictionary entries for multiple-operation errors
Based on the re-synthesis solutions corresponding to single-error cases, we can further
explicitly consider all the cases with more than one errors and generate the re-
synthesis resolutions. Consider the dictionary entries shown in Table 3.1. Suppose
an error has already occurred at Mix 1 and the FSM running on the FPGA has
entered State 1. For the re-synthesis solution in State 1, there are three operations
Re-Mix 1, Mix 4 and Mix 5; here Re-Mix 1 is the recovery operation for Mix 1. Since
we assume that no errors occur in error recovery operations, here only Mix 4 and Mix
5 are considered as candidates for the next error, and we need to generate recovery
solutions for both of them. Finally we get re-synthesis solutions corresponding to
pairs of errors {Mix 1, Mix 4} and {Mix 1, Mix 5}; see Table 3.2. These solutions
are stored as two entries at the second level of the error dictionary. The “parent
node” of these two entries is the entry that corresponds to the solution for the single
error in Mix 1.
Note that each entry that corresponds to the occurrence of multiple errors con-
tains only the re-synthesis result from the moment in time that the latest error is
detected to the moment in time that the entire bioassay is finished. For example, the
dictionary entry that corresponds to State (1, 4) shown in Table 3.2 contains two
error operations, i.e., Mix 1 and Mix 4. According to the synthesis results shown in
Table 3.1, the error that occurs in Mix 1 is detected earlier than the error that occurs
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Table 3.2: Synthesis results corresponding to a pair of errors.
Errors Synthesis result
State (1, 4):
Errors in
{Mix 1, Mix 4}
Operation ts (s) te (s) Resource Location
Re-Mix 4 15 18 24 Mixer (2, 2)
Mix 5 18 21 24 Mixer (2, 2)
State (1, 5):
Errors in
{Mix 1, Mix 5}
Operation ts (s) te (s) Resource Location
Re-Mix 5 21 24 24 Mixer (6, 4)
in Mix 4. Therefore, the dictionary entry records the re-synthesis result from the 15th
second (i.e., the time moment that the error occurs in operation Mix 4 is detected)
to the 21st second (i.e., the time moment that the entire bioassay is completed). The
time span of this dictionary entry is 6 seconds.
3.2.4 Consideration of error-recovery cost and reduction in the number of dictionary
entries
For low-cost disposable biochips, the cost of samples and reagents used in the exper-
iments can be higher than the cost of biochips. When an error occurs on the biochip,
the additional number of droplets needed in error recovery needs to be calculated;
then the decision needs to be made on whether to recover from the error and continue
the experiment, or discard the biochip and run the bioassay on a new chip.
While generating entries for the error dictionary, an evaluation process can be
performed for determining whether an error is “worth being recovered”. Thresholds
for the number of droplets consumed can be set before generating the error dictionary.
Consider the following example. Assume that when there is no error in the bioassay,
the number of droplets consumed is Nf , and the maximum number of additional
droplets needed for error recovery (Nmax) is set as 15% Nf . When we generate the
dictionary entry for operation OE, if the corresponding simulation result indicates
that the number of additional droplets needed for error recovery is more than Nmax,
then the entry for recovering the error in OE will not be added into the dictionary.
Therefore, only cost-efficient entries are recorded by the dictionary. These dictionary
entries are donated as “effective entries” of the error dictionary.
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3.3 Actuation matrix
In order to execute the bioassay based on a synthesized chip, the information of
droplet routes and the schedules of operations must be programmed into the FPGA
[34]. The synthesis results of the bioassay are mapped to electrode actuation se-
quences, in which each element represents the status of the electrode at a specific
time. For an M N array, we can number the electrodes on the array as E1, E2, ...,
EMN . If the completion time of the synthesis result is T clock cycles, the actuation
sequences for all electrodes can be written in the form of an pM  Nq  T matrix,
referred to as the actuation matrix and denoted by A. The status of electrode Ei at
time j is represented by the element in the ith column and jth row of A.
For an arbitrarily chosen operation opt
ri, suppose it is implemented on electrodes
Ee1 , Ee2 ,... Eek at clock cycles Tt1 , Tt2 , ...Ttl , respectively. If we write the set of the
indices of these electrodes as I  te1, e2, ...eku and the indices of clock cycles as
J  tt1, t2, ...tlu, then I is a subset of t1, 2, ...MNu and J is a subset of t1, 2, ... T u.
Thus the actuation matrix for opt
ri, (which is referred as Moptri), can be written as
AI,J . It is a k  l sub-matrix of A that corresponds to the rows with index in set
I and the columns with index in set J . According to the constraints of biochemical
synthesis, no two operations can occupy the same electrode at the same time, thus
for operations opt
ri and optrk, their corresponding sub-matrices Moptri and Moptrk do
not overlap with each other.
Next, we show how to determine the values of elements in the actuation matrices.
We also estimate the percentage of non-zero elements in an actuation matrix. During
the implementation of fluid-handing operations, the status of the electrodes can be
“activated”, “deactivated”, or “don’t-care”. A “don’t-care” status is assigned to an
electrode when it is not required to be either active or inactive. It is important to
note that for various operations, the typical control voltages for activation statuses
are different. For example, in [18], the lowest voltage required to dispense a 300 pl
droplet from a reservoir is 11.4 V, while the actuation voltage required to move a
droplet is 7.2 V. Thus in the memory of the controller, these non-zero elements of
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Figure 3.4: Movement of droplets for (a) mixing; (b) splitting; (c) dispensing [16].
Step A to Step D show the procedure of pulling a droplet from the reservoir.
actuation matrices are recorded as the value of the corresponding control voltages.
In the following parts, we use “0” and “X” to represent deactivated and “don’t-care”
status of electrodes, respectively. We also use “v1” and “v2” to represent the activated
status in terms of different voltages for electrodes in mixing and splitting operations.
As shown in Figure 3.4(a), operation Mix 1 is implemented on an electrode array
with two rows and three columns; at the end of mixing, the product droplet will
be split into two smaller droplets, as shown in Figure 3.4(b). During the mixing
operation, suppose the droplet is moved counterclockwise along the loop consisting
of six electrodes. At each clock cycle, the droplet will be moved from the current
electrode to an adjacent electrode. Suppose that at time instant (clock cycle) t0,
the droplet rests on electrode E1. The actuation sequence for each electrode is now
calculated and listed in Table 3.3, and the last row in Table 3.3 corresponds to the
split operation after the completion of mixing. From Table 3.3, we find that at each
time instance during mixing, there is only one electrode in the mixer that must be
activated. Voltages applied to other electrodes are either “0” or “X”, and all the
“X” terms can be replaced by “0”.
Next we can write the actuation sequences of operation Mix 1 as an actuation
matrix MMix1 . The i
th-row vector in MMix1 depicts the status of E1 to E6 at the
ith clock cycle of Mix 1. Suppose the completion time for operation Mix 1 is 5 clock
cycles and at the 6th clock cycle the mixed droplet will be split. Then MMix1 has
6  6 elements. It can be written as:
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Table 3.3: Actuation sequences for electrodes in the mixer.
Electrodes 1 2 3 4 5 6
Actuation sequences
(ordered in time)
v1 0 X X X 0
0 v1 0 X X X
X 0 v1 0 X X
X X 0 v1 0 X
     
X X X v2 0 v2
MMix1 

v1 0 0 0 0 0
0 v1 0 0 0 0
0 0 v1 0 0 0
0 0 0 v1 0 0
0 0 0 0 v1 0
0 0 0 v2 0 v2
fiffiffiffiffiffiffifl.
We see that each row in MMix1 has one or two non-zero elements, which is a
general case in fluid-handling operations.
Figure 3.4(c) shows the steps involved in dispensing a droplet from an on-chip
reservoir. In order to pull a droplet out from the reservoir, the electrodes in the
transportation path are activated in sequence, as shown from Step A to Step D
in Figure 3.4(c) for a fabricated chip [16]. This procedure is completed in four
clock cycles. The droplet is formed by activating the electrodes on the outlet of
the dispensing port. In this process shown in Figure 3.4(c), the liquid drop in the
reservoir is deformed under the electrical force.
Based on the steps shown in Figure 3.4(c), we derive corresponding actuation
matrix MDis for a dispensing operation. The matrix MDis has four rows and it
includes a total of five non-zero elements.
Since for any two operations opt
ri and optrk, the corresponding sub-matrices Moptri
and Mopt
rk
are non-overlapping, we can estimate the number of non-zero elements
in the actuation matrix A on the basis of the sub-matrices corresponding to all
the operations in the bioassay. Suppose the working frequency of the biochip is f
Hz (f usually varies from 1 to 100 [21]). Thus an operation that is completed in
N seconds includes N  f clock cycles. For the synthesis result shown in the first
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entry of Table 3.1, the number of non-zero elements corresponding to the sequence
matrix of each operation can be calculated according based on their execution time.
Apart from the mixing operations, there are six dispensing operations that are not
shown in Table 3.1, and each of them corresponds to a sub-matrix with 4 non-zero
elements. Thus the total number of non-zero elements in the actuation matrix for the
entire bioassay can be estimated by adding the number of non-zero elements for each
operation. The resulting number is 24 28f . On the other hand, since the completion
time of the bioassay is 4+18f clock cycles, the size of A is p88qp4 18 fq. Thus
the percentage of non-zero elements Pnz in matrix A can be calculated as:
Pnz  24   28  fp8  8q  p5   18  fq  100%.
Since the frequency range is 1 ¤ f ¤ 100 [21], we conclude that 2.45% ¤ Pnz ¤
3.69%. This implies that A is a sparse matrix. Therefore, we can apply data-com-
paction algorithms to the actuation matrices in an error dictionary to reduce the
storage requirement. Two algorithms that can be applied to compact error dictio-
naries will be introduced in Section 3.4. In Section 3.7.1, we will take the specific
example of exponential dilution of protein to highlight that actuation matrices are
sparse.
3.4 Compaction of the error dictionary
In this section, we describe two algorithms to compact actuation matrices of synthesis
results for bioassay. Corresponding algorithms for de-compaction of error dictionary
also will be discussed.
3.4.1 Compaction of the actuation matrix
Suppose the actuation matrix A is an pM  Nq-by-T sparse matrix with K non-
zero elements, where M and N refer to the array dimensions and T is the number
of clock circles for the assay. We describe two algorithms for the compaction of
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the actuation matrix, and we define the compaction ratio as the number of elements
before compaction divided by the number of elements in the matrix after compaction.
Method I: COO (coordinate list) compaction [75]. A can be stored as N three-
tuples. Each tuple records the row indices, column indices and numerical values of
a non-zeros element in the matrix. Thus the number of elements in the actuation
matrix is compacted from NMT to 3K, and its compaction ratio RI can be written
as NMT {3K. For example, the matrix MMix1 in Section 3.3 has 36 elements, and 7
of them are non-zero elements. Thus it can be compacted to 7 three-tuples, which
have 24 elements in total: p1, 1 , v1q, p2, 2 , v1q, ..., p6, 4 , v2q, p6, 6 , v2q.
Method II: run-length encoding [76]. We apply run-length encoding to the
actuation matrices. The actuation matrix of each dictionary entry can be reformat-
ted to a signal sequence. The actuation sequence in which the same status value
occurs in consecutive clock cycles can be compacted according to the single status
value and the corresponding count number. For the actuation sequences for mixing
and dispensing operations, we observe that “0” often occurs consecutively. Thus run-
length encoding is applied to the “all-zero segments”, i.e., runs of 0s in the actuation
matrix. In the compaction result, non-zero elements are represented by their values,
and runs of 0s are represented by the corresponding count number. For example, the
compacted vector “XvaYvb” stands for the following sequence:
Xv 0...00lomon
a
Yv 0...00lomon
b
.
The K non-zero elements will “divide” the MN column vectors in A into at most
MN  K all-zero segments, and each of these segments is represented by its number
of zeros. Thus the actuation matrix can be compacted to a vector with MN   2K
elements, and its compaction ratio can be written as MNT {pMN   2Kq. For the
matrix MMix1 shown in Section III, its first column is divided into two segments,
where the first segment is the single non-zero element “v1” and the second segment
is 5 consecutive “0”, so the first column can be compacted to “pv1qp5q”. Similarly, the
second column is divided into three segments, and it is compacted to “p1qpv1qp4q”.
Based on the above discussion, the relative performance of Method I and Method
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II depends on the relationship between MN and K. When K ¡ MN , Method II
offer higher compaction than Method I; otherwise, Method I is more efficient. Both
compaction algorithms can be implemented when generating the error dictionary.
3.4.2 De-compaction of the error dictionary
Before the execution of the bioassay, the error dictionary must be compacted and
stored in the memory of the FPGA. All compaction procedures described above are
lossless and reversible. When an error occurs on the biochip is reported by the on-chip
sensors, the controller accesses corresponding compacted re-synthesis outcome and
restores it to the complete actuation matrix with the appropriate electrode actuation
vectors.
The de-compaction procedure can be performed by de-compaction modules im-
plemented on an FPGA. As explained above, by applying compaction Method I, the
pM Nq-by-T actuation matrix is compacted to a 1K vector. Each element in the
vector represents a non-zero element in the original uncompacted matrix, denoted
by pi, j, vijq, where vij is the non-zero value; i and j are the row and column indices
of the non-zero element.
Since at each time moment, we only need to apply actuation signals on M  N
electrodes, the actuation matrix is de-compacted “segment by segment” during the
de-compaction procedure. Here we assume that the memory space required for each
element in the original actuation matrix is nb bits. In the de-compaction module, an
pM N  nbq-bit register is used to store the de-compacted M N actuation sub-
matrix. Before applying the actuation matrix on the electrodes of the biochip, the
data stored in the pM N nbq-bit register is reset to zero. Next the de-compaction
module “fills” non-zero elements into the pM N  nbq-bit register, i.e., the module
assigns the elements in the 1  K vector to the pM  N  nbq-bit register. When
the de-compaction procedure of one M  N actuation sub-matrix is finished, the
corresponding actuation signals are applied to electrodes on the biochip. The data
stored in the pM  N  nbq-bit register will be reset to zero again, and the next
segment in the compacted actuation matrix will be de-compacted.
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The compaction results derived from Method II can be restored to the original
actuation matrix in a similar way.
The clock for de-compaction and for writing data into the pM  N  nbq-bit
register can be as high as 16 MHz [69], while the clock frequency of the biochip is
usually between 1 Hz and 100 Hz [21]. The frequency of the FPGA is several orders
of magnitudes higher than the frequency of fluid-handling operations, hence the total
time needed for accessing the dictionary, de-compaction, and transfer of data from
the FPGA to buffers in the peripheral circuit is negligible compared to the clock
cycle of the biochip.
3.5 Implementation of dictionary-based error recovery on FPGA
The circuitry for error recovery on a cyberphysical microfluidic biochip consists of
four main modules, i.e., 1) the sensing module for the detection of errors, 2) the
memory module for the storage of the error dictionary, 3) the FSM module for
the dynamic adjustment of actuation sequences when errors occur, and 4) the de-
compaction module for decoding the actuation matrices. All four modules can be
implemented on an FPGA.
The modules are described using Verilog, and synthesized using Quartus II [77].
All functional and timing simulations for the modules are performed using ModelSim-
Altera [78]. The FPGA used in the simulation belongs to the family of Cyclone IV
[79], which includes a series of devices. The maximum numbers of I/O ports and
logic elements provided by these devices are different [79]. While synthesizing the
modules, Quartus II selects the suitable devices based on the required number of I/O
ports and logic elements. The maximum on-chip memory that the family of Cyclone
IV can provide is 0.83 MB.
The interconnection of the modules is presented in Figure 3.5, and the detailed
implementation of these modules in an FPGA is discussed below.
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Figure 3.5: Modules and their interconnections for the dictionary-based error re-
covery system.
3.5.1 Sensing module
The sensing module can be designed on a biochip based on different sensing tech-
niques. Here, we use the imaging-based droplet detection method as the example
to illustrate the implementation of sensing modules in FPGA. Note that the error-
recovery algorithm approach proposed in this work is general and it can be applied
to cyberphysical biochips with various sensing systems.
In Chapter 2, an imaging-based droplet-tracking algorithm is discussed. During
the execution of the bioassay, an image sensor is used to monitor the entire biochip.
Based on the images captured by the image sensor, the control software can search
for droplets automatically by “template matching” (Section 2.2.1). The acquired
images are first converted to 2-dimensional matrices. For example, an image with
Mw  Nw pixels will be converted to an Mw  Nw matrix, in which each element
represents one pixel of the image.
An image of a typical droplet on the biochip is selected as the “template” (which
is written as T ). Each time, the software crops a sub-image (Ts) from the image of the
entire biochip. The template image and the cropped sub-image are considered as two
vectors, and the correlation index of these two vectors can be used to represent the
similarity between the template and the cropped sub-image. In order to locate the
positions of droplets on the biochip precisely, the correlation index is calculated on a
pixel-by-pixel basis [66]. Therefore, if the image for the entire biochip has Mw Nw
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pixels and the template image has Ms Ns pixels, the calculation of the correlation
factor between the template image and the cropped sub-image must be implemented
pMw Msq  pNw Nsq times. The computational complexity of droplet tracking is
significant when there is a large number of pixels in the image of the entire biochip,
and the image-based droplet-tracking method must be performed by the software on
a computer [66].
Based on the characteristics of the digital microfluidic biochip, the image-based
droplet-tracking procedure can be simplified and accelerated, and all of the calcu-
lations can be performed on the FPGA. The movements of droplets on the biochip
are synchronized under clock control. At the beginning of each clock cycle, all the
droplets are expected to stay at the center of their corresponding electrodes. Then,
actuation signals are applied to all electrodes at the same time, and the droplets are
moved towards their destination electrodes concurrently. At the end of the clock cy-
cle, all the droplets are expected to stay at the center of their destination electrodes.
Therefore, in order to monitor the movement of droplets, we only need to check the
position of each droplet once at the beginning of each clock cycle.
Since the biochip consists of a discrete electrode array, the image of the entire
biochip can be partitioned into sub-images, and each sub-image shows the status of
one electrode. The template T is selected as the image of an electrode on which
there is a typical droplet. Assuming that there are K electrodes on the biochip, the
sub-images derived can be written as I1, I2, ..., IK . By comparing T with these
K sub-images, the positions of the droplets can be determined. Therefore, at each
clock cycle, the calculation for the correlation index between the template and the
sub-image will be implemented only K times.
The calculation of the correlation index between two vectors can be implemented
easily by the image-based droplet-tracking module. In our simulation, we use the
picture of a biochip with 15 electrodes to test the functionality of the module, and
each sub-image contains 2721 pixels. When the working frequency of the FPGA is
20 MHz, the time spent on checking all 15 sub-images is 4.5104 second, while the
time to move a droplet from one electrode to another adjacent electrode is usually
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between 102 second and 1 second [21]. The time spent on checking the droplet is
negligible when compared with the clock period of the biochip. Hence, the imaging-
based droplet-tracking module implemented on FPGA can be used as a real-time
sensor for the biochip.
3.5.2 Memory for storage of the error dictionary
The error dictionary of the bioassay is stored in the read-only memory (ROM) of the
FPGA. During the fault simulation of the bioassay, entries of the error dictionary are
generated, compacted, and then written into a “memory initialization file” (MIF).
The MIF specifies the content for each memory cell in ROM. At the same time,
a table that records the starting and ending addresses of each dictionary entry is
generated and loaded into the module of the FSM (Figure 3.5).
After the compilation of the FPGA project, the contents of the ROM are ini-
tialized by the MIF, and they can no longer be changed. When the FSM sends the
addresses of the memory cells to the ROM, the data stored in corresponding cells
are sent as the output of the ROM.
3.5.3 FSM module
As introduced in Section 3.1, automatic error recovery can be implemented by an
FSM. The input of the FSM is the detection results from sensing module. The
outputs of the FSM are the starting and ending storage addresses of the dictionary
entry that must be applied to the biochip. When the detection module sends a signal
indicating that an error has occurred, the FSM transits from one state to another
state for error recovery. The starting and ending storage addresses of the dictionary
entry that must be applied to the biochip are changed accordingly.
The output of the FSM is connected to the inputs of the ROM. When the FSM
sends the addresses of the dictionary entry, the data that are stored in the corre-
sponding memory cells are sent to the output of the ROM. Since the data stored in
the ROM are the compacted dictionary entries, these data must be de-compacted
before that can be applied to the electrodes on the biochip. Therefore, the output
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Table 3.4: Resource report for synthesized modules.
# Logic # Combinational # Logic # Total # Total
elements functions registers registers pins
Image-based
droplet tracking 4631 4627 230 230 22
De-compaction
(Method I) 249 249 144 14 42
De-compaction
(Method II) 42 42 31 31 42
of the ROM is connected to the input of the de-compaction module, as shown in
Figure 3.5.
3.5.4 De-compaction module
The working principle of the de-compaction module is introduced in Section 3.4.2.
The input of the de-compaction module is the compacted actuation sequence, and
the output is the de-compacted actuation signal sequence that can be directly applied
on the biochip.
The de-compaction modules that correspond to both compaction Method I and
Method II are both implemented by the FPGA. When the working frequency of
the FPGA is set as 20 MHz, one dictionary entry with 930 elements, where each
element is an 8-bit binary number, can be decoded in less than 50 µs. Therefore, the
time spent on dictionary de-compaction is negligible when compared with the time
required to move a droplet from one electrode to an adjacent electrode.
3.5.5 Resource report for synthesized modules
The modules are synthesized by Quartus II. The resource reports for the synthesized
droplet-tracking module and the de-compaction module are listed in Table 3.4. The
FPGA resource occupied by the synthesized controller module depends on the total
number of states in the FSM. The relationship between the number of states and
the number of logic elements is shown in Table 3.5. The actual FPGA used in the
simulation is EP4CGX15BF14C6.
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Table 3.5: Resource report for synthesized FSMs with different number of states.
No. state # Logic # Combinatio- # Logic # Total # Total
of the FSM elements nal functions registers registers pins
50 62 35 50 50 13
500 390 390 9 9 13
800 680 680 10 10 18
1200 419 419 11 11 18
1600 168 168 11 11 35
2 3 1 
Actuated electrodes 
The 2x droplet to be split 
Figure 3.6: Splitting of a droplet: Both Electrode 1 and Electrode 3 are actuated,
and electrowetting forces are generated on the surfaces of these two electrodes.
3.6 Fault simulation in the presence of chip-parameter variations
In this section, we examine the nature of the errors that occur in splitting operations
and present a parameter variation-aware fault simulation algorithm. By considering
the variations in the parameters of the biochip electrodes, the simulator can mimic
erroneous behavior during the execution of bioassay.
As introduced in Section 3.1, error occurrence in the biochip is defined as the
occurrences of droplets with abnormal volumes or concentrations. Experimental
results with fabricated biochips show that the generation of abnormal droplets in
asymmetric splitting operations is the primary cause of errors that occur in biochips
[16]. Furthermore, as introduced in Section 3.2.1, splitting operations are frequently
implemented in bioassays. Most of the errors that occur during the execution of
the bioassay are caused by the asymmetric splitting operations [80]. As shown in
Figure 3.6, to split the droplet on Electrode 2, Electrode 1 and Electrode 3 are
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actuated at the same time. Two electrowetting forces, written as F1 and F3, are
generated on the surfaces of Electrode 1 and Electrode 3, respectively. The droplet
on Electrode 2 will be split under F1 and F3, which are applied in opposite directions.
The electrowetting force applied on a droplet can be written as [81]:
F  p εrdεrh
thεrd   tdεrh q
ε0V
2
2
dAp
dx
, (3.1)
where V is the voltage applied to the actuated electrode, x is the position of the
droplet, td is the thickness of the insulator layer, th is the thickness of the hydrophobic
layer, εrd is the dielectric constant of dielectric layer, εrh is the dielectric constant of
the hydrophobic layer, ε0 is the permittivity of vacuum, and Ap is the area of the
overlapping region between the droplet and the actuated electrode [81].
In an ideal situation, the droplet in Figure 3.6 stays at the center of Electrode 2
at the beginning of the splitting operation. The overlap region between the droplet
and Electrode 1 (Ap1) and the overlap region between the droplet and Electrode 3
(Ap3) are the same, therefore we have:
dAp1
dx
 dAp3
dx
. For Electrode 1 and Electrode
3, their parameters td and th are also the same. Thus the forces generated on the
surfaces of Electrode 1 and Electrode 3 are symmetric, i.e., ‖F1‖‖F3‖  1. The droplet
will be split over the two electrodes into droplets of equal size.
However, due to the randomness inherent in the fabrication process, the param-
eters th and td may vary from electrode to electrode, and the electrowetting forces
generated on the surfaces of Electrode 1 and Electrode 3 may not be exactly the
same. In this case, the droplet will be split under asymmetric forces.
When asymmetric forces are applied, the droplet on Electrode 2 may be split into
two droplets that have unequal volumes [81]. For example, when we split a droplet
whose volume is 2 units, if ‖F1‖‖F3‖  1.10, the volumes of the droplets derived will be
1.13 units and 0.87 unit, respectively [81]. If the “standard” volume of a droplet
is 1 unit, and the error limit for the volume of droplets is 10%, then both of these
droplets will be abnormal. In this case, errors are generated on the biochip.
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By considering the distributions of parameters td and th for the biochip, the
simulator can mimic the behavior of splitting operations in the bioassay. For any
electrode Ei, the thickness of the insulator layer is written as tdpEiq , the thickness
of the hydrophobic layer is written as thpEiq. For given distributions of parameters
td and th for the biochip, and the given synthesis result of the bioassay, the simulator
can calculate the ratio of the two electrowetting forces generated in each splitting
operation.
We assume that the splitting operation OS is performed by electrodes ER and
EL. According to Equation (1), the ratio of the electrowetting forces generated on
ER and EL (written as FER and FEL) can be expressed as:
‖FER‖
‖FEL‖
 pthpELqεrd   tdpELqεrhqpthpERqεrd   tdpERqεrhq . (3.2)
If the ratio of ‖FER‖ to ‖FEL‖ is out of acceptable range, the splitting operation
OS will generate two droplets that have abnormal volumes. In this way, an error is
generated during fault simulation. By running the fault simulation under parameter
variations, we mimic the occurrences of errors during the execution of the bioassay.
3.7 Simulation results
In this section, we first present simulation results for three widely used laboratory
protocols, namely exponential dilution of a protein sample, interpolation dilution of a
protein sample, and mixing tree bioassay, respectively [68][74]. Then the simulation
result of a new benchmark for a flash chemistry application is presented [82].
The error dictionaries for these four bioassays are generated, and the compaction
algorithms for error dictionaries are applied. We also carry out fault simulation to
mimic the occurrences of errors during bioassay execution.
3.7.1 Exponential dilution of a protein sample
Generating error dictionaries
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Figure 3.7: (a) The histogram for the number of extra droplets consumed in all
possible situations of exponential dilution bioassay; (b) the histogram for the time
spans of effective dictionary entries when Nmax  5.
The exponential dilution bioassay contains 103 operations. The sequencing graph
and the detailed description of the bioassay can be found in [68] and it is the most
complex benchmark that is available in the literature related to digital microfluidic
biochips.
By applying the PRSA-based synthesis algorithm [68], the synthesis result for
the bioassay can be derived. When running the bioassay on a 1010 electrode array
and no erroneous operation occurs, the completion time is 208 seconds. Based on the
synthesis result for the error-free case, the dynamic re-synthesis algorithm proposed
in [51] is applied to generate the error dictionary.
When generating entries of the error dictionary, erroneous operations are inserted
into the bioassay. By considering each operation as a possible erroneous operation,
103 dictionary entries with single errors that occurs in the bioassay are generated. If
we set the upper limit for the number of erroneous operations to be two, the number
of possible combinations of errors that must be considered is
 
103
2

, i.e., p103102q{2
(here we assume that errors will not occur in error recovery operations). Therefore,
the total number of entries Ne in the dictionary is given by: Ne  103   p103 
102q{2  5356.
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Table 3.6: Effective dictionary entries corresponding to different values of Nmax in
the exponential dilution bioassay.
No. effective Coverage Max. time Min. time
Nmax entries rate span (s) span (s)
2 4013 74.92% 222 5
3 4113 76.79% 230 5
5 4747 88.63% 237 5
8 5356 100.00% 237 5
The fault simulation is run on a 2.30 GHz Intel i3 dual-core processor with 8 GB
of memory. The CPU time is 1925.7 seconds for generating the error dictionary. The
histogram for the numbers of extra droplets consumed in these 5356 dictionary entries
is shown in Figure 3.7(a). The maximum number of additional droplets consumed
in the process of error recovery is 8.
When we consider the cost of error recovery, not all these 5356 dictionary entries
will be selected as “effective entries” in the error dictionary. For some biochemistry
experiments, the cost of precious samples and reagents can be greater than the cost
of the biochips. If “too many” droplets are consumed in recovering from the error,
running the bioassay on a new biochip may be more cost-effective. In this situation,
the corresponding synthesis results will not be recorded in the error dictionary.
The parameter Nmax denotes the maximum number of additional droplets that
can be used in error recovery when we consider the cost of samples and reagents.
When Nmax is set as 2, 3, 5, and 8, the numbers of effective entries that are recorded
in the dictionary are 4013, 4113, 4747, and 5356, respectively. The maximum and
minimal time spans of these effective entries corresponding to different value of Nmax
can be found in Table 3.6. For example, when Nmax  5, the time spans of the 4747
effective dictionary entries vary from 5 seconds to 237 seconds. One of the dictionary
entries with the shortest time span corresponds to the error that occurs at the 208th
second; after recovering from the error, the entire bioassay is finished at the 213th
second. Therefore, the time span of this dictionary entry is 5 seconds. One of the
longest dictionary entries corresponds to two errors that occur at the 15th second and
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22nd second, respectively; after recovering from these two errors, the entire bioassay
finishes at the 259th second. Hence, the time span of this dictionary is 237 seconds.
The histogram for the time spans of the 4747 effective dictionary entries is shown in
Figure 3.7(b).
The “coverage rate” shown in Table 3.6 is defined as the ratio between the number
of effective entries and the total number of entries in the error dictionary. Recovery
for 74.92% of the errors that occur in a bioassay can be accomplished using no more
than two extra droplets.
Estimation of the percentage of non-zero elements
As discussed in Section 3.3 and Section 3.4, when the actuation matrices are
sparse, we can apply compaction algorithms to reduce the size of the error dictio-
nary. Here we estimate the percentage of non-zero elements in the error dictionary
generated in Section 3.7.1.
According to the underlying physical principle of droplet operations, the number
of actuated electrodes on the array can be estimated on the basis of the number
of droplets that are currently being manipulated on the biochip. For example, if a
droplet is scheduled to stay at its current position, the electrode under the droplet
will be actuated to “anchor” the droplet while all other electrodes that are in contact
with the droplet need to be deactivated. If a droplet is scheduled to be moved from
one electrode to another electrode, the target electrode needs to be actuated while
all the other electrodes that are in contact with the droplet need to be deactivated.
As the biochip contains a 10  10 electrode array, at each time moment, the actu-
ation signals applied on the electrode array can be represented by a 10  10 actuation
sub-matrix. Therefore, by calculating the number of maximum number of droplets
that can be concurrently manipulated on the biochip at each time moment, an up-
per bound on the percentage of non-zero elements in an actuation sub-matrix can be
derived. From the sequencing graph for the exponential dilution of a protein sample
[68], we can find that the maximum degree of parallelism for fluid-handling opera-
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Table 3.7: Compaction ratios of Method I and Method II corresponding to different
values of Nmax in exponential dilution bioassay.
SO SI SII
Nmax (MB) R¯I σI (MB) R¯II σII (MB)
2 21.12 24.13 4.43 0.90 34.89 6.12 0.62
3 21.61 24.23 4.53 0.93 34.98 6.26 0.64
5 24.77 24.09 4.45 1.12 34.77 6.11 0.77
8 28.75 23.82 4.25 1.40 34.47 5.89 0.96
tions is as fellows. We simultaneously implement eight mixing operations (and each
mixing operation involves two droplets) and eight dispensing operations (and each
mixing operation involves one droplet). Therefore, the maximum number of droplets
can be concurrently manipulated on the biochip is calculated as 2  8   8  24. The
maximum number of non-zero elements in each 10  10 actuation sub-matrix is also
24, i.e., the maximum percentage of non-zero elements in the entire actuation matrix
is 24%. It is important to note that this upper bound is independent of the number
of errors occurred during the execution of bioassay. Therefore, we have shown that
each actuation matrix generated in Section 3.7.1 is sparse.
Compaction for error dictionaries
The error dictionary can be compacted by Method I and Method II proposed
in Section 3.4. When we set the value of Nmax as 2, 3, 5, and 8, the number of
effective entries in the error dictionary are different. In Table 3.7, the original size of
the “effective error dictionary” is written as SO; the mean values for the compaction
ratios of all effective dictionary entries are written as R¯I (derived by Method I) and
R¯II (derived by Method II), respectively; the standard deviations for the compaction
ratio of all effective dictionary entries are written as σI (derived by Method I) and
σII (derived by Method II), respectively. Finally, the sizes of the dictionary after
compaction are written as SI (derived by Method I) and SII (derived by Method II),
respectively.
From Table 3.7, we can find that the total memory required to store the original
effective error dictionary is 21.1228.75 MB, which is much larger than memory
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Figure 3.8: (a) The histogram for the numbers of extra droplets consumed in the
233 runs in which 233 errors are generated; (b) the histogram for the time spans of
entries in the 233 runs in which errors are generated.
available on an FPGA. After compaction, the final size of the compacted dictionary
can be smaller than 1 MB.
Fault simulation results
After the generation and compaction of the error dictionary, next we run fault
simulation for the exponential dilution bioassay.
As discussed in Section 3.6, if the ratio of electrowetting forces are out of the
acceptable range, abnormal droplets will be generated. It is important to note that,
in the bioassay protocols, there is an underlying assumption that the splitting of a
droplet is the last step of the mixing/dilution procedure, i.e., splitting operations are
executed at the end of each mixing/dilution operation. If droplets with abnormal
volumes are generated when splitting the droplet at the end of a dilution/mixing
operation OM/D, this situation is defined as “an error occurs in OM/D”.
In the fault simulation setup considered here, we set the distribution function of
the Gaussian random variable Rc  pthεrd   tdεrhq as rc  Np1, 0.032q, where rc is a
nominal value, and Np1, 0.032q is the Gaussian distribution function with mean 1
and variance 0.032.
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For a typical biochip, tdεrh " thεrd for Rc [18]; therefore, here the distribution
function for Rc is estimated according to the process variance of td. For a typical
biochip fabrication process, the average spread in td is 11 nm [84], while the value
of td usually is 450  800 nm [18][84]. Therefore, using a normalized variance of 3%
for Rd is justified.
When a droplet is split by electrowetting forces F1 and F2, and
‖F1‖
‖F2‖ ¥ 1.10 (or
‖F2‖
‖F1‖ ¥ 1.10), we assume that an error occurs. We run the fault simulation procedure
a total of 1000 times. Among the simulation results for the 1000 runs, one error
occurs 233 times and none of these 1000 runs include more than one error.
For the 233 runs with errors, the histogram for the number of extra droplets
consumed in error recovery and the total completion time of bioassay derived by the
proposed error recovery method are shown in Figure 3.8 (a) and (b), respectively. As
shown in Figure 3.8, for these 233 runs, the maximum number of droplets consumed
in error recovery is 5; the maximum total completion time for the bioassay is 237
seconds.
Part of the simulation results for the 233 runs with errors can be found in Ta-
ble 5.4. After the error is detected, the biochip can derive the re-synthesis results
either by the Online Synthesis Strategy (ONS) [64], Fast Online Synthesis [83], or by
looking up the prepared error dictionary. The response time in Table 5.4 is defined as
the time spent in deriving re-synthesis solutions to recover the error. Here we assume
that both ONS and Fast Online Synthesis are using the hardware setup presented
in Figure 2.5, i.e., the biochip and the computer are connected via an FPGA/signle
board controller. The response times of ONS and Fast Online Synthesis include the
time spent on writing the new actuation matrices into the memory initialization files
of the FPGA.
Note that during on-line re-synthesis, all fluid-handling operations for the bioas-
say are suspended. The execution time in Table 5.4 is calculated from the beginning
to the end of the bioassay, without considering the CPU time spent in re-synthesis.
Thus the total completion time for the bioassay is the sum of the response time and
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the execution time.
From Table 5.4, we can find that the CPU time needed for performing on-line
re-synthesis by both ONS and Fast Online Synthesis are longer than the proposed
method. It is important to note that for the laboratorial experiments in biochem-
istry, the reaction time for each step in the chemical synthesis is often very short,
and the intermediate products may degrade or decompose quickly [82][61]. Thus the
increase in response time introduced by the on-line calculations required in [68][83]
may have an adverse impact on reaction outcome [82][61]. Therefore, only the pro-
posed dictionary-based method can recover from the error “seamlessly” and avoid
the degeneration of intermediate products of the bioassay. It is important to note
that, even though ONS and Fast Online Synthesis can achieve online re-synthesis, the
calculation has to be performed on the computer. Therefore, they are not suitable
for the low-cost cyberphysical system that has only a single board controller/FPGA.
3.7.2 Interpolation dilution of a protein sample
The interpolation-based dilution bioassay has 71 operations. When no error occurs,
the execution time of the bioassay is 182 seconds, and 32 droplets are consumed in the
bioassay. Assume that the number of errors occur in the bioassay is no more than 2,
then the total number of cases need to be considered is Ne  71 p7170q{2  2556.
For these 2556 dictionary entries, the histogram for number of droplets consumed in
error recovery is shown in Figure 3.9(a).
By setting different value for Nmax, the number of effective entries in the dictio-
nary will be different. For example, when Nmax is set as 3, 5, and 8, the numbers
of effective entries in the dictionary are 1727, 2156, and 2556, respectively. When
Nmax  3, the histogram for the time span of effective dictionary entries is shown in
Figure 3.9(b).
The error dictionary can be compacted by Method I and Method II proposed
in Section 3.4. When setting the value of Nmax as 3, 5, and 8, the corresponding
simulation results are presented in Table 3.9. The parameters of Table 3.7 are defined
in Section 3.7.1.
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Figure 3.9: (a) The histogram for the numbers of extra droplets consumed in all
possible situations of the interpolation-based dilution bioassay; (b) the histogram for
the time spans of entries in the error dictionary for the interpolation-based dilution
bioassay (when Nmax  3).
Table 3.9: Compaction ratio of Method I and Method II corresponding to different
values of Nmax in interpolation-based dilution bioassay.
SO SI SII
Nmax (MB) R¯I σI (MB) R¯II σII (MB)
3 14.29 20.51 0.97 0.84 29.83 1.53 0.58
5 17.51 20.74 1.05 0.94 30.19 1.67 0.64
8 21.72 20.77 1.03 1.02 30.27 1.64 0.70
In the realistic fault simulation setup considered here, we set the distribution func-
tion of Rc as rc Np1, 0.0352q. We run the parameter various-aware fault simulation
for 1000 times. When a droplet is split by electrowetting forces F1 and F2, and
‖F1‖
‖F2‖ ¥ 1.10 (or
‖F2‖
‖F1‖ ¥ 1.10), then we assume that an error occurs.
Among the simulation results of the 1000 runs, 426 runs have one error occur,
129 runs have two errors, and none of the runs lead to more than two errors. The
simulation results corresponding to 5 runs can be found in Table 5.4. We can find
that the response time as well as the total completion time of the bioassay are reduced
using the proposed dictionary-based re-synthesis procedure.
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3.7.3 Mixing tree bioassay
In this part, we present the simulation results for a biochemical benchmark designed
in [74]. The sequencing graph of the bioassay can be found in [74], it represents
a solution preparation procedure, which has seven different kinds of reagent. The
final output is the droplet which has the mixing ratio of 2 : 3 : 5 : 7 : 11 : 13 : 87
[74]. The bioassay has 37 operations, and the number of droplets consumed is 10.
When the bioassay runs on an 8 8 array, the completion time of the bioassay is 60
seconds. For all the 740 dictionary entries, the numbers of droplets consumed in error
recovery are no more than 4. This is because in the protocol of mixing tree bioassay,
each mixing/dilution operation generates a redundant copy droplet. During error
recovery, these redundant droplet can be utilized, and only a small number of extra
droplets need to be dispensed.
For compaction Method I, the compaction ratios for the dictionary entries vary
from 2.1 to 13.4, The average compaction ratio for these entries is 4.8 and the stan-
dard deviation is 3.2. For compaction Method II, the compaction ratios for the
dictionary entries vary from 2.8 to 18.2, The average compaction ratio for these en-
tries is 6.6 and the standard deviation is 4.4. The size of the complete error dictionary
can be reduced from 6.15 MB to 1.18 MB (Method I) and 0.87 MB (Method II).
3.7.4 Flash chemistry
As introduced in [82], a microfluidic biochip is one of the promising hardware plat-
forms for flash chemistry. In this subsection, the simulation results for two repre-
sentative assays of flash chemistry are presented. The two assays are “synthesis of
unsymmetrical diarylethenes” (S1) and the “bromine-lithium exchange reaction of
o-dibromobenzene” (S2) [82]. The numbers of operations in S1 and S2 are 9 and
5, respectively. Here we assume that the two assays are concurrently executed on a
10  10 electrode array.
As the reaction times in flash chemistry usually are very short, here we assume
that the working frequency of the biochip is 100 Hz, and each mixing operation on
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Table 3.10: Compaction ratios of actuation matrices of an assay in flash chemistry.
No. elements No. non-zero
Errors Bioassay in the dictionary elements in the RI RII
inserted time (s) entry dictionary entry
M2 in S1 0.32 3200 93 11.47 11.19
M4 in S1 0.25 2500 86 9.69 9.19
M1 in S2 0.19 1900 94 6.73 6.60
M2 in S2 0.19 1900 87 7.28 6.93
a 2  4 array takes 0.04 second [82]. Since dispensing each reagent/sample droplet
takes 4 clock cycles [16], the completion time for each dispensing operation is set
as 0.04 second. In the error-free case, the completion time of these three bioassay is
0.19 seconds.
As the total number of operations in the “combined bioassay” is 14, the num-
ber of dictionary entries we generated is Ne  14   p14  13q{2  105. The average
response time for the proposed method is nearly zero. We have also derived the com-
paction ratios for all the dictionary entries, and part of the simulation results are
shown in Table 3.10. We find that for this small assay, Method I is more effective
than Method II.
3.8 Chapter summary and conclusions
In this chapter, we have described a dictionary-based hardware-assisted error recov-
ery approach for flash chemistry based on digital microfluidic biochips. The proposed
method minimizes the response time for error recovery, and provides precise control
of on-chip experiments for chemical synthesis. The proposed error-recovery proce-
dure and dynamic re-synthesis of a reaction can be implemented in real-time on an
FPGA. In order to store the error dictionary in the limited memory available in
the FPGA, we have presented two compaction techniques for reducing data volume.
We have used four laboratorial protocols to show that, compared to software-based
methods, the proposed dictionary-based error-recovery method has negligible impact
on the time-to response. It also requires less complex experimental setup, and needs
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only a small amount of memory on the FPGA board.
As part of future work, we will (i) explore applications of cyberphysical adaptation
to microfluidics for cell sorting [85] and for chip cooling [86]; (ii) explore alternative
methods (e.g., Huffman encoding [87]) for compacting the data in error dictionaries.
91
4Optimization of Polymerase Chain Reaction
4.1 Introduction
The amount of deoxyribonucleic acid (DNA) strands available in the biological sam-
ple is a major limitation for many genomic bioanalyses [88][89]. For example, in
the study of gene dosage in tumor DNA by comparative genomic hybridization, the
analysis procedure requires several hundred nanograms of DNA strands for fluores-
cent labeling [88]. It is impossible to obtain such a large amount of DNA strands
directly from biological samples. To overcome this problem, the polymerase chain
reaction (PCR) technique is used as the first step for these bioanalyses to amplify
(replicate) the initial DNA strands [88][89][90]. Based on the categories of operations
involved, the procedure of genomic analysis can be divided into two separate stages
[91]. The first stage is the amplification of the target DNA strands; the second stage
is the subsequent operations after DNA amplification, including mixing the droplet
that contains DNA strands with other reagents, and detecting the concentration of
intermediate product droplets.
Digital microfluidic biochips are used extensively for the quantitative analysis of
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biomolecular interactions and they offer a viable platform for performing the two
stages of the PCR procedure on the same chip layout [89]. Compared to conven-
tional instruments and analyzers, the digital microfluidic biochip platform offers
several advantages for implementing PCR. It can implement the complete PCR pro-
cedure seamlessly, and achieve short time-to-results, low reagent consumption, rapid
heating/cooling rates, and integration of multiple processing modules [90][92]. The
size and power consumption of the entire PCR system can also be reduced.
An example of a digital microfluidic biochip performing DNA amplification (i.e.,
the first stage of the PCR procedure) is shown in Figure 4.1 [89][93]. A “heated”
region and a “cooled” region are created by thermal units (e.g., a heater). First,
the droplets dispensed from the reservoir “PCR mix” are mixed with the biological
sample that contains the target DNA strands. Next, the well-mixed droplet is al-
lowed to pass through several alternating heating and cooling steps [89][93]. Each
thermal cycle contains two steps, i.e., 1) heating the droplet, which separates the
double-stranded DNA inside the droplet into two strands, called “DNA melting”;
and 2) cooling the droplet, with each strand of the DNA working as a template
for synthesizing new DNA strands, called “primer annealing”. In this way, the ini-
tial DNA strands can be amplified into millions of copies [89]. As the target DNA
strands in the droplet are labeled with fluorophores, by measuring their intensity of
the fluorescence with optical detectors integrated on the biochip, one can monitor
the concentration of the DNA strands in the droplet.
In the second stage of the PCR procedure, the droplet that contains the ampli-
fied target DNA strands are further mixed with other reagents to create analysis
spots with different concentrations of DNA [91]. The fluorescence intensities of these
analysis spots can be measured to analyze the interaction between probe and target
biomolecules.
Despite offering numerous benefits, prior work on PCR implementations on a
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Figure 4.1: Schematic of a digital microfluidic biochip that can perform DNA
amplification [89][93].
digital microfluidic biochip suffers from the following four shortcomings:
1. In all prior work, the functional modules used in the two stages of the PCR
procedure are designed separately [89][93], and they cannot be efficiently inte-
grated on the same layout. This mismatch of the two steps often restricts the
effectiveness and feasibility of execution of the complete bioassay.
2. The inherent randomness and complexity of bioanalyses are not considered.
When a droplet is dispensed into the biochip, there is a probability that the
droplet may not contain enough DNA for the PCR (referred to as an “empty
droplet”) [94]. The biochips designed in prior work are unable to monitor the
presence of empty droplets; hence they cannot terminate the wasteful execution
of the PCR.
3. The interferences (electrical, thermal, optical, fluidic) among the devices on
the biochip, which arise because of proximity effects, are not considered in
previous work. For example, high temperature around the heater may lead to
degeneration of a biological sample in a reservoir [95]; therefore, the heater and
the reservoir cannot be placed too close to each other.
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4. The previously designed PCR biochips are oblivious to the schedule of mixing
operations [91]. This may lead to excessive transportation of droplets during
mixing/dilution/detection operations in the second stage of the PCR proce-
dure; hence the performance and speed of the biochip may be adversely af-
fected.
To overcome the above shortcomings, we propose the first design method that can
optimize the PCR procedure. The key contributions of this chapter are as follows:
1. To overcome the empty-droplet recognition problem, a statistical model for
DNA amplification is used to predict whether the droplet has enough DNA
strands to carry out the PCR. The intensity of fluorescence detected by the
photodetectors (PDs) are fed back to the system on-line, in order to decide
whether or not the thermal cycles are to be continued. This helps us to de-
sign an efficient cyberphysical PCR biochip on a digital microfluidic biochip
platform.
2. We propose a layout design algorithm that considers the interferences among
the on-chip elements such as reservoirs, sensors and thermal units. A heuristic
algorithm is developed to minimize the area and electrode count of the biochip
and satisfy the proximity constraints.
3. The placement of modules considers the time cost of droplet transportation and
defect tolerance of the PCR biochip. The overall mixing/dilution/detection
time for a given bioassay is optimized, and a droplet-routing method is devel-
oped to bypass electrode defects.
This chapter is organized as follows. Section 4.2 describes the statistical model
for the amplification of DNA strands and the on-line decision making method during
95
an actual experiment. Section 4.3 presents the layout design algorithm with the con-
sideration of device interferences. It also describes an application-specific reservoir
allocation method. Simulation results for three widely used bioassays are presented
in Section 4.4. Section 4.5 concludes this chapter.
4.2 Cyberphysical biochip with on-line decision making
Figure 2.5 presents the setup for cyberphysical PCR biochip [96]. The sensing system
on biochip monitors the intensity of fluorescence in the droplet, and provides input
to the control software. In this way, the software can control the execution of the
PCR procedure based on the sensor feedback.
4.2.1 Statistical model for the number of DNA strands in a droplet
When droplets are dispensed from the reservoir into the digital microfluidic biochip,
the number of DNA strands contained in a droplet can be considered to be a random
variable [94][97]. Based on the statistical data derived from several biochemistry
experiments, we note that the dispensing process follows Poisson statistics when the
density of the DNA strands in the biological sample is low. Therefore, the number
of DNA strands in a droplet is given by [94][97]:
P pXc  kq  eλλ
k
k!
(4.1)
where k is the number of DNA strands in the droplet and λ is the average number
of DNA strands per droplet.
When the number of DNA strands in a droplet is too low, the PCR procedure
cannot be carried out successfully [98]. The droplets that contain low amounts of
DNA strands are referred to as “empty droplets”. If empty droplets are detected at
the end of the PCR, the time spent on running the thermal cycles is wasted. In order
to investigate this problem, the feedback signal from the integrated sensors can be
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used for making an online probabilistic decision whether or not a droplet is empty.
As noted in [91][93], during the execution of the PCR, the intensity of fluorescence
in the droplets can be monitored by on-chip detectors. If the probability that “the
droplet is empty” is high, the droplet will be discarded. A new droplet will then be
dispensed into the biochip for PCR processing.
In the next part of this section, we introduce statistical models of the PCR
bioassay based on which an on-line decision making system will be designed.
4.2.2 A simplified statistical model for amplification of DNA
During the calibration of the dispensing operation, the probability of generating a
“good droplet” can be derived [94]. A good droplet is one that contains a sufficient
number DNA strands for running the PCR. Let G denote the event “a good droplet
is dispensed into the biochip”. The complement of G is the event Gc, i.e., “an empty
droplet is dispensed into the biochip”.
We assume that when running the PCR on a good droplet, the probability of
detecting a fluorescence signal (which indicates that the DNA has been amplified)
at the ith thermal cycle is pi. Let Ak denote the event “no signal is obtained from
the droplet at the kth thermal cycle”. Therefore, the joint probability of G and Ak
can be written as:
P pGX Akq 
k¹
i1
p1  piq  P pGq (4.2)
If no signal is detected at the kth thermal cycle, the conditional probability that
“this is a good droplet” (written as P pG |Akq) is defined as the quotient of the joint
probability of G and Ak, and the probability of Ak:
P pG | Akq  P pGX Akq
P pAkq
 P pGX Akq
P pGX Akq   P pGc X Akq
(4.3)
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where P pG X Akq 
k±
i1
p1  piq  P pGq, and P pGc X Akq  P pGcq  1  P pGq.
Therefore, we have:
P pG | Akq 
k±
i1
p1  piq  P pGq
k±
i1
p1  piq  P pGq   1  P pGq
P pGc | Akq  1  P pGqk±
i1
p1  piq  P pGq   1  P pGq
.
4.2.3 An improved statistical model for amplification of DNA
During the calibration of DNA amplification, one may categorize the droplets based
on the number of DNA strands therein. Equation (4.3) remains valid in this scenario.
Let event Gi denote “a droplet with i DNA strands is dispensed into the biochip”.
We assume that Mmin is the minimum number of DNA strands in a droplet needed
to run DNA amplification successfully. Then the event G in Equation (4.3) can be
written as:
G  GMmin YGMmin 1 YGMmin 2 Y    YG8, (4.4)
where the events GMmin , GMmin 1,   , G8 are mutually exclusive.
The event Ak in Equation (4.3) can now be written as:
Ak  A0k Y A1k Y A2k Y   Ajk Y    Y A8k , (4.5)
where Ajk is the event that “no signal has been observed from a good droplet with j
DNA strands (j ¥ Mmin) after k thermal cycles”. It is easy to note that the events
A0k, A
1
k,   , A8k are mutually exclusive.
From the definitions of Gi and A
j
k, it follows that P pGi X Ajkq  0, if i  j or
i  j   Mmin. When i  j ¥ Mmin, the value of P pGj X Ajkq can be empirically
derived by calibrating the amplification of DNA. The probabilities P pG X Akq and
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P pGc X Akq in Equation (4.3) can be calculated as follows:
P pGX Akq P pGX pA0k Y A1k Y A2k Y   Ajk    YAMk qq
P pGMmin X AMmink q   P pGMmin 1 X AMmin 1k q 
P pGMmin 2 X AMmin 2k q        P pG8 X A8k q
P pGc X Akq P pG0q        P pGMmin1q.
When we run DNA amplification on a good droplet that contains m (m ¥Mmin)
DNA strands, we assume that the probability of detecting the fluorescence signal
(i.e., the DNA has been amplified) is pmi at the i
th thermal cycle. Then the value of
P pGXAkq and P pGcXAkq can be derived in terms of pmi . Therefore, if the fluorescence
signal is not detected at the kth thermal cycle, the conditional probability that “the
droplet is an empty droplet” as well as “the droplet is a good droplet” can be analyzed
in a similar way as the method presented in Section 4.2.2.
During DNA amplification on a cyberphysical PCR biochip, the control software
calculates the values of P pG X Akq and P pGc X Akq according to the feedback from
the sensor at each thermal cycle. When the value of P pGcXAkq reaches a threshold
value (e.g., 95%), the control software will conclude that the droplet is empty. It
will initiate a new set of electrode-actuation sequences to discard the empty droplet
and dispense a new droplet into the biochip. The PCR procedure will therefore be
continued in an adaptive manner on the biochip.
4.3 Optimized layout design under proximity constraints
In this section, we present our algorithm for optimizing the layout under design con-
straints. On the PCR biochip, there are three categories of devices: reservoirs, PDs,
and one thermal unit (e.g., a heater). In order to avoid interferences among the
on-chip devices, we assume that the following constraints indicating the minimum
(threshold) intra-pair and inter-pair separation distances between the respective de-
vice pairs, must be satisfied. These constants are provided as inputs to biochip
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designers.
Separation constraints:
1. Reservoir to reservoir separation: In order to avoid fluidic leakage between two
reservoirs, the distance between them should be no less than a threshold LRR
[99]. A typical value of LRR is four times the length of electrodes on the digital
microfluidic biochip [100].
2. PD to PD separation: Two PDs may have undesirable crosstalk if the distance
between them is too short [101]. Therefore, the distance between two PDs
should be no less than a minimum value of LPP. A typical value of LPP is four
times the length of electrodes on the digital microfluidic biochip [27].
3. Reservoir to PD separation: Fluids loaded in the reservoirs may contain fluores-
cent labels and thus they may influence the accuracy of a PD [99]. Therefore,
the separation between a reservoir and a PD should be no less than a threshold
LRP. A typical value of LRP is five times the length of electrodes on the digital
microfluidic biochip [27].
4. Reservoir to heater separation: Since the biological samples and reagents loaded
in the reservoirs may undergo degeneration under heating [95], the distance
between a reservoir and a heater should be no less than a threshold LRH.
A typical value of LRH is five times the length of electrodes on the digital
microfluidic biochip [89].
5. PD to heater separation: A proximity to a heater may affect the sensitivity of
a PD [102]. Hence, the distance between a PD and a heater should be no less
than a minimum value of LPH. A typical value of LPH is three times the length
of electrodes on the digital microfluidic biochip [89].
For simplicity, we define an operator C, which is a mapping from a pair of ar-
bitrarily chosen devices (written as da and db) to the required minimum distance
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between them:
C : pda, dbq Ñ Minimum distance between da and db.
For example, if da denotes a PD and db denotes a heater, then Cpda, dbq  LPH.
In order to design the layout for a PCR biochip with devices d1n on it, we must
determine the coordinates of all the devices (written as px1, y1q, px2, y2q, ..., pxn, ynq)),
such that: b
pxi  xjq2   pyi  yjq2 ¥ Cpdi, djq, @i, j.
4.3.1 Resource placement on PCR biochips
We assume that the PCR layout will be built on an underlying 2D unit square
lattice, where each grid point has integer Cartesian coordinates. Every physical
device/electrode is assumed to be placed around a grid point. If da and db denote
two devices to placed on the chip, we draw two circles each with radius Cpda,dbq
2
,
centering at da and db. If these two disks are disjoint, i.e., non-overlapping, then
the distance between their centers will be no less than Cpda, dbq. In other words, the
corresponding separation constraint will be satisfied. However, in order to minimize
the area of the chip, all the devices need to be placed as closely as possible. An
example of compact placement of a heater and a reservoir is shown in Figure 4.2(a).
The problem for determining such a compact non-overlapping placement is similar to
the widely-studied problem of “circle packing” in the Euclidean space, and is defined
as follows [103]:
Definition 1. “A circle packing is a configuration P of circles realizing a specified
pattern of tangencies.”
However, the device placement problem in a biochip differs from the classical
circle packing in the following two aspects: (i) The layout of a digital microfluidic
biochip consists of a discrete electrode array; hence the devices (which are represented
by the centers of the corresponding circles needed to be packed) are constrained to
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Figure 4.2: (a) Compact placement of a reservoir and a heater; (b) outer isothetic
cover (OIC) that tightly encloses the forbidden region of R2; optimal placement of a
reservoir R2 in the presence of a reservoir R1, a PD P1, and a heater H.
lie on integer grid points, and (ii) for two devices da and db, the radius of the circle
Cpda,dbq
2
, depends on the device pair. Therefore, the definition of “tangency of two
circles” should be modified as follows.
Definition 2. The circles centered at the locations of da and db are tangent to each
other if the distance between their centers is exactly equal to Cpda, dbq.
Since every pair of devices may require a distinct separation constraint, the overall
search space may become very large and we conjecture that the problem of finding
a minimum-area layout is an non-deterministic polynomial-time hard problem [104].
Hence to build our design tool, we use the following greedy algorithm based on an
iterative method.
Let us assume that some devices are already placed while satisfying their mutual
separation constraints, and a new device is now to be placed on the chip. In order to
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satisfy its proximity constraints with each of the other devices, we reformulate the
circle packing approach by defining a forbidden region for each existing device with
respect to the current one. Thus if di denotes an existing device and dj denotes a
new device, a forbidden region where dj cannot be placed will be inside the circle
of radius Cpdi, djq centered at di. The boundary of the overall forbidden region,
at any instant of time, will then be defined by a set of circular arcs whose centers
denote the locations of the devices already placed on the chip. The radius of a circle
is determined by the required minimum distance between the corresponding device
and the new one.
In our iterative method, first we choose one device di and place it at the origin
p0, 0q of the layout grid. Next, another device, say dj is chosen for placement. We
draw a circle of radius Cpdi, djq with its center at di. We flag all the grid points which
lie inside the circle as “forbidden” while placing dj. Thus dj may be placed on any
grid point that lies on or outside the circle to satisfy the separation constraint. At
any instant of time, let us assume that the devices d1, d2, . . . , dk have already been
placed. When considering the placement of the device dk 1, we proceed as follows:
for each device di already placed, we draw a forbidden circle centering at di with
radius Cpdi, dk 1q, and flag all the grid points as “forbidden” that lie in the interior
of the union of all these circles. The point dk 1 may be placed anywhere outside
this forbidden region. However, to minimize the layout area, we place it on a grid
point such that the area of the convex hull [105] of the point set td1, d2, . . . , dk, dk 1u
is minimized. This procedure is illustrated in Figure 4.2(b), where in the presence
of a heater H, a PD P1, and a reservoir R1, we show how a new reservoir R2 can
be optimally placed. We also assume that the heater is placed at the origin of the
layout in the first step of our algorithm.
In each subsequent iteration, we randomly choose a device whose position has
not been determined. The device will be optimally placed by the above algorithm.
In order to manipulate the forbidden region efficiently while implementing our
algorithm, we use the concept of “outer isothetic cover (OIC)” of a digital contour
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[106]. The OIC is a tight-fitting axis-parallel polygon that just encloses a given
contour on a 2D grid. In our case, the contour is defined by a set of circular arcs
(see Figure 4.2(b)). Hence all the grid points that are labeled as forbidden will be in
the interior of the OIC, and all other grid points will be on its boundary or outside.
Since our objective is to minimize the layout area, it is sufficient to limit the search
for possible placements of a new device only to the set of grid points that lie on
the boundary of the OIC. Let Lmax denote the maximum value of all the separation
thresholds (i.e., maximum radius of a forbidden circle). Since Lmax is a constant, the
number of grid points on the boundary of OIC when k devices are already placed, will
be Opkq. Clearly, any grid point chosen on the boundary of the OIC will satisfy all
the separation constraints for placing the next device dk 1. Thus, instead of explicitly
flagging all the Opk2q forbidden grid points lying at the interior of the circles, we
mark only Opkq valid grid points on the boundary of the OIC. During the execution
of our algorithm, for the k devices which are already placed, we maintain a convex
hull on the set of grid points corresponding to their locations. Next, while placing the
device dk 1, we search among the grid points on the boundary of the OIC, such that
the area of the incremental convex hull is minimized. This can be found in Opk2logkq
time, since for each point on the boundary OIC, the new convex hull can be computed
in Opklogkq time [105]. Hence the total time complexity of placing n devices on the
PCR biochip will be Opn3lognq. An improved algorithm can be designed by using
a more sophisticated data structure used for dynamic maintenance of a convex hull
[107].
In our heuristic algorithm, we have chosen the ordering of device placement ran-
domly, and this ordering may influence the layout area. Assume that we have Nr
indistinguishable reservoirs, and Nd indistinguishable PDs, and Nh heaters. Thus
the number of possible orderings of device placement is given by
pNr  Nd  Nhq!
Nr!Nd!Nh!
.
In practice, only a few PDs are integrated on a biochip due to their high fabri-
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cation cost, and a single heating/cooling module suffices. The number of reagents
required in a typical mixing procedure after DNA amplification is around 8. Also,
it is customary to place the output ports of reservoirs around the boundary of the
chip and the heater in the interior. Therefore, the number of possible orderings sig-
nificantly reduces in a practical scenario. Hence we have run the above-mentioned
heuristic algorithm exhaustively on all orderings. The one that yields the minimum
area of the biochip is selected. In the next subsection, we will discuss how to optimize
droplet transportation and mixing time in the context of a specific bioassay protocol.
4.3.2 Bioassay-specific reservoir allocation for PCR biochips
The placement algorithm described in the previous section assigns a location for each
of the devices on a 2D grid. To complete the layout design, we now have to create
the droplet transportation paths among the devices. In a typical mixing procedure
after DNA amplification, several reagents/samples are required to be mixed in a
certain ratio. The number of mix-split operations depends on the mixing algorithm
and the target ratio. The mixing process is generally represented as a mixing (or
a sequencing) graph G, where each leaf node represents a reagent and an internal
node represents a fluidic operation, e.g., mixing/splitting [74]. Hence, the droplet
transportation cost in the PCR should be optimized based on the given mixing
ratio. This needs appropriate allocation of reservoirs to the reagents and scheduling
of mixing/dilution/detection operations as specified in the sequencing graph.
In order to reduce the number of electrodes on the biochip, we do not pre-assign
any specific region for mixer modules. We assume that all the mixing/splitting
operations will be performed on the electrodes lying between the output ports of
reservoirs. Let D1 and D2 denote two dispensing operations from reservoirs R1 and
R2 respectively, and let M1 represent a mixing operation between these two droplets
(Figure 4.3(a)). A possible placement of these modules is shown in Figure 4.3(b).
The droplets dispensed from R1 and R2 are mixed on the electrode array between
these two reservoirs.
Given a specific reservoir allocation to the reagents, the droplet transportation
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D1 D2
M1Mixer assigned for M1
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Figure 4.3: (a) Sequencing graph for the dispensing and mixing of two droplets;
(b) placement of the output port of reservoirs and the mixer; (c) an example of defect
tolerance by droplet rerouting.
cost for the entire bioassay can be estimated from the sequencing graph as follows:
Step 1: Assign a physical location to each node in the sequencing graph G. For a
node Nar in G, we may have the following cases:
1. If Nar represents a dispensing operation, then the coordinates of Nar are set as
those of the corresponding reservoir.
2. If Nar represents a mixing/splitting operation between two nodes N1 and N2,
then the coordinates of Nar are set as:
xNar 
xN1   xN2
2
and yNar 
yN1   yN2
2
,
where pxN1 , yN1q and pxN2 , yN2q are the coordinates assigned to nodes N1 and
N2, respectively.
Step 2: Estimate the cost of droplet transportation for each node in the sequencing
graph G. For a node Nar, we may have the following two cases:
1. If Nar represents a dispensing operation, then the cost of droplet transportation
for Nar is set to zero.
2. If Nar represents a mixing/splitting operation between two nodes N1 and N2,
then the cost of droplet transportation for Nar (written as TNar) is set as the
Manhattan distance between the two nodes:
TNar | xN1  xN2 |   | yN1  yN2 |,
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where pxN1 , yN1q and pxN2 , yN2q are the coordinates of nodes N1 and N2, re-
spectively.
Step 3: Estimate the cost of droplet transportation for detection operation. We
assume that a droplet corresponding to a node Nar will be sent to the nearest PD
for optical detection (the corresponding detection operation is represented as DNar);
then the cost of droplet transportation for DNar is set as:
DNar  minp| xNar  xd1 |   | yNar  yd2 |, | xNar  xd2 |   | yNar  yd2 |, ...,
| xNar  xdNd |   | yNar  ydNd |q,
where pxd1 , yd1q, pxd2 , yd2q, ..., pxdNd , ydNd q are the corresponding coordinates for the
Nd PDs on the layout.
Step 4: For each possible configuration of reservoir allocation, the overall droplet
transportation time for the bioassay is estimated by adding the transportation costs
of all the operations in the mixing procedure. The one with the minimum droplet
transportation time is selected for reservoir allocation.
4.3.3 Layout design of PCR biochips
Once the reservoir allocation step is completed, we establish droplet transporta-
tion pathways to connect these reservoirs based on the sequencing tree. A device
or a mixing module is assigned to each node of the tree based on their coordinates
attached to it. As mentioned in Section 4.3.1, a heater is placed at the origin of the
layout. Typically, all the output ports of reservoirs on the layout are connected in a
“cycle” consisting of electrodes [68][93]. The defect tolerance of PCR biochips with
this circular electrode path can be enhanced. An example is shown in Figure 4.3(c).
Two droplets are scheduled to be mixed together, and their original transportation
paths are indicated by the arrows. When a defect is present on the layout, the
transportation paths of these two droplets can be dynamically adjusted. Therefore,
by using an alternative droplet transportation path, the PCR biochip can be used
despite the presence of the defect.
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1: Phase 1:
2: for each permutation of n devices (written as {dk1 , dk2 , ..., dkn}) to be placed on
the layout do
3: Place dk1 at the origin of the layout;
4: for each dki P{dk2 , dk3 , ..., dkn} do
5: Draw the forbidden circular regions constrained by each of the devices {dk1 ,
dk2 , ..., dki1} with respect to dki . Construct the OIC enclosing the forbidden
regions;
6: Find the grid point gi on the boundary of the OIC, such that area of the
convex hull defined by the points located at {dk1 , dk2 , ..., dki} is minimum.
Place the device dki on gi;
7: end for
8: Output the placement geometry and calculate the area of the biochip;
9: end for
10: Choose the least-area device placement; // At this step, the locations of all the
devices are determined. All the reservoirs are considered identical.
11: Phase 2:
12: Determine the best reservoir allocation of reagents based on the estimated time
cost of droplet transportation and the frequency of reactant usage;
13: Establish routing paths to connect all the devices following the sequencing tree;
Figure 4.4: Pseudocode for layout design for PCR biochips.
Finally, the paths consisting of electrodes are added in order to connect the PDs
to the respective mixer nodes. The pseudocode for the entire design cycle is shown
in Figure 4.4.
4.4 Simulation results
In this section, we first present simulation results to evaluate the proposed method-
ology for designing a cyberphysical and layout-aware PCR biochip for a specific
bioassay. We also present simulation results on three benchmarks for mixing proto-
cols.
4.4.1 Probabilistic approach to control DNA amplification on a biochip
The statistical model proposed in Section 4.2.1 can be used for on-line decision
making during the amplification of DNA strands. It is important to note that the
fluorescence signal from the amplified DNA may not be detected immediately when
the target DNA strands are amplified. This is because of the fact that each PD has
a minimum detectable signal (MDS) [108]. The fluorescence signal of the amplified
DNA cannot be detected if its strength is lower than the MDS. Therefore, in our
statistical model, we assume that, when we perform thermal cycles on a droplet, the
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Figure 4.5: Relationships between i (i.e., the number of thermal cycles that have
been carried out) and P pGc|Aiq (i.e., the probability that “this droplet is an empty
droplet”) derived using three statistical models of PCR procedure.
probability of detecting a fluorescence signal from the amplified DNA strands is zero
before the N th thermal cycle. At the ith (i ¥ N) thermal cycle, the probability of
detecting the fluorescence signal (i.e., the DNA is amplified) is pi.
If we assume that N  20, P pGq  0.8, and pi  0.3 (@ i ¥ 20). The relation-
ship between i (i.e., the number of thermal cycles that have been carried out) and
P pGc|Aiq (i.e., the probability that “this droplet is an empty droplet”) is shown in
Figure 4.5(a). From Figure 4.5(a), we observe that, if there is no sensor signal at
the 25th, 27th, or 28th thermal cycles, the value of P pGc |Aiq is 85%, 90%, or 95%,
respectively. The relationship between i and P pGc |Aiq when setting “P pGq  0.8
and pi  0.2”, and “P pGq  0.7 and pi  0.3” can also be found in Figure 4.5(a).
Since there is an exponential increase in the number of target DNA strands
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when the PCR is performed successively, we can also assume that the probability pi
increases exponentially. For example, we can set N  20, P pGq  0.8, and set pi as
follows:
pi 
$&%
0, if i   N
p  2iN , if N ¤ i ¤ N  log2p
1, if N  log2p   i
In this scenario, the corresponding relationship between P pGc|Aiq and i is shown
in Figure 4.5(b). In the three curves shown in Figure 4.5(b), the value of p is set
as 104, 105, and 106, respectively. For example, when p is set as 105, from
the figure we can conclude that if there is no signal at the 36th thermal cycle, the
probability that “this droplet is an empty droplet” is 60%; if there is no signal at the
37th thermal cycle, the probability becomes 99%. Therefore, if no signal is detected
after the 37th thermal cycle, we have a 99% confidence level that the droplet does
not contain enough DNA strands for PCR, and the droplet should be discarded.
We can also analyze the stage of DNA amplification by considering the more
detailed statistical model introduced in Section 4.2.3. Since in the ideal case, the
number of DNA strands in a droplet increases exponentially, we assume that the
value of pmi can be written as follows:
pmi 
$&%
0, if i   N
p1 miN , if N ¤ i ¤ N  log2p1
1, if N  log2p1   i
where Mmin  3 and N  20. For the distribution of the number of DNA strands in
droplets shown in Equation (4.1), we assume that λ  4. The relationships between
i and P pG | Aiq when the value of p1 is set as 104, 105, and 106, are shown in
Figure 4.5(c).
4.4.2 Layout design for PCR biochips
Consider a biochip with seven reservoirs, two PDs, and one heater; the separation
constraints are set as LRR  4, LPP  4, LRP  5, LRH  5, and LPH  3. The
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Figure 4.6: (a) Device placement obtained by the proposed algorithm. R represents
the output port of the reservoir, P represents the PD, and H represents the heater.
All the reservoirs are treated as identical devices and all the PDs are treated as
identical devices; (b) Reservoir allocation with the minimum droplet routing cost.
R17 are reservoirs assigned to inputs x17 in Figure 4.7, P1 and P2 are PDs, and H
is the heater. The white squares correspond to electrodes.
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Figure 4.7: Sequencing graph for a solution preparation procedure. The inputs
of the mixing procedure are seven different kinds of samples/reagents and the final
output is the droplet that has the mixing ratio of 2:3:5:7:11:13:87 [74]. These seven
samples/reagents are loaded into reservoirs R17 on the PCR biochip.
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simulation is run on a 2.30 GHz Intel i3 dual-core processor with 8 GB of memory.
The CPU time needed to generate all the possible device placements is 92.0 seconds.
One of these layout designs with the minimum area is shown in Figure 4.6(a). The
output ports of reservoirs, PDs, and the heater are represented by “R”, “P”, and
“H”, respectively. If each electrode is assumed to have unity area, the size of the
smallest-area rectangle enclosing the layout turns out to be 14  10.
After we design a layout with the minimum area, a suitable reservoir allocation
for reducing droplet transportation is determined based on the protocol of a specific
PCR. Figure 4.7 shows a mixing procedure for solution preparation, which is referred
as Bioassay 1 [74]. Let us assume that reagent x6 contains the amplified DNA strands
obtained from the first stage of PCR, and output droplets of the mixing operations
M2, M6, M10, and M13 will be detected by the PDs. According to the frequency
of reactant usage in the mixing procedure, the optimal result of reservoir allocation
can be derived by the heuristic algorithm proposed in Section 4.3.2. Figure 4.6(b)
shows the final layout obtained after reservoir allocation that minimize droplet trans-
portation time. Reagents x17 in Figure 4.7 are loaded into R17. The CPU time
needed to compute this result of reservoir allocation is 0.4 second and the number
of electrodes on the layout is 45. It is important to note that, the heater is used to
create a high temperature zone on the layout and it will not be connected with other
devices.
While executing the bioassay, the electrode path that connects the output ports
for a pair of reservoirs can be assigned as mixers. All the mixing operation in the
protocol can thus be performed “locally” without long-distance transportation or
conflicts in droplet routing. For example, the inputs of operations M1, M4, and M8
are reagents x4 and x7, and accordingly, these mixing operations will be performed
on the electrodes between R4 and R7.
In addition, since the conflicts of resource-sharing and droplet routing on the
biochip can be avoided, the degree of parallelism for fluid-handling operation is high.
We assume that the completion time of mixing on a 14 mixer is 5 seconds, and
the time to move the droplet from electrode to another electrode is tm second (tm
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Figure 4.8: (a) The result of device placement derived by the baseline algorithm.
The output ports of reservoir 1  7, PD 1  2 and the heater are placed on the
boundary of the layout one by one. R1 and R2 here represent the output ports of
two reservoirs; (b) conflicts of droplet routing on the layout derived by the baseline
algorithm.
usually varies from 0.01 to 1 [21]). Then the execution time of the whole bioassay
on the layout shown in Figure 4.6(b) will be (35+16tm) seconds.
Here we design another device placement as the baseline algorithm. In the base-
line method, all the devices (including the output ports of reservoirs, PDs, and the
heater) are placed at the boundary of the layout one by one. The distance between
any two devices is set as Lmax  max{LRR, LPP, LRP, LRH, LPH}, as shown in Fig-
ure 4.8. A circular path, which consists of all the boundary electrodes, connects all
these devices.
The size of the electrode array derived by baseline algorithm is 17  17, and the
number of electrodes required for this design is 64. When we execute the mixing
bioassay on the layout derived by the baseline algorithm, conflicts in droplet routing
and resource sharing may occur. An example is shown in Figure 4.8(b). As defined
by the sequencing graph shown in Figure 4.7, the droplets dispensed from R1 and R4
need to be mixed together in M5, and the droplets dispensed from R3 and R5 need to
be mixed together in M3. The transportation paths of the droplets dispensed from
R1, R3, R4, and R5 are indicated by the arrows in Figure 4.8(b).
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It is easy to observe that the mixing operations M3 and M5 cannot be executed
concurrently. The execution time of the complete bioassay on the layout shown in
Figure 4.6(b) will be (55+36tm) seconds.
Compared with the baseline algorithm, the proposed design method can thus
reduce the chip area by 52%, the number of electrodes by 27%, and the execution
time by 38% (when the value of tm is set as 0.1).
Next, we study a protocol, which represents a real-life PCR mixing ratio [109].
This bioassay is referred to as Bioassay 2. The mixing ratio of the eight components
is written as [109]:
{Reaction buffer: Mag Sulf: dNTPs: Forward primer: Reverse Primer: Opti-
mase: Water: DNA} = t10% : 10% : 8% : 0.8% : 0.8% : 1% : 68.4% : 1%u. The
corresponding mixing tree can be derived by the ratioed mixing algorithm (RMA)
[74]. The simulation results of the PCR biochip designed for Bioassay 2 are shown
in Table 4.1.
We consider another mixing protocol called Bioassay 3 [58], which has three
input reagents/samples. The results are shown in Table 4.1. In all the three cases,
the layout size, electrode count, and execution time of bioassays are significantly
improved compared to the baseline method.
4.4.3 Defect tolerance of layouts for PCR biochips
Because of manufacturing imperfections and degradation of electrodes, physical de-
fects may occur on digital microfluidic biochips. The defects can be classified into
two categories based on their locations on the biochip. If a defect disconnects a
droplet path into two “isolated parts” (i.e., droplets cannot be moved from one part
to the other part), it is defined as a “catastrophic defect”. All other defects are
defined as “non-catastrophic defects”.
If a catastrophic defect occurs, the PCR biochip cannot be used further. On the
layout designed for Bioassay 1, the positions of electrodes where defects are catas-
trophic are shown in Figure 4.9(a). For each of these three PCR biochips designed
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Figure 4.9: (a) The positions of “catastrophic defects”. If the electrodes at these
positions have defects, the biochip cannot be used any more; (b) non-catastrophic
defect can be by-passed by adjusting the routing of droplets.
Table 4.2: Defect tolerance of PCR biochips.
Total number Average Standard deviation
of electrodes execution time of execution time
where defects when a non-catastrophic when a non-catastrophic
Bioassay are catastrophic defect is injected (s) defect is injected (s)
1 17 58.7 8.3
2 16 86.8 12.6
3 7 33.9 11.6
for Bioassays 1  3, the total number of electrodes where defects are catastrophic is
shown in Table 4.2.
If a non-catastrophic defect occurs, we can re-route the droplets to send them
to their destinations, as shown in Figure 4.9(b). It is important to note that re-
routing the droplet may increase the length of the transportation path, and reduce
the degree of parallelism of fluid-handling operations. Therefore, compared with
the defect-free biochip, the execution time of the bioassay on a biochip with a non-
catastrophic defect is higher. Nevertheless, we can achieve defect tolerance through
software adaptation.
For each PCR biochip, we randomly insert a non-catastrophic defect into the
biochip, and then calculate the execution time of the bioassay. The defect-insertion
simulation is exhaustive in that it is executed for all possible non-catastrophic defects
on the layout. The average value and the standard deviation for execution time of
running bioassays on biochips with defects are shown in Table 4.2. The value of tm is
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set as 0.1. From the table, we find that the percentage of electrodes where defects are
catastrophic is 23.3%37.8%, i.e., most of the defects can be tolerated by rerouting
the droplets. With the presence of a single non-catastrophic defect, the PCR biochip
can be used via graceful degradation with a 29.4%66.4% increase in the execution
time of bioassay.
4.5 Chapter summary and conclusions
In this chapter, we have shown how the cyberphysical integration of a PCR protocol
on digital microfluidics can be used to reliably execute on-chip bioassays, despite the
uncertainties inherent in fluidic operations such as dispensing operation and thermal
cycling. The proposed design approach facilitates dynamic on-line decision making
for the termination of thermal cycles in response to feedback from sensors. We have
also presented new algorithms for device placement and layout design that safeguard
the bioassay against undesirable device interferences and reduce the execution time.
Simulation results on three laboratory protocols demonstrate that the proposed de-
sign method can achieve high reliability and defect-tolerance with minimum chip
area and electrode count.
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5Biochemistry Synthesis under Completion-Time
Uncertainties in Fluidic Operations
5.1 Introduction
Digital microfluidics enables the integration of fluid-handling operations, biochemical
reaction-outcome detection, and software-based control in a biochip. Biochemical as-
says, such as the dilution of samples and reagents, crystallization of protein molecules,
on-chip chemistry for DNA sequencing, multiplexed real-time polymerase chain reac-
tion (PCR), protein crystallization for drug discovery, and glucose measurement for
blood serum, have been successfully implemented on digital microfluidic biochips.
The precision of fluidic operations is vital for the accuracy of analytical bioassays.
For example, in the quantitative measurement for glucose concentration in blood
[54], accurate measurements cannot be obtained if the mixing time for blood sample
and enzymatic reagent is not controlled precisely. In order to determine appropriate
parameter settings and increase the precision of on-chip operations, bioassays need to
be thoroughly characterized [21; 110; 111], i.e., fluidic operations must be repeatedly
executed and monitored to obtain statistically significant results [110]. Based on
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these results, a module library is derived to define the execution time for each type
of operation, and this library is used as the guideline for the execution of on-chip
operations.
However, as the characterization of bioassays requires repeated execution of each
operation, it is a time-consuming process and leads to the wastage of sample and
reagent droplets. Even after careful characterization, the problem of inaccuracy re-
mains due to the inherent variability and randomness of biological/chemical processes
[21; 32; 43; 110; 111; 112]. When a large number of fluidic operations are involved,
the bioassay yield is low due to the compounding inaccuracy for multi-step assays.
Here the yield of bioassay is defined as the percentage of bioassay instances that can
produce outcome droplets with expected concentrations.
In order to overcome the drawbacks associated with characterization, biochips
integrated with sensing systems, i.e., cyberphysical microfluidic biochips, are being
developed [54][111][113][114]. The feedback provided by the sensing system enables
real-time concentration checking, error detection, and error correction for fluidic
operations [54]. Therefore, essential operations such as droplet dispensing and mixing
can be precisely implemented on cyberphysical microfluidic biochips without the need
for characterizing a bioassay or specifying a module library [54][113].
However, today’s synthesis algorithms for mapping biochemistry protocols to
the chip still rely on characterization procedures for bioassays [51; 64; 115]. Hence
the advantages of cyberphysical integration are not fully exploited, and precious
samples/reagents and time are wasted during characterization. In addition, current
design methods suffer from the following limitations:
1. Prior work is oblivious to variability and uncertainty in biochemical processes.
The competition-time of fluidic operations in practical applications may be
different from the time defined in a module library, therefore the accuracy of
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fluidic operations cannot be guaranteed.
2. The synthesis results in [51; 64; 115] are not robust when timing uncertainties
of operations exist. When the feedback from on-chip sensors indicates that the
completion time of an operation is different from the time defined in the module
library, the re-synthesis procedure has to be performed. In each re-synthesis
procedure, the control software must adjust the schedule and module-placement
for a series of operations. These cumbersome on-line computation steps require
high CPU time. The resulting response time may interrupt the execution of the
bioassay and lead to the degeneration of intermediate products of the bioassay
[96].
3. On-line computation in prior work does not generate the information for droplet
transportation, which is essential for the execution of a bioassay.
To overcome the above drawbacks, we propose a new design for on-line decision-
making using cyberphysical microfluidic biochips. The key contributions and benefits
of this work are as follows:
1. We propose the design of microfluidic biochips using multiple clock frequen-
cies. The execution time of the bioassay can be reduced without additional
degradation of electrodes or hardware cost.
2. We propose an “operation-interdependence-aware” synthesis algorithm, the
first on-chip biochemistry synthesis procedure that does not use the module
library as a design guideline. Using this algorithm, the characterization pro-
cess can be eliminated. The algorithm leads to a design approach that con-
siders completion-time uncertainties for fluidic operations, hence the accuracy
of fluidic operations is improved. The proposed approach explicitly considers
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the transportation of droplets. Hence it guarantees the feasibility of droplet-
routing, and determines the transportation path for each droplet.
3. We propose the on-line droplet-routing method that has low computational
complexity. The response time of the cyberphysical system is negligible. There-
fore, the degeneration of intermediate products for the bioassay can be avoided.
The remainder of this chapter is organized as follows. Section 5.2 presents the
design of microfluidic biochips with multiple clock frequencies. Section 5.3 introduces
the framework of operation-dependency-aware synthesis. Based on results derived
from the proposed synthesis algorithm, integrated on-line decision-making for droplet
transportation path is presented in Section 5.4. Simulation results for three widely
used bioassays are presented in Section 5.5. Section 5.6 concludes the chapter.
5.2 Biochips with multiple clock frequencies
Experimental results published in the literature demonstrate that the degradation
of an electrode is directly related to the number of times that it is switched on and
off [116]. With the same sequence of electrode actuation vectors, electrodes will
degrade more quickly under higher clock frequency. On the other hand, an increase
in the clock frequency can reduce the execution time of fluid-handling operations
[21]. Hence, in order to ensure the reliability of electrodes on the biochip, and at the
same time complete the bioassay under timing constraints, it is important to choose
an appropriate clock frequency.
Fluid-handling operations are divided into two categories: frequency-sensitive
operations and frequency-insensitive operations. The completion time of droplet
transportation and dispensing is determined by clock frequency, because the droplet
will be moved from one electrode to another adjacent electrode in each clock cy-
cle; hence the rate at which a droplet is transported or dispensed is proportional
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to the clock frequency. Note that, if the transportation or dispensing path for a
droplet consists of P electrodes, then the number of clock cycles required to move
or dispense the droplet is also P . This number of clock cycles only relates to the
length of the transportation path, and it is independent of the clock frequency. If we
increase the electrode switching frequency for droplet transposition and dispensing,
the time needed for these operations can be reduced without additional degradation
of electrodes. Hence, we conclude that by increasing the clock frequency, the trans-
portation and dispensing time of droplets can be accelerated without affecting the
chip reliability.
The execution times of mixing and dilution operations cannot be significantly
reduced by increasing the clock frequency. For example, experimental results for
droplet mixing show that, at a frequency of 8 Hz, the time spent on the mixing
operation is 12 seconds; when the frequency is increased to 16 Hz, the mixing time
decreases to 11 seconds [21]. Hence the mixing time only decreases 8.3% while
the rate of degradation of electrodes increases 100%. Therefore we conclude that
increasing the clock frequency for dilution/mixing operation may adversely affect
the lifetime of the biochip, while the completion time of the operation will not be
significantly reduced.
In order to minimize the time required to complete a bioassay with least im-
pact on chip reliability, it is desirable to run different categories of operations at
different clock frequencies. Hence we propose to schedule transportation/dispensing
operations and dilution/mixing operations at different time segments. The time seg-
ment to implement droplet transportation is defined as the “transportation phase”
(T phase), and the segment to implement dilution/mixing operations is defined as
the “dilution/mixing phase” (D/M phase); see Figure 5.1(a). For each phase, only
transportation operations or the dilution/mixing operations are carried out on the
chip.
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Figure 5.1: (a) Droplet transportation and dilution/mixing operations are sched-
uled in different phases; (b) start and end time of a D/M phase.
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Figure 5.2: A tunable frequency-divider controlled by the feedback from sensors.
Assume that we have already determined the set of dilution/mixing operations
to be implemented at each D/M phase before the execution of a bioassay. At run-
time, the biochip operates under clock frequency fT in the T phase. Output droplets
of previous steps and droplets dispensed from reservoirs are moved to the modules
where the subsequent dilution/mixing operations are to be carried out. After all the
droplets arrive at their destination modules, the biochip enters the D/M phase. The
dilution/mixing operations that are scheduled in the same phase start together, and
they are carried out under clock frequency fD/M. When the feedback from sensors
indicates all the dilution/mixing operations have already been completed, the D/M
phase ends and the biochip enters the next T phase, as shown in Figure 5.1(b). In
this way, based on sensor feedback, the biochip “switches” between the T phase and
123
NR
SRSL
1 2 3
5
4
6 7
8 9
(a) (b)
1
2
6
t
(c)
Region assigned
for operation 6
1 2
Mixing region 
1 2 3 4
5
1 2
S1
S2 Storage unit
(d)
Region assigned
for operation 6
1 2
Mixing region 
1 2 3 4
5
1 2
S1
S2 Storage unit
(e)
1 2
Region assigned
for operation 6
MSL 1
2
6
(a) (b) 
t
NR
MSL
(a) 
MSR
NR
(f)
Region assigned
fo  operation 6
1 2
Mixing region 
1 2 3 4
5
1 2
S1
S2 Storage unit
(g)
Figure 5.3: Sequencing graph with tree structure (a) all edges are directed towards
the root of the tree; and (b) all edges are directed away from the root; (c) scheduling
results for mixing operations 1, 2, and 6; (d) module-placement for 1, 2 and 6; (e) stor-
age units S1 and S2 inside the modules assigned for operations 1 and 2; (f) packaged
macro-operations MSL and MSR ; (g) a feasible solution for module-placements of
operation 1  5 on an 8  8 array.
the D/M phase with different clock frequencies.
Two different methods can implement this biochip design using multiple clock
frequencies, with negligible extra cost, based on the hardware setup shown in Fig-
ure 2.5. The first method uses the control software to switch the working frequency
of the biochip. Since the output frequency of the signal generator can be controlled
by the software, the frequency can be adjusted dynamically during the execution of
the bioassay. Recent work in a different context, viz. to understand the reliability
impact of multiple frequencies, has demonstrated the feasibility of such a hardware
setup [116].
The second method uses a tunable frequency-divider implemented on the field-
programmable gate array (FPGA) of the cyberphysical system, as shown in Fig-
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ure 5.2. Based on the feedback from the sensors, the tunable frequency divider can
adjust the frequency of the output signals that are applied on the biochip.
In the D/M phase, the biochip operates at a nominal frequency (for example,
fD/M = 8 Hz), while in the T phase, higher-frequency signals (for example, fT = 16
Hz) are applied to the electrodes. The time spent on dispensing and transporting
droplets can be reduced significantly without additional degradation of electrodes or
any additional cost in hardware.
Since the time spent on each dilution/mixing operation is determined by sen-
sor feedback rather than a pre-determined module library, we can derive a “semi-
deterministic” design for biochips with the consideration of timing uncertainties. The
design includes the synthesis result (Section 5.3), and droplet transportation paths
in each T phase (Section 5.4).
5.3 Operation-dependency-aware synthesis
In this section, we describe how synthesis results can be achieved in the presence of
completion-time uncertainties of fluidic operations. Using the proposed algorithm,
we can obtain the synthesis results that include: (i) the module-placement for each
operation; (ii) the set of operations to be implemented in each D/M phase. It is
important to note that, the exact start time and end time of operations are not
included in the results derived by the proposed synthesis algorithm; they are deter-
mined based on the feedback from sensors during the bioassay run-time. Therefore,
the derived synthesis results are semi-deterministic.
The proposed synthesis algorithm focuses on the interdependency among dilu-
tion/mixing operations that are given by the sequencing graph of a bioassay. A
sequencing graph is an abstract description for a bioassay; each node in it represents
a fluidic operation, and each edge represents the interdependency for a pair of oper-
ations. For any two operations Oa and Ob, if the output droplet of Oa is the input
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of Ob, then there is an edge from Oa to Ob. The sequencing graph in this method
is reduced by deleting all nodes that represent dispensing operations. Two exam-
ples of sequences graphs for bioassays are shown in Figure 5.3(a) and Figure 5.3(b),
respectively.
A sequencing graph for a bioassay has two important properties: (i) it is a directed
acyclic graph, because there is no infinite loop or a repeated step under identical
conditions in an assay protocol; (ii) the numbers of input droplets and output droplets
for each operation are no more than 2. Therefore, the in-degree and out-degree of
each node in the sequencing graph are at most 2.
In the following parts, we first introduce the synthesis algorithm for sequencing
graphs with the structure of directed-trees, and then introduce the steps for synthe-
sizing a bioassay in the general case.
5.3.1 Synthesis for sequencing graphs with directed tree structure
First we study bioassays whose sequencing graphs are directed trees. Examples
are shown in Figure 5.3(a) and Figure 5.3(b). The node without children nodes in
Figure 5.3(a) and the node without parent nodes in Figure 5.3(b) are defined as the
root nodes of the directed trees. The node without parent nodes in Figure 5.3(a)
and the node without children nodes in Figure 5.3(b) are defined as the leaf nodes
of the directed trees. The operations represented by these leaf nodes are defined as
“the lowest-level operations” of the bioassay.
The difference between these two sequencing graphs is that, all edges in Fig-
ure 5.3(a) are directed towards the root of the tree, while in Figure 5.3(b), all edges
are directed away from the root. After switching the directions of all of the edges,
the directed tree in Figure 5.3(b) can be analyzed in the same way as the one in
Figure 5.3(a). Thus, we use the structure with all edges directed towards the root of
the tree (shown in Figure 5.3(a)) to analyze the proposed synthesis procedure.
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In the synthesis procedure, starting from the lowest-level operations, we can de-
termine the schedule and module-placement for the operations on a level-by-level
basis. Consider the following example. Operations 1, 2, and 6 are three mixing
operations shown in Figure 5.3(a). Here 1 and 2 are the lowest-level operations and
their outputs are the inputs of 6, hence 1 and 2 must be completed before 6 starts.
Based on the interdependency relationship, operations 1 and 2 are implemented in
the same D/M phase, while the operation 6 is schedule to be implemented in the
next D/M phase, as shown in Figure 5.3(c). If we write the set of operations to be
implemented at the i-th D/M phase as Si, then the schedules of operations 1, 2, and
6 can be written as: t1, 2u  S1 and t6u  S2.
Next, mixing operations 1 and 2 are mapped to two mixers on the biochip. The
sizes of widely-used mixers on digital microfluidic biochip can be found in [21][32]. As
in prior work [32; 51; 64; 96; 115], segregation cells are set as wrappers for each mixer
in order to isolate droplets that are being manipulated concurrently on the biochip.
Since the mixing operation 6’s inputs are the outputs of operations 1 and 2, we can
refer to the region that overlaps with the modules for 1 and 2 as the “execution
region” of operation 6, as shown in Figure 5.3(d). After the mixing operation has
been completed for each mixer, the product droplet stays inside the mixer until the
end of the D/M phase, i.e., part of the mixer works as a “storage” unit. Therefore,
in the synthesis approach, there is no need to assign specific storage modules. An
example is as follows. S1 and S2 in Figure 5.3(e) represent the storage units inside
the mixers assigned to operations 1 and 2, respectively. Since the execution region of
operation 6 overlaps with S1 and S2, the outputs of mixing operations 1 and 2 can be
“fed” directly into operation 6 without any module-to-module transportation. After
operation 6 is completed, the storage unit for the product droplet of operation 6 will
overlap with either S1 or S2.
In this way, the module-placement and schedule for operations 1, 2, and 6 are
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obtained. After operation 6 is finished, the execution region of operation 6 will be
assigned for operation 8.
Next, operations 1, 2, 6, and 8 are packaged as a “macro-operation” MSL ; simi-
larly, operations 3, 4, 7, and 9 are packaged as a “macro-operation” MSR as shown
in Figure 5.3(f). The schedule for operations 1  4 and 6  9 are: t1, 2, 3, 4u  S1,
t6, 7u  S2, and t8, 9u  S3.
Similarly, the placement of modules for MSL , MSR and NR in Figure 5.3(f) can
be determined based on their interdependency. The module for MSL will be placed
“beside” the region occupied by MSR , and after the completion of MSL and MSR ,
NR will be mapped to the same region that is assigned to MSL and MSR . In this
way the schedule and resource assignment results for all the operations shown in
Figure 5.3(a) can be derived level by level.
Suppose we arbitrarily pick a node NR from the directed-tree structure shown
in Figure 5.3(a), and write the set of operations on the left and right sub-trees of
NR as SL and SR , respectively. Then the derived synthesis results of the proposed
operation-interdependency-aware synthesis algorithm have the following three char-
acteristics:
Characteristic 1: Operations in SL and SR do not share any on-chip resources,
i.e., they are executed in two separate regions of the biochip.
Characteristic 2: Assume that ESL and ESR are the sets of electrodes where op-
erations in SL and SR are conducted, respectively, and ENR is the set of electrodes
that is assigned to operation NR, then we have: ENR  pESL Y ESRq.
Characteristic 3: If the storage units assigned for operations in SL and SR are
written as S 1SL and S
1
SR
, respectively, and the storage unit assigned to operation NR
is written as SNR, then we have: SNR  pS 1SL Y S 1SRq.
Based on Characteristic 2, we conclude that the resource bound to an operation
(i.e., the module-placement) is determined in turn by its predecessor operations. For
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Figure 5.4: (a) Partitioning of a sequencing graph; (b) the interdependency of
macro-operation MT , operation L and operation R.
a sequencing graph with a directed-tree structure, the resources for other operations
can be determined easily when resources assigned to operations represented by leaf
nodes are determined.
For instance, the synthesis result for the sequencing graph shown in Figure 5.3(a)
can be determined as follows. According to the proposed resource binding steps, the
modules for operations 1 and 2 will be placed beside each other, and the modules
for operations 3 and 4 also will be placed beside each other. Since operations that
are scheduled in the same D/M phase are performed concurrently, we assume that
the size of the mixers allocated to all these operations are also the same. Without
loss of generality, we can assume that operations 1  5 are executed in 1 4 mixers.
The corresponding result for the placement of the modules on a 7 7 array is shown
in Figure 5.3(g). Each mixing module has one storage unit inside. When the mixing
operation is completed, the product droplet stays inside the corresponding storage
unit. Based on the module-placement for operations 1  5, module-placement for
other succeeding operations can be derived. For example, the regions where oper-
ations 1 and 2 are implemented will be assigned to their successor operations. In
this way, the module placement of operations in the directed-tree structure are de-
termined. The schedules of operations in the directed-tree can also be determined
based on their input/output interdependency.
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5.3.2 Synthesis for sequencing graphs in general cases
For sequencing graphs that are not directed trees (i.e., there are nodes whose out-
degrees are greater than 1, as shown in Figure 5.4(a)), we can derive their synthesis
results using the following steps:
1. Graph partitioning: determine the set of nodes tNn1 , Nn2 , ..., Nnku whose
out-degrees are greater than 1, then remove all the edges directed away from
these nodes. Then the graph is partitioned into multiple directed trees {T1,
T2, ,..., Tn}, and each node in tNn1 , Nn2 , ..., Nnku becomes the root node in a
directed tree.
2. Synthesis for directed trees: apply operation-interdependency-aware syn-
thesis to each directed tree, and derive the corresponding synthesis result.
3. Sorting of directed trees: for any pair of trees TA and TB, suppose there ex-
ists a node OTA1 P TA and a node OTB1 P TB, such that OTA1 is the predecessor
of OTB1 . Then we express the relationship between trees TA and TB as TA   TB.
Any two elements Tx and Ty in tT1, T2, ..., Tnu may stand in any of three mu-
tually exclusive relationships to each other: Tx   Ty, or Tx ¡ Ty, or Tx  Ty
(neither of the other two). The conflicting case (i.e., “Tx Ty and Tx¡Ty”) will
never occur. The proof can be found in Lemma 5.3.1 of this section.
4. Merge the synthesis results: the synthesis result of tT1, T2, ..., Tnu are
merged together based on their order. If Tx   Ty then operations in Tx must be
implemented before Ty; if Tx ¡ Ty then operations in Tx must be implemented
after Ty; if Tx  Ty then operations in Tx and Ty are implemented in parallel.
Based on the method of graph partitioning, we have the following lemma:
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Figure 5.5: Assume two directed trees Tx and Ty have the relationships that Tx   Ty
and Tx ¡ Ty.
Lemma 5.3.1. For any two elements Tx and Ty in the set of directed tree tT1, T2, ...Tnu
partitioned from a sequencing graph, the conflict relationship “Tx Ty and Tx¡Ty”
never occurs.
Proof : This lemma can be proved by reductio ad absurdum. First we assume
that these two directed tree have the relationships Tx   Ty and Tx ¡ Ty. Then as
shown in Figure 5.5, we can find two nodes Ox1 P Tx and Oy1 P Ty, such that Ox1 is
the predecessor of Oy1 ; we can also find two node Ox2 P Tx and Oy2 P Ty, such that
Oy2 is the predecessor of Ox2 . Without loss of generality, here we draw the node Ox1
as the immediate predecessor of Oy1 , and the node Oy2 as the immediate predecessor
of Ox2 .
Next we can prove that Ox1 is the root node for Tx. As introduced in Section 5.4,
we first find out all the nodes tNn1 , Nn2 , ...Nnku whose out-degrees are more than 1.
Then remove all the edges directed away from these nodes. Hence in the trees we
derived from the partitioning procedure, the out-degrees of all the nodes except the
root node is equal to 1. The out-degree of the root node is equal to 0. Assume Ox1 is
not the root of Tx. Then in Tx, there must be an edge from Ox1 to another node in
Tx. As shown in Figure 5.5, there is another edge from node Ox1 to Oy1 . Therefore,
the out-degree of Ox1 in the original sequencing graph (i.e., the sequencing graph
before being partitioned) is equal to 2.
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Based on the step of graph partitioning, Ox1 whose out-degree is equal to 2, must
be a root node of a directed tree derived. Hence we have reached the conclusion that
Ox1 is the root node for Tx. Similarly, we can reach the conclusion that Oy2 is the
root node for Ty.
Then based on the characteristic of directed tree, there must exist a directed path
from the node Ox2 toward the root node Ox1 in Tx, and there must exist a directed
path from the node Oy1 towards the root node Oy2 in Ty. Since there are the edges
from Ox1 to Oy1 , and the edge from Oy2 to Ox2 , we get a directed circle that connects
the nodes Ox1 , Ox2 , Oy1 and Oy2 in the sequencing graph. However, as introduced
in Section 5.3, a sequencing graph for bioassay will not have a directed cycle.
Hence we have proved that, the conflict relationships between Tx and Ty will not
exist. This completes the proof of the lemma. l
From the above steps, the synthesis results can be derived for general sequencing
graphs. An example is shown in Figure 5.4(a). The graph is divided into three parts:
the node that represents operation L, the node that represents operation R, and a
directed tree T . The operations in T are packaged as a “macro-operation” MT . As
operation L and R both are predecessors of operations in T , the interdependency of
macro-operation MT , operation L and operation R is show in Figure 5.4(b). Accord-
ing to the above discussion, the relationship among R, L, and MT can be written as
R  L ¡MT .
Therefore, operations L and R will be executed concurrently, and operations in
MT will be executed after operations L and R are both completed. The corresponding
module-placement result can be derived in a similar way as the sequencing graph
shown in Figure 5.3(f).
The operation-interdependency-aware algorithm described above can derive the
semi-deterministic synthesis result for a bioassay. The synthesis result assigns each
dilution/mixing operation to a specific D/M phase, while completion-times of these
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1: Partition a sequencing graph G into directed-trees {T1, T2, ..., Tn};
2: for each Ti P{T1, T2, ..., Tn} do
3: Start from leaf nodes, determine relative positions of dilution/mixing modules
on a level-by-level basis;
4: Determine schedules of operations;
5: Package operations the entire directed tree as a “macro-operation” MTi ;
6: end for
7: Sort the directed trees based on operation interdependencies;
8: Derive new sequencing graph which consists of macro-operations for directed trees;
9: Merge synthesis results of directed trees based on their orders.
Figure 5.6: Pseudocode for operation-interdependency-aware synthesis.
operations are determined on-line during the execution of the bioassay. The robust
module-placement thus derived is independent of the execution time of each oper-
ation. When timing uncertainties of dilution/mixing operations exist, the module-
placement of a bioassay remains unchanged. The pseudocode for the entire operation-
interdependency-aware synthesis approach is shown in Figure 5.6.
5.4 Droplet-routing procedure
The practical application of cyberphysical microfluidics requires control software to
ensure the synthesis results of the bioassay are routable, and also, to determine
droplet transportation paths for each droplet transportation phase.
As introduced in Section 5.2, in the D/M phase, the biochip will stop an operation
when the feedback from sensors indicates the operation has been finished. Then the
output droplet will be stalled inside the modules, and will wait to be used as the
input of the following operation in the next D/M phase. In each T phase, all the
dilution/mixing operations implemented in the last D/M phase have already finished,
and their output droplets of operations are stalled in their modules. The electrodes
where these droplets stay, as well as their neighboring electrodes, are considered
as “obstacles” for droplet transportation. The droplet transportation paths cannot
overlap with the obstacles, otherwise interference between droplets may occur.
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The transportation of droplets during a bioassay consists of three parts: moving
droplets from one module to another module; moving droplets from on-chip reservoirs
to the modules; and moving the “extra product droplets” to waste reservoirs. For
some bioassays, it is important to note that not all of the intermediate product
droplets are used for subsequent operations. Those product droplets that are not
used in the bioassay are defined as extra product droplets, and they must be col-
lected in the waste reservoir.
As introduced in Section 5.3, the placements of modules for dilution/mixing op-
erations are determined based on their input/output interdependencies. For any
droplet that contains an intermediate product of the bioassay, the module where
the droplet is generated and the module where it will participate during the next
operation, are overlapped. The output droplets of each module only need to “wait”
at the original position; they will be directly “fed” into the module of the following
operation. Therefore, the transportation of droplets from modules to modules can
be eliminated. Only droplet transportation from reservoirs to modules and from
modules to the waste reservoir need to be considered in the T phase.
In this section, first we consider the routability for the result derived by the
operation-interdependency-aware synthesis approach. Then the method of online
decision-making on the transportation paths of droplets is introduced.
5.4.1 Routability analysis
If we randomly select an operation ON from the sequencing graph, and the immediate
predecessor operations of ON are written as OL and OR, then we have the following
lemma:
Lemma 5.4.1. Transportation paths from a reservoir R to the module of ON ex-
ist if there are transportation paths from the reservoir to the modules of immediate
predecessor operations OL and OR.
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Proof : The existence of transportation paths from the reservoir R to the modules
of operations OL and OR means that paths from the reservoir to the modules can
be found when there are obstacles RAB on the biochip. Here, the set of storage
units and their neighboring electrodes is written as RAB. Even if no droplet stays
on the storage unit, we still consider the “empty” storage unit (and its neighboring
electrodes) as obstacles.
The set of obstacles is written as RN when we search for the transportation
path from the reservoir to the module of operation RN . Based on Characteristic 3
of the results derived by the operation-interdependency-aware synthesis procedure
proposed in Section 5.3, the droplet that stays in module ON is restricted to be inside
one of the regions that have ever been assigned as storage units for operation OL
and OR.
Thus we have RN  RAB, i.e., each electrode in the obstacle RN is contained by
obstacle RAB.
We have already assumed that the routing problem has a solution with the ex-
istence of obstacle RAB. Therefore, with the existence of RN , there must exist a
routing solution from the reservoir to the module of ON . This completes the proof
of the lemma. l
During the execution of bioassays, the input droplets for ON can come from
different reservoirs, while it is important to note that Lemma 5.4.1 is insufficient to
ensure the existence of the transportation from any on-chip reservoir to the module
for ON . Therefore, in order to guarantee that droplets dispensed from any on-chip
reservoir can be transported to the module of ON , the droplet-routing paths between
reservoirs need to be considered.
In the synthesis result of a bioassay, for each operation, if there exist transporta-
tion paths to move its input droplets into the module and there exist transportation
paths to move the extra droplets into the waste reservoir, then the synthesis result is
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“routable”. By applying Lemma 5.4.1 to the sequencing graph with the directed-tree
structure, as well as considering the differences between reservoirs, we can further
derive the following lemma that gives the sufficient conditions for routability of syn-
thesis results:
Lemma 5.4.2. For a given bioassay whose sequencing graph is a directed-tree, its
corresponding synthesis result is routable if the following two constraints are satisfied:
Constraint 1: There exist transportation paths that connect all the modules of
the lowest-level operations and their corresponding reservoirs. Here the “lowest-level
operations” is defined as “the operations that are represented by leaf nodes in the
sequencing graph of bioassay”.
Constraint 2: There exist transportation paths that connect all the on-chip reser-
voirs.
Proof : We write the set of modules corresponding to the lowest-level operations
in the sequencing graph, Mleaf, as tML1 , ML2 , ..., MLN u, and the set of reservoirs R
as tR1, R2, ..., Rru.
For each reservoir Ri, the sequencing graph of the bioassay defines the set of mod-
ules whose input droplets come from Ri. For example, if the input sample/reagent
of tMLi1 , MLi2 , ..., MLik u is stored in reservoir Ri, then the droplets dispensed from
Ri need to be transported to these modules.
Constraint 1 ensures that there exist transportation paths from reservoir Ri to
modules tMLi1 , MLi2 , ..., MLik u. Constraint 2 ensures that the reservoirs {R1, R2,
..., Rr} are interconnected by transportation paths. Hence for any arbitrarily chosen
reservoir in R, and any arbitrarily chosen module from Mleaf, there exist transporta-
tion paths between them.
Then based on Lemma 5.4.1, we know that there exist transportation paths
from any reservoir in R to any immediate successor operation of these lowest-level
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operations.
By applying Lemma 5.4.1 level-by-level to the sequencing graph until we reach
the root node, we find that there exist transportation paths from a reservoir in R to
the module corresponding to any operation in the bioassay. Hence for each operation,
there exist transportation paths from the corresponding reservoirs to the module of
the operation, no matter which reservoir the input droplet comes from. Therefore,
the synthesis result is routable. This completes the proof of the lemma. l
5.4.2 Searching droplet-routing paths
As discussed in Section 5.3, the synthesis results derived by the operation-interdepen-
dency-aware synthesis procedure is independent of the execution time of operations.
For each T phase, the corresponding module-placement configuration remains un-
changed when the execution time of the operations varies. The routability of the
synthesis result, the starting position and destination of each droplet, as well as the
positions for storage unites of droplets, have already been determined before the
execution of a bioassay. With this available information, the droplet transporta-
tion paths for each T phase can be derived by the algorithms proposed in previous
publications [28; 117; 118; 119].
5.4.3 Online decision-making for droplet-routing
By applying the operation-interdependency procedure discussed in Section 5.3 and
the computation steps for droplet transportation as discussed above, we can derive
the following information before the execution of bioassay: (i) schedule of opera-
tions, i.e., the set of operations to be implemented in each D/M phase; (ii) module-
placement for operation that are not affected by timing uncertainties in the execution
of fluidic operations; (iii) droplet transportation paths for each T phase.
Since the uncertainties about execution times for the fluid-handling operations
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have no influence on the routability of the synthesis results or the transportation
paths of droplets, routing paths can be derived before the execution of the bioassay
by applying A algorithm [28]. The response time of on-line decide-making for the
cyberphysical system is not affected by the computational complexity of the A
droplet routing algorithm.
During bioassay run-time, the control software only needs to make on-line deci-
sions about when a dilution/mixing operation can be deemed to have been completed
based on sensor feedback. Assume that the maximum number of dilution/mixing
operations that are concurrently being executed on the biochip is N , and the com-
putational complexity of processing the feedback signal for one operation is O(1),
then the computational complexity for on-line decision-making during the execution
of bioassay is O(N ). As the computational complexity is low, the response time of
the control system is negligible.
Based on the pre-determined module-placement results and droplet transporta-
tion paths, the bioassay can be performed under the completion-time uncertainties
and yet provide high accuracy in the final reaction outcome.
5.5 Simulation results
In this section, we first present the simulation results for three widely used laboratory
protocols, namely exponential dilution of a protein sample, interpolation dilution
of a protein sample, and polymerase chain reaction (PCR), respectively [32]. The
sequencing graph and the detailed description of the protocol for these bioassays can
be found in [32]. We compare our results with prior work on biochip synthesis in
[32], and a recently published cyberphysical software-based recovery method based
on a greedy algorithm [51][96]. The same as all prior work in this area, both these
baseline methods are oblivious of timing uncertainties in fluidic operations.
In order to compare the uncertainty-oblivious baseline methods with the proposed
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design method, and study the synthesis results in the presence of timing uncertainty,
in this section the baseline methods are adjusted using three methods: (i) adding
additional time to module library specifications; (ii) running dynamic re-synthesis
when a timing overshoot is detected; and (iii) adding interruption whenever there is
a timing overshoot.
5.5.1 Yield estimation for biochips with no feedback-based adaptation
As discussed in Section 5.1, the execution time of a fluidic operations needs to be
considered as a random variable rather than a known constant. If no feedback-based
control is used and the synthesis of the biochip only relies on a module library with
constant operation times, there is a high likelihood that many operations cannot
complete within the allocated time. The outputs of these “unfinished operations”
will be unqualified droplets, and the outcome of the bioassay will be unacceptable.
Next we compute the probability that a bioassay will fail due to the occurrence of
unfinished operations. Assume that the execution time for each operation is Gaussian
random variable, and for any two operations in a bioassay, their execution times are
independent of each other. Suppose that for any operation Oi, its completion time
Ti has mean value µi and variance σ
2
i .
If we define the time spent on operation Oi as Ti  µi σi, and the real execution
time T i does not exceed Ti, then Oi will be executed correctly; otherwise Oi is deemed
to have failed. A bioassay terminates with an acceptable outcome only if all the
operations are executed correctly. Let Pi be the probability that a dilution/mixing
operation Oi is executed correctly, and let the number of dilution/mixing operation
in a bioassay be Nb. Then the probability Psuccess that the bioassay is successfully
implemented is given by: Psuccess 
Nb±
i1
Pi  PNb (if Pi  P for any i).
Therefore, the probability of successful implementation Psuccess decreases expo-
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Table 5.1: Probabilities of bioassays being successfully implemented without unfin-
ished operations.
No. of dilution/ Psuccess, Ti listed
Bioassay mixing operations µi µi   σi µi   2σi
PCR 7 0.01 0.30 0.85
Interpolating dilution 35  0  0 0.45
Exponential dilution 47  0  0 0.34
nentially with the number of dilution/mixing operation. Hence for a realistic bioassay
with a large number of fluidic operations, the compound yield will be unacceptably
low.
Next, based on above discussion, we compute the numerical values of Psuccess for
three test-case bioassays. Let Ti be the time spent on operation Oi when a static
synthesis method is used based only on a module library, and Pi be the probability
that Oi is successfully completed before the next operation is started. Based on the
characteristics of the Gaussian distribution, if we set the time spent on operation Oi
as Ti  µi σi, then Pi  0.84; if we set Ti  µi  2σi, then P  0.98. Table 5.1 lists
the probabilities that bioassays are successfully completed (i.e., with no unfinished
operations) when no cyberphysical adaptation is used. When we conservatively set
Ti  µi   2σi (and increase the operation times considerably) and obtain Pi 
0.98, the probability for successfully implementing the exponential mixing of protein
bioassay is still low, only 0.34. We can further calculate that, in order to improve
the yield of the exponential dilution bioassay to 0.90 and above, we need to set
Ti  µi   4σi.
We therefore conclude that the bioassay execution on conventional biochip plat-
forms without a sensing system, closed-loop control, or uncertainly-aware synthesis,
will lead to unacceptably low bioassay yield and low confidence in reaction outcomes.
From Table 5.1, we also find that Psuccess can be increased by increasing Ti.
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However, on the other hand, increasing Ti will elongate the reaction completion
time, and increase the risks of excessive heating and evaporation of droplets [120].
Therefore Ti should be set to be within in a reasonable range. Due to the lack of
sufficient data thus far from real experiments on fabricated chips, the additional
probability of bioassay failure caused by excessive heating and evaporation is not
considered here. In this way, we do not quantify this important shortcoming of the
baseline methods that we use for comparison.
Next we compare the bioassay completion times of the parallel recombinative
simulated annealing (PRSA)-based synthesis algorithm [32][121] with the proposed
operation-interdependency-aware synthesis algorithm. Here we use the module li-
brary defined in [32], and run simulations by considering timing uncertainty. We
assume that for each operation, its average execution time µi is the time defined in
the library, and σi is 0.1µi. For example, for a dilution operation executed on a 23
array, µi  6 seconds, and σi  0.6 second.
In order to increase the yield for the baseline design, when we run the PRSA-
based algorithm, we add extra execution time ∆Ti for each operation. In the simula-
tions, we assume that the PCR bioassay, the exponential dilution bioassay, and the
interpolation dilution bioassay are all executed on an 8  8 direct-addressing array.
The simulation results with ∆Ti set to σi, 2σi, and 4σi are shown in Table 5.2.
The completion time of the bioassays derived by PRSA-based algorithm increases
with ∆Ti, and it is discovered that by applying the proposed method, time-to-results
of bioassays can be reduced.
As shown in Table 5.2, for exponential dilution and interpolation dilution bioas-
says, the completion time derived by PRSA algorithm increases only slightly when
the execution time for each dilution/mixing operation increases. It can be explained
that for these two bioassays, most of the execution time is spent on droplet trans-
portation operations, whose execution times are known to have low variability.
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Table 5.2: Comparison of bioassay completion time derived by PRSA-based algo-
rithm [32] and proposed method.
Completion time (s)
PRSA-based algorithm
[32], ∆Ti listed
Bioassay 0 σi 2σi 4σi Proposed method
PCR 26 28 31 35 25
Interpolation dilution 177 184 195 201 158
Exponential dilution 195 196 202 208 182
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Figure 5.7: Comparison between the number of droplets consumed in the biochips
of [51][96] (droplet consumptions are the same for the methods of these two papers)
and the proposed method.
5.5.2 Number of droplets consumed
For the synthesis algorithm proposed in [51][96], bioassays need to be characterized
before they are executed on the biochip. In the characterization procedure, each
operation needs to be executed at least three times [113]. The comparison of the
number of droplets consumed for each bioassay in [51][64][96] and the proposed design
is shown in Figure 5.7. Note that the prior methods consume the same number of
droplets each. We find that the number of droplets is greatly reduced in the proposed
design based on a cyberphysical platform and uncertainly-aware synthesis.
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Table 5.3: Synthesis results derived by the operation-interdependency-aware synthe-
sis approach on direct-addressing biochips.
Completion time (s)
Size of
D/M phases T phases Total
Bioassay the biochip
8  8 57 125 182
Exponential 9  9 32 106 138
dilution 10  8 37 117 154
bioassay 12  8 22 145 167
8  8 44 114 158
Interpolation 9  9 29 102 131
dilution 10  8 32 114 146
bioassay 12  8 21 130 151
5.5.3 Results derived by the operation-interdependency-aware synthesis approach on
pin-limited biochip
We assume that the completion times of mixing operations performed by different
kinds of mixers are the same as the data defined in the module library in [32]. If the
bioassays are mapped to direct-addressing biochips, the synthesis results derived by
the operation-interdependency-aware synthesis approach can be found in Table 5.3.
Here the completion time of D/M phases is defined as the sum of time spans for all
the D/M phases in the bioassay. The completion time of T phases is defined as the
sum of time spans for all the T phases in the bioassay. The working frequency of T
phase is set as 1 Hz.
5.5.4 Response time in the presence of timing uncertainties
In the re-synthesis algorithm proposed in [51], when a sensor detects that the status
of a droplet is different from expected result, e.g., an operation has not finished within
the pre-determined time, a re-synthesis procedure will be performed. The control
software dynamically updates the synthesis steps using a greedy algorithm, and the
operation with unexpected completion time will be re-executed in the re-synthesis
result. To compare with [51], we first randomly select a fluidic operation, and assume
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Table 5.4: Comparison of response times (one fluidic operation with timing uncer-
tainty).
Response time (s)
Operations
Greedy algorithm [51] Proposed algorithm
Bioassay with uncertainty
Dlt39 0.34  0
Exponential Dlt12 4.97  0
dilution Dlt4 2.44  0
bioassay Dlt12 1.47  0
Average (s) 1.12  0
Dlt15 0.91  0
Interpolation Dlt8 1.23  0
dilution Dlt19 1.45  0
bioassay Dlt16 0.34  0
Average (s) 0.85  0
its execution time is longer than the time defined in the module library. Then
after the re-synthesis procedure is triggered, the response time for the re-synthesis
procedure in [51] is recorded. Here the response time is defined as the CPU time
spent in deriving resynthesis solutions when the timing overshoot is detected. During
on-line re-synthesis, all fluid-handling operations for the bioassay are suspended.
The simulation is repeated 20 times (with different operation with uncertainty
injected each time), and a snapshot of the results is shown Table 5.4. The simulation
is carried out on a 2.30 GHz Intel i3 processor with 8 GB of memory. Compared
to the greedy algorithm [51], the response time is significantly reduced using the
proposed design. Note that in the simulations, we insert only one fluidic operation
with timing uncertainties; however in a real application, each operation may have
timing uncertainty. Therefore, in the design of [51][96], the re-synthesis procedure
will be carried out multiple times, and the CPU time for extensive on-line re-synthesis
of the entire bioassay will be considerable. Even a few seconds of CPU time for re-
synthesis will be magnified for multiple operations and pose a serious problem for
applications such as flash chemistry [96][122].
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5.5.5 Number of operations interrupted under uncertainty
Suppose we run the synthesis results derived by the PRSA-based algorithm on a
cyberphysical biochip. If the execution time of an operation Olonger is longer than the
time defined by the module library, then the controller can stop all other operations
until operation Olonger is completed. In this way, time-consuming on-line re-synthesis
can be avoided. However, the executions of other operations have to be interrupted.
Based on the Gaussian assumption in Section 5.5.1, the probability that an op-
eration’s execution time is longer than the time defined in the module library is 0.5,
if we do not add extra execution time for each operation. We simulate the bioassay
and count the number of operations that must be interrupted. During the execution
of bioassay, an operation may be interrupted multiple times; however, we count such
cases as one interrupted operation. Hence the number of interruptions reported for
the baseline method is less than the actual number of interruptions experienced.
The total number of operations, and the number of operations that are inter-
rupted in the three bioassays, are listed in Table 5.5. We note that nearly all the
operations are interrupted for the synthesis results derived using the PRSA-based
algorithm. The interruptions that occur during the execution of the bioassay may
influence the quality of output droplets [51]. On the other hand, in the proposed
algorithm, no operations are interrupted, and the assay proceeds in an unimpeded
manner.
5.5.6 Completion time with multiple clock frequencies on pin-limited biochip
For the biochip with multiple clock frequencies, if we increase the clock frequency for
T phase, then the execution time for the bioassay can be reduced. When bioassays
are executed on a 88 direct-addressing biochip, the relationship between execution
time of bioassays and the clock frequency of the T phase is shown in Figure 5.8.
By increasing fT from 1 Hz to 10 Hz, the execution time for exponential dilution
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Table 5.5: Comparisons for the number of operation interrupted between PRSA-
based algorithm [32] and the proposed method.
No. of operations
Total no. No. of operations interrupted
Bioassay of operations interrupted [32] (proposed method)
Exponential dilution 103 97 0
Interpolating dilution 71 65 0
PCR 15 3 0
0
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Figure 5.8: The relationship between completion time of bioassays and fT on an
8  8 direct-addressing biochip.
bioassay can be reduced from 182 seconds to 70 seconds. The completion time for
interpolation dilution and PCR are also listed in Figure 5.8.
From the simulation results, we find that when the clock frequency of the T phase
increases, the completion time of PCR bioassay on the direct-addressing biochip does
not decrease significantly. This is because the time for droplet transportation in the
PCR bioassay is relatively low.
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5.6 Chapter summary and conclusions
In this chapter, we have shown how cyberphysical integration in digital microfluidics
can be used to carry out on-chip bioassays despite the timing uncertainties inher-
ent in fluidic operations such as mixing, dilution, and thermal cycling. We have
presented an operation-interdependency-aware synthesis method that is responsive
to such uncertainties. The proposed design approach facilitates dynamic on-line
decision-making for the execution of fluidic operations and droplet-routing in re-
sponse to detector feedback. We have also incorporated the use of multiple clock
frequencies to accelerate the time-to-response without any adverse impact on elec-
trode reliability. We have used three common laboratorial protocols to demonstrate
that, compared to uncertainty-oblivious biochip synthesis, the proposed dynamic
synthesis approach decreases the likelihood of erroneous reaction outcomes, and it
leads to reduced time-to-result, less repetition of reaction steps, and less wastage of
precious samples and reagents. This work is therefore a step forward towards fully
automated on-chip biochemistry with reliable assay outcomes and low cost.
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6Pin-Count Minimization for
Application-Independent Chips
In this chapter, we propose design methods for pin-limited general-purpose microflu-
idic biochips. The number of control pins used to drive electrodes is a major con-
tributor to fabrication cost for disposable biochips in a highly cost-sensitive market.
Most prior work on pin-limited biochip design determines the mapping of a small
number of control pins to a larger number of electrodes according to the specific
schedule of fluid-handling operations and routing paths of droplets. Such designs are
therefore specific to the bioassay application, hence sacrificing some of the flexibility
associated with digital microfluidics. We propose a design method to generate an
application-independent pin-assignment configuration with a minimum number of
control pins. Layouts of commercial biochips and laboratory prototypes are used as
case studies to evaluate the proposed design method for determining a suitable pin-
assignment configuration. Compared with previous pin-assignment algorithms, the
proposed method can reduce the number of control pins and facilitate the “general-
purpose” use of digital microfluidic biochips for a wider range of applications.
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6.1 Motivation and related prior work
In recent years, the complexity of digital microfluidic biochips continues to increase
as new applications are targeted by this platform. For example, recently announced
commercial products contain up to 5000 electrodes [123; 124]. In order to ensure
complete reconfigurability and the ability to run any given bioassay on the digital
microfluidic platform (i.e., “general-purpose use”), it is desirable that every electrode
be controlled by an independent pin. However, a one-to-one mapping between control
pins and electrodes (referred to as direct-addressing pin-assignment) is not practical
for low-cost disposable chips. A large number of control pins leads to high fabrication
cost, large form factors and interconnect routing problems [6].
In order to reduce the number of control pins and to control the digital microflu-
idic array without significantly affecting concurrent droplet operations, a number of
design of optimization techniques have been published in the literature. These tech-
niques can be categorized as being either bioassay-independent [36; 37] or bioassay-
specific [34][38][65]. In bioassay-independent techniques such as the use of a bus-
phase addressing [36] or cross-referencing [37], the number of control pins required
for addressing the electrodes is independent of the target application. For exam-
ple, cross-referencing requires m   n pins for an m  n array of electrodes, analo-
gous to row/column-based addressing in memories. Bioassay-specific pin-assignment
methods lead to fewer control pins since they utilize knowledge about the operation
schedule, module placement, and droplet routing pathways of the target bioassay.
Prior methods on bioassay-specific pin assignment suffer from three main draw-
backs. First, these techniques are not effective for the design of multi-functional
biochips, which can be reconfigured post-fabrication for different applications by
loading the appropriate control software. General purpose (application-independent)
biochips, where software can be used as a differentiator, offer the promise of higher
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production volume and reduced cost. Second, fluid-handling operations on an applica-
tion-specific biochip are constrained by the pre-determined pin-assignment, hence
post-fabrication tuning of the bioassay protocol, schedule, and droplet routing are
not possible. Finally, it is difficult to estimate the number of control pins a priori
since the number of pins is application-dependent. The cross-referencing technique
described above is application-independent; however, it requires a special electrode
structure which both top and bottom plates are divided into discrete electrode arrays.
This results in increased complexity and higher manufacturing cost [37].
To overcome the above drawbacks, we propose a new method to generate pin-
assignment configurations. This method does not depend on actuation sequences of
electrodes, or does the scheduling and the routing of droplets. Any target application
can be mapped to the array without any restriction on droplet manipulation. The
degree of freedom for droplet movement is therefore maximized.
The main contributions of this chapter are as follows:
1. An analysis of pin-actuation conflicts, and derivation of necessary and sufficient
conditions for control-pin sharing to ensure high flexibility in the concurrent
movement of two droplets, and freedom of movement of a single droplet in all
feasible directions (Section 6.2).
2. An integer linear programming model for designing a pin-assignment with the
smallest number of pins (Section 6.3).
3. A graph-theoretic method to formulate an acceptance test for a pin-assignment
configuration and a lower bound on the number of pins (Section 6.4).
4. A heuristic algorithm that generates a pin-assignment configuration for biochips
(Section 6.4).
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5. Extension of the study from 1 volume droplets to 2 and even larger droplets
(Section 6.5).
6. A scheduling algorithm that can be applied to biochips with pin-constraints
(Section 6.6).
7. Results for commercial biochips and experimental prototypes (Section 6.7).
6.2 Analysis of pin-assignment
In this section, we discuss the relationship between droplet movement and voltages
applied to the electrodes. Next, the concept of pin-actuation conflict is introduced.
Finally, several pin-assignment configurations are analyzed in order to determine the
conditions that guarantee conflict-free pin-assignment.
6.2.1 Pin-actuation conflicts
To manipulate a droplet that currently resides on an electrode E , appropriate control
voltages must be applied to a group of electrodes. According to the principle of
electrowetting-on-dielectric (EWOD)-based microfluidic biochips, movements of a
droplet are determined by the group of electrodes that are directly in contact with
the droplet. Suppose a droplet of unit volume (referred to as a “1” droplet) is
held on electrode E . Then the electrode group that can determine the movement of
the 1 droplet consists of the central electrode E and all its non-diagonally adjacent
electrodes. Each non-diagonally adjacent electrode is a possible destination for the
droplet. Figure 6.1(a) presents an example. Each square in Figure 6.1(a) stands for
an electrode on the microfluidic biochip; letters such as “A”, “B” and “C” stand for
the names of control pins that are connected to the corresponding electrodes. The
control voltages applied to the control pins are either “High”, “Low” or “don’t-care”.
Here we introduce two definitions:
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Control electrode group (CEG): An electrode on which the droplet rests at
any given time and all other electrodes that have direct contact with the droplet are
defined as the elements of the control electrode group (CEG).
For a 1 droplet, its CEG includes the central electrode on which the droplet
rests and all the non-diagonally adjacent electrodes, see Figure 6.1(a). Most bioassays
executed on biochips only include the transportation of 1 droplets, hence in the
following sections (Section 6.2.2 through Section 6.4), we only discuss the case of 1
droplets on the biochip. The pin-assignment problem associated with biochips that
have larger droplets on them is discussed in Section V.
Control pin group (CPG): All pins that are connected to the electrodes in
the CEG are defined as the elements of the control pin group (CPG).
(a) (b) (c) (d)
Figure 6.1: (a) A central electrode and its non-diagonally adjacent electrodes com-
prising an electrode group; (b) an example of pin-actuation conflicts; (c) an example
where two diagonally adjacent electrodes in the same CEG share one pin (Pin A);
(d) an example where two non-adjacent electrodes in the same CEG share one pin
(Pin A).
When multiple fluid-handling operations are implemented on a biochip with a
given pin-assignment configuration, pin-actuation conflicts must be considered. An
example is shown in Figure 1(b), where droplets D1 and D2 are on the array, and
they are scheduled to move in the directions of the arrows concurrently. The groups
of control pins for D1 and D2 are {A, B, H} and {A, C, D, H}, respectively. Note that
Pin A and Pin H are common (shared) control pins for droplets D1 and D2. In order
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to move D1 in the designated direction, the voltages applied to A, B, H should be
set as Low, Low, and High, respectively. Similarly, in order to move droplet D2, the
voltages of A, C, D, H should be set as High, Low, Low, and Low, respectively. Thus,
the movement of D1 requires the application of “High” voltage on Pin H, while the
movement of D2 requires the application of “Low” voltage on Pin H. Since it is not
possible to apply these different voltages to Pin H at the same time, the movements
of D1 and D2 cannot be implemented concurrently. This problem is referred to as
“conflict in pin-actuation signals”.
6.2.2 Control-pin sharing and concurrent movement of droplets
To analyze pin-actuation conflicts, we consider an electrode array with any arbitrary
pin-assignment configuration. Assume that Droplet 1 and Droplet 2 are on two arbi-
trarily chosen electrodes in the array and their control electrode groups are written
as CEG1 and CEG2, respectively, and these control electrode groups have no over-
lap with each other. The central electrodes of CEG1 and CEG2 are written as E1C
and E2C , respectively. Note that any pin-actuation conflict involving more than two
droplets can be studied as a two-droplet problem by examining all possible pairs of
droplets.
Without loss of generality, we first assume that two electrodes E11 and E12 in
CEG1 share one pin (Pin A). Then we have the following scenarios, exhaustively
enumerated by Cases (1.a)(1.c):
(1.a) E11 and E12 are non-diagonally adjacent electrodes: In this case, the move-
ment of a droplet along some directions cannot be achieved because of the electric
shorting of adjacent electrodes [125].
(1.b) E11 and E12 are diagonally adjacent electrodes: An example is shown in
Figure 6.1(c). Two non-diagonally adjacent electrodes of the droplet are controlled
by Pin A. If “High” signal is applied to Pin A, the two electrodes that are connected
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Figure 6.2: Six pin-assignment configurations that are analyzed in Cases
(2.a)(2.c) and Cases (3.a)(3.e): (a) Case (2.a); (b) Case (2.b); (c) Case (2.c);
(d) Case (3.a); (e) Case (3.c); and (f) Case (3.d).
to Pin A will pull the droplet from two directions at the same time. The droplet
may undergo unwanted and unpredictable movement.
(1.c) E11 and E12 are non-adjacent electrodes: An example is shown in Fig-
ure 6.1(d). Two non-adjacent electrodes of the droplet are controlled by Pin A. If
Pin A activates the two electrodes at the same time, the droplet may be split.
According to above discussion for Cases (1.a)(1.c), we conclude that in order to
avoid unwanted movement or splitting of droplets and also guarantee the flexibility
of droplet movements, electrodes in the same CEG cannot share control pins.
Next we assume that CEG1 and CEG2 share one pin (without loss of generality,
154
we assume that the shared pin is Pin A). Then we have the following scenarios,
exhaustively enumerated by Cases (2.a)(2.c):
(2.a) Pin A is connected to both E1C and E2C : An example is shown in Fig-
ure 6.2(a). The two droplets can be moved concurrently to any non-diagonally adja-
cent electrode without pin-actuation conflicts. Thus, there are 16 possible concurrent
movements of the pair of droplets, and no unwanted movement or splitting will occur
for these 16 concurrent movements.
(2.b) Pin A is neither connected to E1C nor E2C : An example is shown in Fig-
ure 6.2(b). Suppose Droplet 1 and Droplet 2 are scheduled to move in the directions
indicated by the arrows. For the movement of Droplet 1, the control voltages applied
to Pins A, B, C, D, and E should be set as High, Low, Low, Low, and Low, respec-
tively. Similarly, for the movement of Droplet 2, the control voltages on Pins A, F,
G, H, and I should be set as Low, Low, Low, High, and Low, respectively. Therefore,
the status of Pin A corresponding to the movements of Droplet 1 and Droplet 2 are
different. To avoid a conflict, Droplet 1 and Droplet 2 must be moved in different
clock cycles. Assume that Droplet 1 is moved first; a “High” voltage will be applied
to Pin A. To make Droplet 2 stay at its current position, a “High” voltage will also
be applied to the electrode under Droplet 2 (i.e., a “High” voltage will be applied to
Pin F). Note that when a high voltage is applied to the electrode under the droplet,
the droplet will remain at its current position without movement or splitting, even if
high voltage is applied to one of its adjacent electrodes; this scenario has been demon-
strated experimentally [46]. After Droplet 1 has arrived at its destination electrode,
the movement operation for Droplet 2 will be implemented. Thus, the number of
all possible concurrent movements for the droplet pair is 3  3   1  10, and no
unwanted movement or splitting will occur for these 10 concurrent movements.
(2.c) Pin A is connected to E1C or E2C : Without loss of generality, we assume
that Pin A is connected to E1C . An example is shown in Figure 6.2(c). Droplet 1
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can be moved in any non-diagonal directions freely, while Droplet 2 can be moved
to the electrodes controlled by Pin G, Pin H, and Pin I. Thus, the number of all
possible concurrent movements for the droplet pair is 43 = 12, and no unwanted
movement or splitting will occur for these 12 concurrent movements.
Based on the above analysis for Cases (2.a)(2.c), we find that when two CEGs
share one control pin, and electrodes in the same CEG do not share any control
pin, unwanted movement or splitting of droplet will not occur. The number of
all possible concurrent movements for the droplet pair varies from 10 to 16. Even
though in Cases (2.b) and (2.c) the flexibilities of droplet movements are not as high
as direct-addressing biochips, they are still adequate for the concurrent manipulation
of droplets.
Finally, we assume that CEG1 and CEG2 share two pins (Pin A and Pin B). Then
we have the following scenarios, exhaustively enumerated by Cases (3.a)(3.e):
(3.a) Both E1C and E2C are connected to Pin A (or Pin B): Without loss of
generality, we assume that both E1C and E2C are connected to Pin A. One example
is shown in Figure 6.2(d). When Droplet 1 is moved in the direction indicated by the
arrow, the control voltages applied to Pins A, B, C, D, and E should be set as Low,
High, Low, Low, and Low, respectively. In this case, the electrode under Droplet 2 is
applied “Low” voltage, while one of the non-diagonal electrodes (which is connected
to Pin B) is applied “High” voltage. Therefore, Droplet 2 has to be moved in the
direction indicated by the arrow, no matter where the scheduled movement direction
points. In this case, the unwanted movement of the droplet may occur. The number
of all possible concurrent movements for the droplet pair is 1  3 3  10. To avoid
unwanted movement of droplets that may be located on any two arbitrary positions
of the layout, the pin-assignment configurations discussed in this case should be
forbidden.
(3.b) Pin A connects to E1C and Pin B connects to E2C (or vice versa): Assume
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Pin A is also connected to electrode E2L P CEG2, and Pin B is also connected to
electrode E1L P CEG1. Then CEG2L denotes the control electrode group whose
central electrode is E2L. Since E2C and E2L are two adjacent electrodes, it is easy to
see that E2C P CEG2L. Therefore, CEG1 and CEG2L share two pins and their central
electrodes are both controlled by Pin A. The pin-assignment configuration for CEG1
and CEG2L is the same as the configuration discussed in Case (3.a), and may lead to
the unwanted movement of a droplet. The pin-assignment configurations discussed
in this case should also be forbidden.
(3.c) Pin A and B are connected to neither E1C nor E2C : An example is shown
in Figure 6.2(e). Suppose Droplet 1 and Droplet 2 are scheduled to move in the
directions indicated by the arrows. For the movement of Droplet 1, the control
voltages applied to Pins A, B, C, D, and E should be set as Low, High, Low, Low, and
Low, respectively. Similarly, for the movement of Droplet 2, the control voltages on
Pins A, B, F, G, and H should be set as High, Low, Low, Low, and Low, respectively.
Therefore, the status of Pin A and Pin B corresponding to the movements of Droplet
1 and Droplet 2 are different. To avoid a conflict, Droplet 1 and Droplet 2 must be
moved in different clock cycles. Assume that Droplet 1 is moved first; a “High”
voltage will be applied to Pin B. To make Droplet 2 stay at its current position, a
“High” voltage will also be applied to the electrode under Droplet 2. Therefore, for
the pin-assignment configuration discussed in this case, one droplet can be moved
freely, while the other droplet may have to stall on the current electrode. The number
of all possible concurrent movements for the droplet pair is 1 1 22  6. Note that
even though droplets will not undergo unwanted movement or splitting in this case,
the number of possible movements is relatively low. This shows that the flexibility
of droplet movement in this case is rather limited, hence we should avoid such a
pin-assignment.
(3.d) Pin A is connected to E1C or E2C , and Pin B is neither connected to E1C
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nor E2C : Without loss of generality, we assume that Pin A is connected to E1C . An
example is shown in Figure 6.2(f). In this pin-assignment configuration, unwanted
movement or splitting of droplets will not occur. The number of possible concurrent
movements in this case is 1 6  7, as explained below. Droplet 1 and Droplet 2 can
be moved to the electrodes controlled by Pin B concurrently (1 possible concurrent
movement); Droplet 1 can be moved to the electrodes controlled by Pins E, C, and
D; while Droplet 2 can be moved to the electrodes controlled by Pins G and H (32
possible concurrent movements).
(3.e) Pin B is connected to E1C or E2C , and Pin A is neither connected to E1C
nor E2C : This case can be analyzed in the same way as Case (3.d). The number of
all possible concurrent movements for the droplet pair is 7.
Based on the above analysis, we conclude that when two CEGs share two pins,
for Case (3.a) and Case (3.b), droplets may undergo unwanted movement. For Cases
(3.c)(3.e), unwanted movement or splitting of droplet will not occur. However, the
number for possible concurrent movements is no more than 7. Comparing with a
direct-addressing biochip, the flexibilities of droplet movements in Cases (3.c)(3.e)
are relatively low. Hence we ensure that such pin assignments are not considered in
the biochip designs studied in this chapter.
Based on the above discussion, we obtain the following lemma, which provides a
necessary and sufficient condition for the acceptance of any arbitrary pin-assignment
configuration with two droplets on two arbitrary positions of the biochip. The goal is
to prevent unwanted splitting or movement of droplets, and also guarantee significant
flexibility for the concurrent movement of droplets.
Lemma 6.2.1. Consider an electrode array with any arbitrary pin-assignment con-
figuration. Suppose two droplets are located at any two arbitrarily chosen electrodes.
The following constraints are necessary and sufficient to avoid any unwanted splitting
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or movement of droplets, to permit the movement of each droplet along any feasi-
ble direction in the array, and to guarantee that the number of possible concurrent
movements is no less than 10:
Constraint 1: Any two electrodes in the same control electrode group cannot be
connected to the same control pin.
Constraint 2: Any two non-overlapping electrode groups cannot share more than
one pin.
Proof: The necessity of Constraint 1 can be proven by reductio ad absurdum.
We assume that two electrodes in the same CEG share one pin. Suppose unwanted
splitting and movement of droplets can be avoided, and each droplet can be moved
along any feasible direction in the array. From the discussion of Cases (1.a)(1.c),
we can find that droplets may undergo unwanted splitting or movement, or the
movement of a droplet along some directions can never be achieved. Hence we have
reached a contradiction.
The necessity of Constraint 2 also can be proven by reductio ad absurdum. We
assume that two CEGs share k control pins, where k ¡ 1. From the discussion
of Cases (3.a)(3.e), we find that in some cases, droplets may undergo unwanted
splitting or movement. In every other case, the number of possible concurrent move-
ments for the two droplets is no more than 7. The sufficiency of Constraint 1 and
Constraint 2 is proven based on the analysis for Cases (2.a)(2.c). When Constraint
1 and Constraint 2 are satisfied, unwanted movement or splitting of droplets will not
occur. The number of all possible concurrent movements for the droplet pair is at
least 10, and each droplet can be moved along any feasible direction in the array.
Based on the above discussion, the necessity and sufficiency of Constraint 1 and
Constraint 2 in Section 6.2.1 are proven. l
Note that Constraint 1 and Constraint 2 also ensure that when one droplet is
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split, the other droplet does not undergo any unwanted splitting or movement. Since
the movement of a droplet from one electrode to its adjacent electrode is the basic
operation for dispensing, mixing, and transportation operations, Constraint 1 and
Constraint 2 can ensure the maximum degree of freedom for any concurrent fluid-
handing operations involving any two droplets.
6.3 ILP model for pin-assignment
In this section, we develop an integer linear programming (ILP) model to optimally
solve the pin-assignment problem. As explained later, the model forms the basis for
evaluating heuristic solutions. On an M  N electrode array, let xi,m,n be a binary
variable defined as below.
xi,m,n 
$&%
1, if Pin i is connected to the electrode at the
mth row and nth column of the array
0, otherwise
where 1 ¤ i ¤ L. The parameter L is the maximum possible index for the number
of control pins and the value of L can be set to an easily-determined loose upper
bound.
The index of the control pin connected to the electrode at the mth row and nth
column of the array is defined as Pm,n. It can be expressed as Pm,n 
°L
i1 i  xi,m,n.
The total number of pins that are assigned to electrodes is equal to the maximum
value of Pm,n (where 1 ¤ m ¤ M and 1 ¤ n ¤ N). Hence, the total number
of pins assigned to electrodes in the layout (i.e., Ntol) can be written as: Ntol 
Max1¤i¤L,1¤m¤M,1¤n¤Nti  xi,m,nu. Since the target of the ILP model is to derive a
feasible pin-assignment configuration that has the minimum number of control pins.
The objective function of the ILP model for a pin-limited digital microfluidic biochip
is defined as:
minimize: Ntol (6.1)
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Next we map Constraint 1 and Constraint 2 of Section 6.2.1 into inequalities of
the ILP model. The electrode group whose central electrode is at the mth row and
nth column of the array is written as EGm,n. In any electrode group EGm,n, the
number of electrodes that are connected to any Pin i is defined as Ni,m,n, which can
be written as:
Ni,m,n  xi,m,n   xi,m+1,n   xi,m-1,n   xi,m,n+1   xi,m,n-1. (6.2)
Therefore, Constraint 1 of Section 6.2.1 can be expressed as the following set of
constraints: Ni,m,n ¤ 1, @1 ¤ i ¤ L, 1 ¤ m ¤M, 1 ¤ n ¤ N .
The Constraint 2 of Section 6.2.1 can be further derived as follows. For two
electrode groups EGm,n and EGm+p,n+q, if p and q are integers and |p|   |q| ¥ 3,
then these two electrode group are non-overlapping. Based on the definition given by
Equation 6.2, for EGm+p,n+q, the number of electrodes that are connected to Pin i is
Ni,m+p,n+q. For EGm,n and EGm+p,n+q, the numbers of electrodes that are connected
to another Pin j are written as Nj,m,n and Nj,m+p,n+q, respectively. Assume that
Constraint 2 in Section 6.2.1 is violated, and EGm,n and EGm+p,n+q share Pin i and
Pin j. Then there will be: Ni,m,n ¥ 1, Ni,m+p,n+q ¥ 1, Nj,m,n ¥ 1, and Nj,m+p,n+q ¥ 1.
Therefore, when Constraint 2 is violated, there must exist integers i, j, m, n, p, and
q, such that Ni,m,n   Ni,m+p,n+q   Nj,m,n   Nj,m+p,n+q ¥ 4. In order to make sure
Constraint 2 is not violated, we have the following inequalities:
Ni,m,n  Ni,m+p,n+q  Nj,m,n  Nj,m+p,n+q ¤ 3,
@1 ¤ i  j ¤ L, 1 ¤ m ¤M, 1 ¤ n ¤ N, |p|   |q| ¥ 3. (6.3)
The objective function given by (1) can be linearized using standard techniques.
This completes the ILP model for optimization. For the M N microfluidic array,
the number of CEGs is MN . The number of inequalities derived from Constraint
1 and Constraint 2 are OpMNLq and OpM2N2L2q, respectively. Thus for the ILP
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1: Phase 1: Derive the lower bound NL on the number of control pins;
2: PinAvailable = {Pin 1, Pin 2, ... Pin NL}; // Initialize the set of pins that can be
assigned to the layout
3: Phase 2: Construct a feasible pin-assignment configuration by greedy algorithm;
4: Give each electrode an index number, and name electrodes as E1, E2, ..., ENlayout ;
// For example, we can number electrodes one by one from upper right corner of
the layout to the lower left corner
5: ElectrodesNeedAssigned = {E1, E2, ..., ENlayout}; // This is the set of electrodes
that need to be assigned pins
6: ElectrodesAlreadyAssigned = H; // This is the set of electrodes that have already
been assigned pins
7: Randomly select an electrode ER and assign Pin 1 to it;
8: Set ElectrodesNeedAssigned = {ER}; // ER is the randomly selected “seed” of the
pin-assignment process.
9: while ElectrodesNeedAssigned  H do
10: Select the electrode Eneighbor that has the minimum index from the neighboring
electrodes of ElectrodesAlreadyAssigned;
11: for each Pin i in PinAvailable do
12: Assign Pin i to Eneighbor;
13: CheckFeasible; // Check whether the pin-assignment is a feasible solution
14: if CheckFeasible = True then
15: ElectrodesNeedAssigned = ElectrodesNeedAssignedEneighbor;
16: ElectrodesAlreadyAssigned = ElectrodesAlreadyAssigned Eneighbor;
17: Break;
18: end if
19: end for
20: if no pins in PinAvailable can be assigned to Eneighbor for a feasible solution
then
21: PinAvailable = PinAvailable + Pnew; // Add a new pin to the layout
22: Assign Pnew to Eneighbor; //Assign the newly added pin to Eneighbor
23: ElectrodesNeedAssigned = ElectrodesNeedAssigned Eneighbor;
24: ElectrodesAlreadyAssigned = ElectrodesAlreadyAssigned Eneighbor;
25: end if
26: end while
Figure 6.3: Pseudocode for the construction of the pin-assignment configuration
using a greedy algorithm.
model introduced above, the number of variables in the ILP model is OpMNLq, and
the number of constraints is OpM2N2L2q. It is important to note that, since L is a
loose upper bound for the number of pins, we have L = OpMNq. The ILP model is
clearly not scalable for a large problem instance; nevertheless, we use it to evaluate
the quality of the heuristic solution that we design in the next section.
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6.4 Heuristic optimization method
The ILP model introduced in Section 6.3 has high computational complexity and the
CPU time is unacceptable for large biochips. In this section, we develop a heuristic
algorithm to generate a pin-assignment configuration efficiently; the pseudocode for
this algorithm is shown in Figure 6.3. The algorithm includes two phases; the first
phase is to establish a lower bound on the number of pins, and the second phase is to
construct the pin-assignment configuration in a greedy fashion. In order to improve
the efficiency of the greedy algorithm, we propose a mapping from a pin-assignment
configuration to an undirected graph, and then we use the graph to ascertain whether
the pin-assignment configuration is a feasible solution. A lower bound on the number
of pins from the graph model is also described.
For simplicity, we define two operators. First, the pin-assignment configuration
is defined as the operator C, which is a mapping from the set of all electrodes on the
chip (E) to the set of pins that are assigned to the electrodes (P ).
C : E Ñ P (6.4)
For example, Figure 6.4(a) shows the coordinate locations for the electrodes and
Figure 6.4(b) shows the corresponding pin-assignment configuration. Here, the elec-
trode at position pi, jq is represented by Epi,jq, and E 

i,j
Epi,jq. When the operator
C is applied to Ep1,1q, we get CpEp1,1qq  Pin A.
For any electrode E P E, we can virtually place a droplet on this electrode
and obtain the CEG, referred as Egroup for this virtual droplet. By taking any two
elements from Egroup, we can get an unordered pair of electrodes. The set that
consists of all such electrode pairs is represented by Epair.
Next, the operator Φ is defined as a mapping from the set of electrodes E to the
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(1,1) (1,2) (1,3)
(2,1) (2,2) (2,3)
(3,1) (3,2) (3,3)
A B C
D E F
G A C
(a)
(1,1) (1,2) (1,3)
(2,1) (2,2) (2,3)
(3,1) (3,2) (3,3)
A B C
D E F
G A C
(b)
C
F
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,3))Link(E(1,3),E(2,3))
C
E
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
C
E
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
F
Link(E(1,2),E(2,3))
Link(E(1,3),E(2,3))
B A
F
C
Link(E(3,2),E(3,3))
Link(E(2,3),E(3,3))Link(E(2,3),E(3,2))
E
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
Link(E(3,2),E(3,3))
Link(E(2,3),E(3,3))
Link(E(2,3),E(3,2))
C
F
E
F
Link(E(1,3),E(2,2))
Link(E(1,3),E(2,3))
Link(E(2,2),E(2,3))
C
Link(E(1,3),E(3,3))
Link(E(2,3),E(3,3))
Link(E(2,3),E(3,3))
(c)
C
F
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,3))Link(E(1,3),E(2,3))
C
E
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
C
E
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
F
Link(E(1,2),E(2,3))
Link(E(1,3),E(2,3))
B A
F
C
Link(E(3,2),E(3,3))
Link(E(2,3),E(3,3))Link(E(2,3),E(3,2))
E
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
Link(E(3,2),E(3,3))
Link(E(2,3),E(3,3))
Link(E(2,3),E(3,2))
C
F
E
F
Link(E(1,3),E(2,2))
Link(E(1,3),E(2,3))
Link(E(2,2),E(2,3))
C
Link(E(1,3),E(3,3))
Link(E(2,3),E(3,3))
Link(E(2,3),E(3,3))
(d)
C
F
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,3))Link(E(1,3),E(2,3))
C
E
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
C
E
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
F
Link(E(1,2),E(2,3))
Link(E(1,3),E(2,3))
B A
F
C
Link(E(3,2),E(3,3))
Link(E(2,3),E(3,3))Link(E(2,3),E(3,2))
E
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
Link(E(3,2),E(3,3))
Link(E(2,3),E(3,3))
Link(E(2,3),E(3,2))
C
F
E
F
Link(E(1,3),E(2,2))
Link(E(1,3),E(2,3))
Link(E(2,2),E(2,3))
C
Link(E(1,3),E(3,3))
Link(E(2,2),E(3,3))
Link(E(2,3),E(3,3))
(e)
C
F
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,3))Link(E(1,3),E(2,3))
C
E
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
C
E
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
F
Link(E(1,2),E(2,3))
Link(E(1,3),E(2,3))
B A
F
C
Link(E(3,2),E(3,3))
Link(E(2,3),E(3,3))Link(E(2,3),E(3,2))
E
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
Link(E(3,2),E(3,3))
Link(E(2,3),E(3,3))
Link(E(2,3),E(3,2))
C
F
E
F
Link(E(1,3),E(2,2))
Link(E(1,3),E(2,3))
Link(E(2,2),E(2,3))
C
Link(E(1,3),E(3,3))
Link(E(2,3),E(3,3))
Link(E(2,3),E(3,3))
(f)
Figure 6.4: (a) Coordinate locations for the electrodes; (b) pin-assignment for the
electrodes; graphs corresponding to electrode (c) Ep1,2q; (d) Ep1,3q; (e) Ep2,3q; and (f)
Ep3,3q.
set of electrode pairs Epair.
Φ : E Ñ Epair (6.5)
For example, as shown in Figure 6.4(a), when the operator Φ is applied to Ep1,3q,
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the following mapping is obtained:
ΦpEp1,3qq  tpEp1,3q, Ep1,2qq, pEp1,3q, Ep2,3qq, pEp1,2q, Ep2,3qqu.
Based on operators C and Φ defined above, for any electrode Epi,jq on the layout,
a graph Gpi,jq can be constructed as follows. First, a droplet is placed virtually on
the electrode Epi,jq and the corresponding CEG (Egrouppi,jq) is obtained. By applying
operator C to each element of Egrouppi,jq, we get the CPG (Pgrouppi,jq) that corresponds
to this virtual droplet. Each pin in Pgrouppi,jq is mapped to a node in Gpi,jq.
By applying operator Φ on E, the set of electrode pairs Epairpi,jq can be derived.
For each electrode pair pEx, Eyq in Epairpi,jq, we apply operator C to it and get the
corresponding pin pair pPx, Pyq, and add an edge between the two nodes that repre-
sent Px and Py in the graph. This edge is labeled as LinkpEx,Eyq. Since pEx, Eyq is
an unordered pair, we consider the edges with labels LinkpEx,Eyq and LinkpEy ,Exq as
the same edge, i.e., we do not distinguish between them.
In this way, a one-to-one mapping from the set Epairpi,jq to the edges in Gpi,jq
is defined. Figures 6.4(c)-(f) show graphs Gp1,2q, Gp1,3q, Gp2,3q, and Gp3,3q, which
correspond to electrodes Ep1,2q, Ep1,3q, Ep2,3q, and Ep3,3q in Figure 6.4(a), respectively.
If two or more elements in the CEG of Epi,jq share the same control pin, as in
the case of electrode Ep2,3q shown in Figure 6.4(a), graph Gpi,jq will contain cyclic
edges, and there will be multiple edges between certain pairs of distinct nodes. The
graph Gp2,3q corresponding to electrode Ep2,3q, which is a multigraph, is shown in
Figure 6.4(e).
Based on above examples, we conclude thatGpi,jq is a complete graph if Constraint
1 in Lemma 6.2.1 is satisfied (i.e., the elements in the CEG of Epi,jq are assigned to
different pins). Hence the number of edges in the graph Gpi,jq can be derived from the
number of nodes in Gpi,jq (i.e., the number of elements in the corresponding CEG).
For a given pin-assignment configuration, let the set of electrodes be defined as
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CF
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,3))Link(E(1,3),E(2,3))
C
E
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
C
E
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
F
Link(E(1,2),E(2,3))
Link(E(1,3),E(2,3))
B A
F
C
Link(E(3,2),E(3,3))
Link(E(2,3),E(3,3))Link(E(2,3),E(3,2))
E
B
Link(E(1,2),E(1,3))
Link(E(1,2),E(2,2))Link(E(1,1),E(2,2))
A
Link(E(1,1),E(1,3))
Link(E(1,1),E(1,2))
Link(E(1,3),E(2,2))
Link(E(3,2),E(3,3))
Link(E(2,3),E(3,3))
Link(E(2,3),E(3,2))
C
F
E
F
Link(E(1,3),E(2,2))
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Figure 6.5: (a) The union of graphs Gp1,2q and Gp1,3q; (b) the union of graphs
Gp1,2q and Gp3,3q. The graphs Gp1,2q, Gp1,3q, and Gp3,3q are shown in Figure 6.4(c),
Figure 6.4(d), and Figure 6.4 (f), respectively.
Elayout. By virtually placing a droplet on electrode Ex P Elayout, the graph GEx
for any electrode can be derived. The graph for the pin-assignment configuration,
which is written as Glayout, is defined as the union of all GEx (Ex P Elayout), i.e.,
Glayout 

Ex P Elayout
GEx , where the set of nodes in Glayout is obtained by applying
the union operation to the set of graphs in GEx , @ Ex P Elayout. Edges with the same
label are considered as the same edge in the union graph [126].
Next, we use two examples to illustrate the union of two graphs. Figure 6.5(a)
shows the union of graphs Gp1,2q and Gp1,3q. Graphs Gp1,2q and Gp1,3q can be found
in Figure 6.4(c) and Figure 6.4(d), respectively. Note that the edge between nodes
B and C in Gp1,2q and the edge between nodes B and C in Gp1,3q are both labeled as
LinkpEp1,2q,Ep1,3qq, hence they are considered to be the same edge in the merged graph.
In the merged graph Gp1,2q Y Gp1,3q, there is only one edge LinkpEp1,2q,Ep1,3qq between
nodes B and C. By checking the number of edges between each pair of nodes, we
find that the merged graph is a simple graph.
Figure 6.5(b) is the union of graphs Gp1,2q and Gp3,3q. Graphs Gp1,2q and Gp3,3q
can be found in Figure 6.4(c) and Figure 6.4(f), respectively. Note in graph Gp1,2q
the edge between nodes A and C is labeled as LinkpEp1,1q,Ep1,3qq, and in graph Gp3,3q
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the edge between nodes A and C is labeled as LinkpEp3,2q,Ep3,3qq. Therefore the merged
graph Gp1,2q Y Gp3,3q has two edges between nodes A and C, i.e., Gp1,2q Y Gp3,3q is a
multigraph.
The following lemma results from the structure of Glayout and the acceptability of
the pin-assignment (Section 6.2.1). Note that depending on the mapping of control
pins to electrodes, Glayout may be a simple graph (no self-loop and no more than
one edge between any two distinct nodes) or a multigraph (either with a self-loop or
more than one edge between some pairs of nodes) [126].
Lemma 6.4.1. A pin-assignment configuration satisfies Constraint 1 and Constraint
2 in Section 6.2.1 if and only if the graph Glayout is a simple graph.
Proof: First we assume that Constraint 1 in Lemma 6.2.1 is violated. Thus, an
electrode group Egrouppxq exists in which two elements share the same control pin.
According to the definition of edges for GEx , there will be cyclic edges and multiple
edges between two nodes. Thus GEx is a multigraph. Since GEx is a subgraph of
Glayout, Glayout is also a multigraph.
We next assume that Constraint 2 in Lemma 6.2.1 is violated. Thus two non-
overlapping CEGs Egroup1 and Egroup2 exist, and their corresponding CPGs share
more than one common pin. Assume the graph derived from Egroup1 and Egroup2 are
G1 and G2, respectively. Suppose Ex1 P Egroup1 and Ex2 P Egroup2 are both connected
to pin X, and Ey1 P Egroup1 and Ey2 P Egroup2 are both connected to pin Y. According
to the definition of the one-to-one mapping from the set of electrode pairs to edges
in the graph, electrode pair {Ex1 , Ey1} is mapped to an edge between the nodes that
represent pin X and pin Y. The label of this edge is LinkpEx1 ,Ey1 q (or LinkpEy1 ,Ex1 q).
Electrode pair {Ex2 , Ey2} is mapped to an edge between the nodes that represent
pin X and pin Y. The label of this edge is LinkpEx2 ,Ey2 q (or LinkpEy2 ,Ex2 q). Based on
the definition of the union of two graphs, when G1 and G2 are merged to G1YG2,
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there will be two edges with different labels between the nodes that represent pin X
and pin Y. Thus G1YG2 is a multigraph. Since G1YG2 is a subgraph of Glayout, we
can conclude that Glayout also is a multigraph.
According to the definition of Glayout, it is easy see that if it is a simple graph,
then the pin-assignment configuration satisfies Constraint 1 and Constraint 2. l
For any given layout, according to its shape, we can estimate a lower bound on
the number of control pins needed to avoid pin-actuation conflicts for any target
application.
Here we show two instances on the calculation of the lower bound of the number
of control pins.
Theorem 6.4.2. Consider an mn digital microfluidic array. Then suppose a pin-
assignment configuration with M pins exists, such that Constraint 1 and Constraint
2 in Section 6.2.1 are satisfied. A lower bound on M is given by:
M
2


¥ 6mn 5m 5n  2.
For a m  n electrode array, and for any electrode Epi,jq in this array, since its
corresponding graph Gpi,jq is a complete graph, the number of edges can be derived
from the number of elements in the CPG. For different positions of the electrodes,
the numbers of elements in CPG are different. Thus we calculate the number of edges
Glayout by classifying electrode into three categories according to their positions, as
shown in Figure 6.6(a).
The first category includes the electrodes located at the corner of the array and
the corresponding graph is shown in Figure 6.6(b). For each graph, there are three
nodes and the number of edges is
 
3
2

=3. Since the number of such electrodes in the
m  n array is 4, we get 4 graphs with 3 edges. The second category includes the
electrodes located at four sides but not the corners of the array, and the corresponding
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Figure 6.6: (a) Three categories of electrodes and the graphs correspond to elec-
trodes of (b) the first category (c) the second category (c) the third category.
graph is shown in Figure 6.6(c). For each graph, there are four nodes and the number
of edges is
 
4
2

=6. Since the number for such electrodes is 2(m+n-4), we have 2(m+n-
4) graphs with 6 edges. The third category includes the electrodes located within
the array and the corresponding graph is shown in Figure 6.6(d). For each graph,
there are five nodes and the number of edges is
 
5
2

=10. Since the number of such
electrodes is pm 2q  pn 2q, we will get pm 2q  pn 2q complete graphs with
10 edges.
On the other hand, the number of edges that are contained in two graphs is
pm  1q  n+pn  1q m+2  pm  1q  pn  1q. Therefore, using the principle of
inclusion/exclusion, we set the total number of edge in the graph Glayout to be:
Nedge  4  3   12pm  n 4q   10pmn 2m 2n  4q
 rpm 1qn  pn 1qms  2  pm 1q  pn 1q
 6mn 5m 5n  2
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Figure 6.7: An m n outlined rectangle.
According to Lemma 6.4.1, if the pin-assignment configuration satisfies Con-
straint 1 and Constraint 2, then graph Glayout is a simple graph. Assume that there
are M control pins in the pin-assignment configuration. The number of nodes in
graph Glayout is equal to M . The maximum number of edges in the simple graph
Glayout that has M nodes is given by:
Nedge max=
 
M
2

=MpM1q
2
Finally, we derive the desired lower bound in the number of control pins. Since
Nedge max is an upper limit on the number of edges in a graph, we have the inequality
Nedge max ¥Nedge. l
Based on Theorem 6.4.2, we have following corollary:
Corollary 6.4.3. For large values of m and n, the lower bound on the number of
control pins can be approximated as Mmin  2
?
3mn, and if m  n  t, we get
Mmin  2
?
3t. In other words, the number of pins is Ωp?Nq when the total number
of electrodes in the array is N .
Next we calculate the lower bound for the number of control pins required by
an m  n outlined rectangular layout. The layout is shown in Figure 6.7, and the
outlined rectangular array is used extensively in commercial biochips [123][124]. For
the outlined rectangular array, we have the following theorem:
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Theorem 6.4.4. A lower bound on the number of control pins in the mn outlined
rectangle is given by following inequality:

M
2


¥ 4m  4n 8.
Proof: For this layout, there are (2pm nq 4) CEGs in total and each CEG has
three electrodes. When we map the layout to the graph model, we get (2pm nq4)
complete graphs, and each graph has three nodes and three edges. Some edges are
contained in more than one sub-graph. The number of edges that are contained
in two graphs is (2  pn  1q+2  pm  1q). Therefore, by using the principle of
inclusion/exclusion, we get the total number of edges in the graph Glayout as:
Nedge  3  p2pm  nq  4q  p2  pn 1q   2  pm 1qq
 4m  4n 8
According to Lemma 6.4.1, if the pin-assignment configuration satisfies Con-
straint 1 and Constraint 2, then graph Glayout is a simple graph. Assume that there
are M control pins in the pin-assignment configuration, the number of nodes in graph
Glayout is equal to M . The maximum number of edges Nedge max in the simple graph
Glayout, which has M nodes, is given by:
Nedge max 

M
2


 M  pM  1q
2
Finally, we derive the desired lower bound in the number of control pins for the
outlined rectangular layout. Since Nedge max is an upper limit on the number of edges
in a graph, we have the inequality Nedge max ¥Nedge. l
Based on Theorem 6.4.4, we have following corollary:
Corollary 6.4.5. For large values of m and n, the lower bound on the number of
control pins can be approximated as Mmin  2
?
m  n, and if m  n  t, we get
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Mmin  2
?
2t. In other words, the number of pins is Ωp?Nq when the total number
of electrodes in the array is N .
For an electrode array that has other shapes, the number of control pins can be
lower-bounded in a similar manner.
Let us now return to the pseudocode shown in Figure 6.3. In the first phase, we
determine the lower bound NL on the number of pins, and then initialize the set of
available pins (which is written as PinAvailable in Figure 6.3) as {Pin 1, Pin 2, ...,
PinNL}. In the second phase, we set an index number for each electrode on the layout
by numbering the electrodes one by one, from the electrode on the upper-right corner
to the lower-left corner. Then an electrode ER is randomly selected as the “seed” of
the pin-assignment process, and Pin 1 is assigned to ER. The set of electrodes whose
control pins have been determined is written as “ElectrodesAlreadyAssigned” (as
shown in Figure 6.3). The graph corresponding to the pin-assignment configuration
of ElectrodesAlreadyAssigned is written as GEAA.
Then electrode ER is the first element that is added into the set Electrode-
sAlreadyAssigned. The pin-assignment configuration for the layout is constructed
electrode-by-electrode around the seed ER. In each step, we locate all the neighbor-
ing electrodes of ElectrodesAlreadyAssigned and sort out the electrodes to identify
the one that has the minimum index number. The electrode with the minimum index
number is written as Eneighbor as shown in Figure 6.3. Then, starting from Pin 1 and
proceeding through Pin NL, we search for the control pin that can be assigned to
Eneighbor to obtain a feasible pin-assignment solution. Here are the detailed steps of
the searching process.
Each time we virtually assign a control pin to Eneighbor, and update GEAA by
doing the union of the original GEAA with the graph that corresponds to the new
electrode. Then we determine whether the updated GEAA is a simple graph. Based
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on Lemma 6.4.1, if GEAA is a simple graph, then we have expanded the feasible local
solution successfully and Eneighbor will be added into the set ElectrodesAlreadyAs-
signed, as shown in Figure 6.3. Otherwise, we will change the pin that is assigned
to Eneighbor.
If none of the pins in set PinAvailable can be assigned to Eneighbor, a new pin
is added into PinAvailable, and this newly added pin is assigned to Eneighbor. By
repeating the above procedure, the set ElectrodesAlreadyAssigned can be expanded
step-by-step until it covers the whole layout. When we assign pins to the newly-
added electrode, the complement of the graph GEAA, referred to as HEAA, is used
to reduce the search scope. All the pins corresponds to isolated nodes in HEAA are
“unavailable pins” and they cannot be assigned to Eneighbor.
Assume that the number of electrodes on the array is N and the number of pins
assigned to the electrodes is P . The computing complexity for checking whether
GEAA is a simple graph is O(P2). Each time when we assign a pin to Eneighbor, we have
to verify whether GEAA is a simple graph. Thus for the worst case, the computational
complexity of assigning a pin to Eneighbor is O(P3). Since all electrodes are added step-
by-step to the set ElectrodesAlreadyAssigned, the overall computational complexity
of the heuristic procedure is O(P3N ).
The heuristic algorithm can therefore quickly generate a feasible pin-assignment
configuration, and for each given array layout, the number of control pins derived
by the heuristic algorithm can be used as the upper bound on the number of control
pins. For nn rectangular layouts and nn outlined rectangular layouts, the lower
bounds for the number of pins derived from the theoretical analysis and the upper
bounds for the number of pins derived from the heuristic algorithm are shown in
Figure 6.8.
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(a)
(b)
Figure 6.8: The relationships between lower/upper bounds on pin-counts and the
sizes of the electrode arrays for (a) rectangular layouts; (b) outlined rectangular
layouts.
6.5 Manipulation of large droplets
Bioassay benchmarks used to evaluate biochip design automation methods in the lit-
erature make the assumption that all input and output droplets of mixing/dilution
operations are 1 droplets [35][73]. However, with recent advances in fabrica-
tion technology, digital microfluidic biochips can now transport 2 and even larger
droplets; the transportation of larger droplets requires higher actuation voltages
[127]. Some newly developed bioassay protocols for lab-on-chip include the manipu-
lation of 2 droplets. For example, to capture antibodies, a 1 blood droplet needs
to be mixed with a 2 droplet that contains magnetic beads in the “on-magnet in-
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cubation” protocol [124]. To execute this bioassay, the biochip needs to be able to
transport 2 and even larger droplets.
To move droplets with large volumes, more electrodes need to be activated at
each clock cycle [128]. However, the manipulation of droplets with different volumes
introduces new constraints for the design of pin-limited biochips. We discuss these
details below.
6.5.1 Transportation of 2 droplets
To avoid pin-sharing conflicts, the layout of a biochip that can manipulate 2
droplets must satisfy Constraint 1 and Constraint 2 derived in Section 6.2.1. A
difference here is that more pins must be actuated to manipulate large droplets, i.e.,
the CPG of a large droplet may contain more pins than the CPG of a 1 droplet.
As shown in Figure 6.9(a), a 2 droplet will elongate in the direction of movement
[128]. Here, the CPG of the droplet movement includes Pins A, B, C, D, E, and F.
To move the 2 droplet in the direction of the arrow, the signals applied to pins B
and C must be set as “High”, and the signals applied to Pins A, D, E, and F must
be set as “Low”. It is important to note that when the 2 droplet is moved to a
different direction, the elements in the CPG of the 2 droplet are changed to Pins
A, B, D, E, F, and G, as shown in Figure 6.9(b).
When we convert the CPG of a 2 droplet to its graph model, we must consider
all the possible directions in which the droplet can move. An example is shown in
Figure 6.10(a). The 2 droplet has two possible movement directions, i.e., Direction
1 and Direction 2. If the droplet is moved in Direction 1, the elements in its CPG are
Pins A, B, C, and F. The corresponding graph model for this CPG (GD1) is shown
in Figure 6.10(b); if the droplet is moved in Direction 2, the elements in its CPG are
Pins A, B, F, and G. The corresponding graph model for this CPG (GD2) is shown
in Figure 6.10(c). The graph model for the CPG of the droplet can be derived by
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Figure 6.9: (a) To move the 2 droplet to the arrow’s direction, Pins B and C
must be “High”, and Pins A, D, E, and F must be “Low”; (b) to move the droplet
in another direction, pins F and G must be “High”, and Pins A, B, D, and E must
be “Low”.
calculating the union of graphs GD1 and GD2 , as shown in Figure 6.10(d).
For the given pin-assignment configuration discussed in Section 6.4, let the set
of electrodes be defined as Elayout. When considering the transportation of the 2
droplet, we can construct a graph model for the layout Elayout by virtually placing
a 2 droplet on electrode Ex P Elayout. As discussed above, when the 2 droplet
is moved in different directions, the elements in the CPG are different. Note that
when we design the pin-assignment configuration, we do not assume any knowledge
of the position of the 2 droplets or the directions in which they must be moved
in different clock cycles. Therefore, 2 droplets can be present at any position in
the layout, and these 2 droplets can be moved in any non-diagonal direction. To
derive the graph GEx for any electrode, we must consider all the possible directions
in which the droplet can move, and obtain their corresponding graphs as explained
below.
The graph for the pin-assignment configuration, which is written as Glayout, is
defined as the union of all the GEx graphs, i.e., Glayout 

Ex P Elayout
GEx , where
GEx is defined as: GEx 
 tGExD1 , GExD2 , ... GExDDu, and D1, D2, ..., DD are the
possible directions for the movement of the 2 droplet that stays on electrode Ex.
We can easily prove that, for the biochips involving the transportation of 2
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(a) (b) (c) (d)
Figure 6.10: (a) The 2 droplet has two possible movement directions; (b) GD1 :
graph model of CEG corresponding to the movement in Direction 1; (c) GD2 : graph
model of CEG corresponding to the movement in Direction 2; (d) graph model
derived by the union of GD1 and GD2 .
droplets, Lemma 6.4.1 can still be used as an acceptance test for feasible pin-
assignment configurations. The heuristic algorithm shown in Figure 6.3 can be used
for the biochip with manipulations of 2 droplets, and similarly we can determine
the upper and lower bounds for the number of control pins.
For an n n array, the lower bound and upper bound for the number of control
pins are shown in Figure 6.11(a). For an n  n outlined rectangular array, the
lower bound and the upper bound for the number of control pins are shown in
Figure 6.11(b). By comparing the lower/upper bounds on the number of control
pins presented in Figure 6.8 and Figure 6.11, we can find that in order to manipulate
2 droplets, the number of pins assigned to the biochip has to increase.
6.5.2 Influence of diagonal electrodes
In this subsection, we discuss the influence of diagonally adjacent electrodes on the
movement of a droplet. Assume that the droplet shown in Figure 6.12(a) will be
moved in the direction of the arrow, and the electrode that the droplet will be
moved to is actuated. The contact line between the droplet and the actuated elec-
trode is shown in Figure 6.12(a). According to the principle of EWOD, the total
electrowetting force F applied to the droplet can be written as [128]:
F  fm  L  sinα, (6.6)
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(a)
(b)
Figure 6.11: (a) Relationship between lower/upper bounds on pin-counts and the
sizes of the electrode array (rectangular layouts) for biochips with 2 droplets; (b)
relationship between lower/upper bounds on pin-counts and the sizes of the electrode
array (outlined rectangular layouts) for biochips with 2 droplets.
where L is the diameter of the droplet, and the angle α is shown in Figure 6.12(a)[128].
The parameter fm is the driving force per unit length of the contact line [128], which
is determined by the surface characteristics of the device and the actuation voltage
applied to the electrode. For a given liquid in the droplet and a given biochip, fm
can be regarded as a constant [128].
For a typical EWOD device, the size of the square electrodes is 1  1 mm. As
shown in Figure 6.12(a) and Figure 6.12(c), there is a gap between the two adjacent
electrodes. The gap between two adjacent electrodes in the typical EWOD device is
20 µm [129]. So, if we set the length and width of the electrode as 1 unit length, the
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Figure 6.12: (a) The force applied to the droplet when a non-diagonally adjacent
electrode is actuated; (b) relationship between the diameter of the droplet and the
force F applied to the droplet; (c) the force FD applied to the droplet when a
diagonally adjacent electrode is actuated; (d) relationship between the diameter of
the droplet and }FD}
}F }
.
gap between electrodes is 0.02 unit length. Assume that the diameter of the droplet
is D unit length, then according to Equation 6.6, the relationship between D and
the force applied to the droplet is shown in Figure 6.12(b). We can find that, when
the diameter of the droplet increases to 1.46 unit length, the force applied to the
droplet does not increase any further.
Note that when the size of the droplet increases, it may contact diagonally adja-
cent electrodes as well as non-diagonally adjacent electrodes (Figure 6.12(c)). In this
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case, if a non-diagonal electrode is actuated, there will be a force (FD) applied to
the droplet in the diagonal direction. For the same droplet, the relationship between
the diameter of the droplet and the value of }FD}
}F }
can be found in Figure 6.12(d).
We can find that the value }FD}
}F }
increases as the diameter of the droplet increases.
When the diameter of the droplet increases to 1.78 unit length, we have }FD}  }F }.
This means that, for a “large” droplet, the influence of its diagonal electrodes can
no longer be ignored. In this case, when we move a droplet from one electrode to
its non-diagonally adjacent electrode, all the diagonal electrodes of the droplet must
be applied “Low” voltage. Otherwise these diagonal electrodes of the droplet will
influence the movement of the droplet. In this case, we note that biochips that are
required to manipulate a large droplet must satisfy Constraint 1 and Constraint 2
in Section 6.2.1, with the difference that the CEG includes all the nine electrodes in
contact with the droplet.
6.6 Scheduling of fluid-handling operations
For general-purpose biochips, fluid-handling operations must be scheduled after the
pins are assigned to electrodes. This is in contrast to bioassay-specific design where
the scheduling precedes pin-assignment. In our work the initial schedule is derived
without considering any pin constraints, and then the schedule is adjusted according
to the pin-assignment configuration.
For example, when multiple fluid-handling operations are scheduled to be exe-
cuted concurrently, their control signals may conflict with each other. In order to
solve this problem, we must decide the order in which the fluid-handling operations
will be implemented and determine the appropriate voltages to be applied to the
electrodes.
Assume that we have a given initial schedule. Then at each time slot t, the posi-
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tions and scheduled fluid-handling operations of all the droplets are already known.
Therefore, the corresponding actuation signals that need to be applied on the pins
can be easily derived. Based on the actuation signals, the set of pins that must be
applied “High” signal (SHptq), and the set of pins that must be applied “Low” signal
(SLptq) can be determined. Conflicts in the actuation of the pins can occur if and
only if Cptq  SHptq X SLptq  ∅, i.e., the operation schedule requires some control
pins to be set to “High” and “Low” at the same time. In this situation, the operation
schedule must be adjusted.
An example is shown in Figure 6.13(a). Assume at time t  t0, droplets D1, D2,
and D3 are scheduled to be moved in the directions indicated by the arrows, and D4 is
scheduled to be split. To implement the fluid-handing operation for droplets D3, we
have the following set of pins that must be applied “High” voltage: SD3H pt0q  t11u;
to implement the fluid-handing operation for droplets D4, we have the following set
of pins that need to be applied “Low” voltage: SD4L pt0q  t2, 11, 14u. Hence we have
SD3H pt0q X SD4L pt0q  ∅, i.e., the fluid-handling operations scheduled for droplets D3
and D4 cannot be implemented concurrently, otherwise the actuation signals for D3
may lead to unintended movement of D4. Note that the moving and splitting of
droplets are the basic operations implemented on the biochip, and other operations
such as droplet dispensing and mixing can be considered as a sequence of these basic
operations.
To determine the actuation signals that must be applied to the electrodes and
the order in which to implement the fluid-handling operations, we map the conflict
relationships of multiple droplets to a directed graph, and each droplet is mapped to
a node. For two droplets DA and DB, if the fluid-handling operation of DA may lead
to unintended splitting or movement of DB, then in the conflict graph, there will be
a directed edge starting from the node DA to node DB. The operations for droplets
that correspond to the nodes with zero out-degrees in the conflict graph must be first
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Figure 6.13: (a) Droplets D1, D2, and D3 are scheduled to be moved in the di-
rections indicated by the arrows, and D4 is scheduled to be split; (b) conflict graph
derived from the pin-assignment configuration and scheduled fluid-handling opera-
tions of droplets D14.
1: Derive initial operation schedule without considering of pin-constraints;
2: Derive the sets of pins SHptq and SLptq at time t;
3: if SHptq X SLptq then
4: Derive the conflict graph of droplets and determine the priorities of fluid-
handling operations for droplets;
5: if operations for set of droplets F ptq can be executed without leading to
unintended splitting or movement of other droplets then
6: Execute fluid-handling operations for droplets in set F ptq;
7: else
8: Adjust the operation schedule; // Deadlock occurs and operations need
to be re-scheduled.
9: end if
10: else
11: Execute fluid-handling operations concurrently based on initial scheduling.
12: end if
Figure 6.14: Pseudocode for determining the priorities of the movements of the
droplets.
executed, as these operations will not result in unintended splitting or movement of
other droplets.
Figure 6.13(b) is the conflict graph derived from the scheduled fluid-handling
operations of droplets shown in Figure 6.13(a). According to the conflict graph,
we can see that droplets D1 and D2 can be moved at time t  t0, because their
fluid-handling operations will not lead to unintended splitting or movement of other
droplets. Droplets D3 and D4 must remain at their current positions.
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Deadlock in fluid-handling operations occurs if the manipulation of any droplet
may lead to unintended splitting or movement of one or more other droplets. In
this case, none of the fluid-handling operations can be executed. From the conflict
graph, we can find the following necessary and sufficient condition for the occurrence
of deadlock.
Lemma 6.6.1. Deadlock occurs at time t if and only if all the nodes in the corre-
sponding conflict graph have non-zero out-degrees.
Proof: First, assume that deadlock occurs and none of the scheduled fluid-
handling operations can be executed. Hence, executing the operation of an arbitrarily-
chosen droplet DK may lead to the unintended splitting or movement for a group of
other droplets tDK1 , DK2 , ..., DKnu. Based on the definition of edges in the conflict
graph, directed edges will start from the node that represents droplet DK and go to
the nodes that represent droplets tDK1 , DK2 , ..., DKnu. The out-degree of the node
that represents droplet DK is non-zero. Since DK is an arbitrarily-chosen droplet,
we can conclude that all the nodes in the conflict graphs have non-zero out-degrees
when deadlock occurs.
Next, we prove that Lemma 6.6.1 provides a sufficient condition for the occurrence
of deadlock. Based on the definition of a directed edge in the conflict graph, if the
out-degree for a node is non-zero, moving the droplet that is represented by the node
may lead to unintended splitting or movement of other droplets. If all the nodes in
the conflict graph have non-zero out-degrees, we can conclude that the manipulation
of any droplet may lead to unintended splitting or movement of other droplets. Hence
the deadlock occurs.
Based on the above argument, the necessity and sufficiency of the condition in
Lemma 6.6.1 are proven. l
When the deadlock occurs, one or more fluid-handling operations must be re-
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scheduled. Here are the details of the re-scheduling procedure. Assume that a set of
operations Sd is scheduled to be implemented concurrently, and the deadlock occurs.
Then an operation OR is randomly selected from Sd and it is re-scheduled to be
implemented after all the other operations in Sd are finished. Therefore, operation
OR will not have conflicts with any operations in the set SdztORu any more. If
the deadlock still exists, then another operation from SdztORu is randomly selected
and it is also re-scheduled to be implemented after all the other operations are
finished. This re-scheduling process is repeatedly implemented until the deadlock no
longer occurs. The existence of a schedule without the deadlock is guaranteed by the
following lemma:
Lemma 6.6.2. Deadlock never occurs when there are only two droplets concurrently
manipulated by the proposed general-purpose pin-limited biochip.
Proof: This lemma can be proven by reductio ad absurdum. First we assume
that at time t  td, deadlock occurs for two droplets Dx and Dy. According to the
definition of deadlock, we know the operation on Dx may lead to the unintended
splitting or movement for Dy, i.e., S
Dx
H ptdq X SDyL ptdq  ∅. Then we know the
operation on Dy may lead to the unintended splitting or movement for Dx, i.e.,
S
Dy
H ptdq X SDxL ptdq  ∅.
For each control pin of droplet Dx, it is either in the set of S
Dx
H ptdq or in the set
of SDxL ptdq. So we have SDxH ptdq X SDxL ptdq  ∅, and the control pin group of Dx can
be written as CPGDxptdq  SDxH ptdq Y SDxL ptdq.
Similarly, for droplet Dy, we have S
Dy
H ptdq X SDyL ptdq  ∅, and the control pin
group of Dy can be written as CPGDyptdq  SDyH ptdq Y SDyL ptdq.
So we have CPGDxptdqXCPGDyptdq  pSDxH ptdqXSDyL ptdqqY pSDyH ptdqXSDxL ptdqq.
It is already known that SDxH ptdq X SDyL ptdq  ∅ and SDyH ptdq X SDxL ptdq  ∅, we can
conclude that the CPGs of droplet Dx and Dy have at least two common elements.
184
This is in conflict with Constraint 2 in Section 6.2.1. This completes the proof. l
Lemma 6.6.2 shows that in the worst case, we can reduce the number of concur-
rent fluid-handling operations to two, and deadlock will not occur. Therefore, by
re-scheduling the fluid-handling operations, we can always implement the bioassay
without deadlock.
The pseudocode for the scheduling algorithm based on pin-actuation sequences
is shown in Figure 6.14. Note the scheduling algorithm can be applied to any pin-
limited biochip, including the bioassay-specific biochips proposed in [65][130].
6.7 Simulation results
In this section, we present results for two commercial biochips and several laboratory
prototypes.
6.7.1 Commercial biochips
Commercial biochip for n-plex immunoassay
In an n-plex immunoassay, a sample is concurrently analyzed for n different
analytes. Sample droplets are mixed with n different reagents, and the mixed product
droplets are moved to the detection area which includes an optical detector [123][124].
The commercial biochip for the n-plex immunoassay consists of more than 1000
electrodes [123][124]. The layout of this biochip and the pin-assignment derived by
the proposed heuristic algorithm are presented in [123].
Table 6.1 shows the comparison of the number of control pins for the existing
design for the fabricated commercial biochip [35], the result derived by bioassay-
specific algorithm in [35], and the result derived by the proposed heuristic method.
The proposed heuristic method leads to comparable or smaller number of control
pins than both [35] and the fabricated commercial biochip. Since the pin-assignment
derived by the proposed method is bioassay-independent, it also provides the added
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Table 6.1: Comparison of the numbers of control pins and CPU time for the existing
design of the fabricated commercial biochip in [35], the results derived by bioassay-
specific algorithm in [35], and the results derived by the proposed heuristic method.
No. pins No. pins No. pins
(fabricated (bioassay-specific (proposed heuristic
chip [35]) method [35]) method)
Type I unit cell 7 6 7
Type II unit cell 19 13 11
Total No. of pins 26 19 18
CPU time NA 130 min [131] 7.4 s
benefit of being flexible for multiple target applications.
The CPU time for designing the layout for the commercial biochip can be found in
Table 6.1. The existing pin-assignment configuration is derived manually, so it does
not have CPU time [131]. The CPU time needed to generate the pin-assignment in
[131] is 130 minutes while the CPU time is reduced to 7.4 s for the proposed heuristic
algorithm.
Commercial biochip for PCR bioassay
We next apply the proposed algorithm to the commercial biochip for PCR bioas-
say [35][131]. The chip consists of over 1000 electrodes [35][131]. The layout for the
complete chip and the existing pin-assignment in the fabricated biochip (14 pins) can
be found in [35][131]. Table 6.2 compares the number of control pins for the existing
design for the fabricated commercial biochip in [35], the number of pins derived by
bioassay-specific algorithm in [35], and the number of pins derived by the proposed
heuristic method. Similar with the results of n-plex immunoassay chip, the CPU
time of the proposed heuristic algorithm is 3.5 s, while the CPU time needed for
generating the pin-assignment in [131] is 320 minutes.
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Table 6.2: Comparison of the numbers of control pins and CPU time for the exist-
ing design of the fabricated commercial biochip in [124][35], the results derived by
bioassay-specific algorithm in [35], and the results derived by the proposed heuristic
method.
No. pins No. pins No. pins
(fabricated (bioassay-specific (proposed heuristic
chip [35]) method [35]) method)
Routing region 7 6 6
Reaction region 14 10 14
Detection region 11 8 10
Total No. of pins 32 24 30
CPU time NA 320 min [131] 3.5 s
6.7.2 Experimental biochips
Next we apply the pin-assignment algorithm to the layouts of four laboratory proto-
types described in [65], namely a multiplexed assay biochip, a PCR biochip, a pro-
tein dilution biochip, and a multifunction biochip. These layouts have subsequently
been incorporated in commercial chips [14]. Their pin-assignment configurations are
shown in Figure 6.15.
First we compare the number of pins and bioassay completion time between
the proposed general-purpose biochips and other biochips, which include the cross-
referencing biochip in [37], the bioassay-specific biochips in [65] and [130], and the
direct-addressing biochips. We implemented the ILP-based design method of [130]
to obtain a complete set of simulation results. The simulation results are presented
in Table 6.3.
Note that both the cross-referencing biochip in [37] and the proposed general-
purpose biochip are bioassay-independent. When we map bioassays to bioassay-
independent chips, droplet operations are scheduled after the pin-assignment con-
figuration is determined. Therefore, the operation schedule and routing pathways
are more flexible, and they can be adjusted according to the requirements of bioas-
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Figure 6.15: Pin-assignment configurations for (a) multiplexed assay chip; (b) PCR
chip; (c) protein dilution chip; (d) multi-functional chip.
says. Table 6.3 shows that the proposed method can achieve fewer number of pins
and shorter execution time, compared with that cross-referencing biochips in [37].
The proposed general-purpose biochip can greatly reduce the number of control pins
with only a slight increase in the bioassay completion time, compared with the direct-
addressing biochips.
In order to compare the proposed method with the bioassay-specific biochips
in [65], we first derive the synthesis results of bioassays without considering pin-
assignment configurations. The initial synthesis results can be derived from synthesis
tools such as [83][132][133]. Then the operations schedules are adjusted based on
the signals applied to pins, as introduced in Section 6.6. Table 6.3 shows that, the
proposed method can achieve fewer number of control pins and shorter execution time
for multiplexed bioassay and protein dilution bioassay, compared with the bioassay-
specific biochips in [65].
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In the following discussion, the multiplexed assay biochip, PCR bioassay biochip,
protein dilution biochip, and the multi-function biochip presented in Figure 6.15 are
referred to as Chips 14; these four bioassay-specific biochips designed in [65] are
referred to as Chips AD; and these four biochips derived by ILP-based pin-count
aware design in [130] are referred to as Chips E G.
By executing multiplexed bioassay, PCR bioassay, and protein dilution bioassay
on Chips 14, we can evaluate the flexility of the proposed general-purpose biochip.
The completion times of these bioassays can be found in Table 6.4. Note even though
the Chips 14 are general-purpose biochips, their applications are still limited by their
available input/output ports. For example, Chip 1 has only 6 input/output ports,
while the PCR bioassay requires at least 8 input ports (because it has 8 different
input reagents). Hence the PCR bioassay cannot be executed on Chip 1, and the
corresponding execution time is not available (written as “NA” in the table). From
the simulation results presented in Table 6.4, we can find that the proposed general-
purpose biochip can be adapted to different bioassays with only a slight increase
in the bioassay completion times. Therefore, the proposed general-purpose biochip
offers high flexibility when we run various bioassays on a dedicated layout.
Although Chips A  D and Chips E  G are bioassay-specific biochip, we still
can “force” them to execute various bioassays by applying the scheduling algorithm
proposed in Section 6.6. The execution times for running multiplexed bioassay, PCR
bioassay, and protein dilution bioassay on Chips A  D can be found in Table 6.5.
The execution times for running multiplexed bioassay, PCR bioassay, and protein
dilution bioassay on Chips E G can be found in Table 6.6.
By comparing the execution time in Table 6.4, Table 6.5 and Table 6.6, we can
find that Chips 14 can achieve shorter execution time comparing with Chips AD
and Chips EG in most scenarios. This is because some operations that are imple-
mented in parallel on Chips 14 have to be scheduled for sequential implementation
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Table 6.3: Comparison of proposed pin-limited biochip, bioassay-specific biochips
[65], cross-referencing biochips [37], and direct-addressing biochip.
Multiplexed Protein
bioassay PCR bioassay
(No. Pins/Time) (No. Pins/Time) (No. Pins/Time)
Proposed
heuristic method 19/63 s 19/22 s 18/180 s
Cross router [37][65] 30/132 s 30/26 s 30/195 s
Direct-addressing 59/70 s 62/19 s 52/179 s
Bioassay-specific [65] 25/70 s 14/20 s 27/216 s
ILP-based [130] 11/73 s 6/19 s 12/161 s
Table 6.4: Execution time of bioassays on Chips 14.
XXXXXXXXXXXXBioassay
Biochip
Chip 1 Chip 2 Chip 3 Chip 4
Multiplexed bioassay 63 s 65 s NA 62 s
PCR bioassay NA 22 s NA 23 s
Protein bioassay 195 s 221 s 180 s 217 s
Table 6.5: Execution time of bioassays on Chips AD.
XXXXXXXXXXXXBioassay
Biochip
Chip A Chip B Chip C Chip D
Multiplexed bioassay 70 s 77 s NA 73 s
PCR bioassay NA 20 s NA 20 s
Protein bioassay 264 s 441 s 220 s 223 s
on Chips A  D and Chips E  G due to deadlocks. Therefore, compared with
the bioassay-specific biochip in [65], the proposed design has higher flexibility when
running various bioassays on the same layout. Compared with the proposed general-
purpose biochip, the ILP-based design method can reduce the pin-count by 33.3%
to 69.4%. We have noted that there is a trade-off between pin-count and flexibility
when the bioassay-specific designs (Chips A  D [65] and Chips E  G [130]) and
general purpose designs (Chips 14) are compared.
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Table 6.6: Execution time of bioassays on Chips E G.
XXXXXXXXXXXXBioassay
Biochip
Chip E Chip F Chip G
Multiplexed bioassay 87 s 131 s NA
PCR bioassay NA 20 s NA
Protein bioassay 375 s 566 s 161 s
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Figure 6.16: (a) pin-assignment configuration for an 8  8 electrode array; (b)
pin-assignment configuration for a 10  10 electrode array.
6.7.3 Simulation results on regular array
Next we run bioassays on an 88 and a 1010 electrode array to evaluate the perfor-
mance of the proposed general-purpose biochip. The pin-assignment configurations
of the 8  8 and 10  10 biochip are shown in Figure 6.16(a) and Figure 6.16(b),
respectively. There are 32 pins assigned to the 8 8 layout, and 43 pins assigned to
the 10  10 layout. The numbers of control pins for the 8  8 direct-addressing and
cross-referencing biochips are 64 and 16; the numbers of control pins for the 10 10
direct-addressing and cross-referencing biochips are 100 and 20, respectively.
The completion times of running bioassays on the direct-addressing biochips, the
cross-referencing biochips, and the proposed general-purpose biochips can be found in
Table 6.7. Compared to the direct-addressing biochips, the general-purpose biochips
can reduce the number of control pins by 50% or more with only a slight increase in
the bioassay completion times.
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Table 6.7: Execution time of bioassays mapped to an 8 8 (10 10) electrode array.
XXXXXXXXXXXXBiochip
Bioassay
Multiplexed PCR Protein
Direct-addressing biochip 72 s (72 s) 20 s (20 s) 160 s (142 s)
Cross-referencing biochip [37] 72 s (72 s) 20 s (20 s) 215 s (142 s)
Proposed general-purpose biochip 72 s (72 s) 24 s (20 s) 179 s (157 s)
Table 6.7 shows that for the protein dilution bioassay, the execution time on the
8  8 cross-referencing biochip is 20% longer than that for the proposed 8  8 pin-
limited biochip; for multiplexed bioassay and PCR bioassay, the execution times on
these two biochips are almost the same. For the 10  10 array shown in Table 6.7,
the cross-referencing biochip leads to lower completion time for the protein assay.
However, cross-referencing biochips require special electrode structures (two elec-
trodes per unit cell), which introduce fabrication challenges and additional processing
steps [6]. As a result, the fabrication cost for cross-referencing biochip is likely to be
higher than biochips without two electrodes per unit cell. For low-cost disposable
chips, it is arguable whether cross referencing is always the right solution due to
higher fabrication cost.
Finally, we present a comparison between the lower bound on the number of pins
predicted by Theorem 6.4.2, the exact optimization results obtained using ILP model,
and the results obtained using the heuristic procedure. Note that the lower bound
on the number of pins may not always be achievable in practice and correspond to
an actual pin-assignment configuration. On the other hand, the ILP model and the
heuristic procedure can produce the configurations of the layouts. Hence the actual
minimum number of required pins that we obtain by the ILP model is either equal
to or larger than the lower bound.
Without loss of generality, we use various rectangular layouts as test cases. The
results are shown in Table 6.8. The ILP model is solved using Xpress-MP [134],
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Table 6.8: Comparison between lower bound, ILP model, and heuristic solution.
Array No. pins No. pins No. pins
size (lower bound) (ILP model) (heuristic method)
3  3 9 9 9
5  7 18 21 23
7  8 24 29 30
8  8 26 32 32
9  9 30 Computationally impractical 40
which is a widely used commercial ILP solver. The tool is run on a server with 64
GB of memory and two quad-core 2.53 GHz Intel Xeon processors. The computing
time for the 8  8 array is about 5 hours while for a 9  9 array, and the solver
runs out of memory. The heuristic method is run on a 2.27 GHz Intel i3 Dual core
processor with 2 GB of memory. The CPU times are less than 5 minutes for all cases.
6.8 Chapter summary and conclusions
We have presented a new method for mapping control pins to electrodes in the design
of “general-purpose” (bioassay-independent) digital microfluidic biochips. We have
derived necessary and sufficient conditions for pin-assignment to guarantee conflict-
free concurrent manipulation of multiple droplets. The manipulation of droplets with
different volumes on the biochip is considered. We have also presented a lower bound
on the number of control pins required for an electrode array. A graph-theoretic
“acceptance test” has been developed for a given pin-assignment. An optimization
technique based on ILP has been described to automatically derive conflict-free pin-
assignments. The ILP model is not scalable to large designs, but it can be used
for partitioned designs and to evaluate the quality of heuristic solutions. We have
presented an efficient heuristic approach for mapping control pins to electrodes. The
heuristic method has been evaluated using commercial biochips and laboratory pro-
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totypes. Compared with previous techniques, the proposed method can reduce the
number of control pins and facilitate the “general-purpose” use of digital microfluidic
biochips for a wide range of applications.
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7Pin-Limited Cyberphysical Microfluidic Biochip
7.1 Introduction
On a digital microfluidic biochip, the number of control pins used to drive electrodes
is a major contributor to the fabrication cost [6]. The layout of a typical biochip is
shown in Figure 7.1(a), it has three regions:
1. Active region: where the biochemistry assays are executed; electrodes and
on-chip reservoirs are fabricated in this region.
2. Contact region: where the contact pads of the input pins are fabricated.
Here each contact pad corresponds to one input pin of the biochip. In order
to reduce the contact resistance, the area of each pad is usually larger than an
electrode [6].
3. Wire routing region: where metal wires are fabricated. The wires connect
electrodes to the contact pads of the input pins.
From Figure 7.1(a), it is evident that most area of the biochip is occupied by the
connection wires and contact pads. Therefore, the area and the fabrication cost of a
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Figure 7.1: (a) Layout of a biochip. The biochip has three regions: the region
for fabricating electrodes and on-chip reservoirs, the region for wire routing, and the
region for fabricating contact pads of input pins (Figure Courtesy: Bang-Ning Hsu,
Duke University); (b) side view of the substrate and bottom layer for the two-metal-
layer biochip [135][24]; (c) side view of the interconnection between an electrode and
its corresponding contact pad.
biochip will increase when the number of the input pins increases.
In order to reduce the number of input pins in biochips, several design meth-
ods for pin-limited biochips have been presented in the literature. These design
methods map a larger number of electrodes to a small number of control pins ac-
cording to: (i) the specific synthesis result of a bioassay (i.e., bioassay-specific design
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for pin-assignment configurations) [130], or (ii) the arrangement of electrodes on
the biochip (i.e., application-independent design for pin-assignment configurations)
[37; 136; 137].
In particulary, the design method proposed in [136][137] generates an application-
independent pin-assignment configuration with a minimum number of control pins.
Compared with the bioassay-specific pin-assignment algorithms [130], the method in
[136][137] can reduce the number of control pins and facilitate the “general-purpose”
use of digital microfluidic biochips for a wider range of applications; each general-
purpose pin-limited biochip can be used to perform various target bioassays.
In a cyberphysical microfluidic system, the control software may have to dynami-
cally adjust the schedules of fluid-handling operations as well as the routing paths of
droplets. Different bioassays can execute on the same biochip, general-purpose pin-
limited biochips [136][137] are good candidates as hardware platforms for low-cost
cyberphysical microfluidic systems.
However, despite the flexibility of general-purpose pin-limited biochips, the routabil-
ity of metal wires in such chip has remained an open problem until now [136][137].
In order to solve the wire-routing problem and reduce the cost of the cyberphys-
ical microfluidic system, in Section 7.2 we first discuss the wire-routing solution for
general-purpose pin-limited biochips based on the two-metal-layer fabrication tech-
nique developed in recent years [135][24]. Next, we discuss the specific design flow
for pin-limited cyberphysical biochips in Section 7.3. Simulation results for three
experimental bioassays are discussed in Section 7.4. Finally, conclusions are drawn
in Section 7.5.
The key contributions and benefits of this work are as follows:
1. We present a design flow for pin-limited cyberphysical biochip that can further
reduce the cost of a cyberphysical microfluidic system.
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2. We propose the wire-routing method for pin-limited biochips based on a two-
metal-layer fabrication technique [135][24]. The method guarantees that for the
commonly used pin-limited biochips, feasible wire-routing solutions can always
be derived.
7.2 Wire routing for general-purpose pin-limited biochips
For a biochip fabricated using the two-metal-layer technique of [24][135], the side
view of the substrate and the lower plate are shown in Figure 7.1(b).
In the active region of the layout, the biochip has one metal layer for fabricating
electrodes (i.e., the 1st Chromium layer shown in Figure 7.1(b)), and another metal
layer for wire routing (i.e., the 2nd Chromium layer shown in Figure 7.1(b)); these
two metal layers are isolated by SiO2. Under each electrode, there is an aluminum
via that connects the electrode to its corresponding routing wire.
Similarly, in the contact region of the layout, the 1st metal layer is used to fabri-
cate the contact pads of the input pins. For each contact pad, there is an aluminum
via that connects the contact pad to the corresponding routing wire (which is fab-
ricated by the 2nd metal layer). The side view of the interconnection between the
electrode and the corresponding contact pad is shown in Figure 7.1(c). By using the
two-metal-layer fabrication technique, electrodes in a large array can be connected
to their corresponding input pins.
Assume that we have already derived the pin-assignment configuration for a W 
H electrode array, and the electrodes are mapped to P pins. Based on the existing
two-metal-layer fabrication technique [24][135], the wire routing solution of the pin-
limited biochip can be derived using the following steps.
1. Adding “routing rings” in the wire routing region. In the wire routing
region, “routing rings” are fabricated using the 1st metal layer, as shown in
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Figure 7.2: (a) An electrode array and “routing rings” for Pins 1 to P ; (b) a large
electrode array that is partitioned into four parts. The wire routing solution for
these parts can be derived separately; (c) top view of an electrode sub-array and
the underneath routing wires on the direction which is parallel with one edge of the
array; (d) top view of an electrode and the underneath routing wires.
Figure 7.2(a). Each routing ring is assigned to one control pin of the biochip,
and all the routing rings are axis-parallel rectangles. The total number of
fabricated routing rings is P . The edges of any two rectangles do not intersect,
and the routing rings are electrically isolated from each other.
2. Partitioning an electrode into four parts. A large electrode array can be
“equally” partitioned into upper left, upper right, lower left, and lower right
sub-arrays, as shown in Figure 7.2(b). The wire routing for these four sub-
arrays are derived separately. In the active region, routing wires in different
sub-arrays do not interference with each other.
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3. Connecting electrodes to routing rings. Based on the pin-assignment
configuration, electrodes are connected to their corresponding routing rings.
An example is as follows. We assume that the electrode array shown in Fig-
ure 7.2(c) is the upper left sub-array of the electrode array shown in Fig-
ure 7.2(b). In this sub-array, three electrodes are assigned to be connected to
Pin 1. The vias at the centers of these three electrodes electrically connect
the electrodes to three routing wires. As shown in Figure 7.2(c), routing wires
of these three electrodes intersect with the routing ring for Pin 1. At these
crosspoints, vias are added to electrically connect the routing wires with the
routing ring for Pin 1. Using this method, all the electrodes that are assigned
to Pin 1 are connected to the routing ring for Pin 1.
In the similar manner, all electrodes that are assigned to Pin p (1 ¤ p ¤ P )
are connected to the routing ring for Pin p.
In order to simplify the wire-routing solution and to avoid any interference
between two metal wires on the two-metal-layer biochip, all routing wires are
aligned parallel to the edge of the electrode array (in either the direction of
x-axis or y-axis), as shown in Figure 7.2(c).
4. Connecting routing rings to input pads. In the contact region, P contact
pads are fabricated using the 1st metal layer, and each routing ring is connected
to its corresponding contact pad. The connection wires are fabricated using
the 2nd metal layer.
Among the above steps, we note that the routability of a pin-limited biochip
is determined in Step 3, i.e., if there is enough space underneath each electrode to
place the parallel routing wires, the pin-limited biochip is routable. As shown in
Figure 7.2(c), at the edge of the sub-array that is perpendicular to the routing wires,
the electrodes have the maximum number of routing wires underneath them (i.e.,
200
the four electrodes at the first row of the 4 4 sub-array each has four routing wires
underneath it). Similarly, for a Ws Hs (Ws  Hs) rectangular sub-array, if the
routing wires are aligned parallel to the longer edge of the rectangle, the maximum
number of routing wires fabricated underneath the electrodes is maxtWs, Hsu; if the
routing wires are aligned parallel to the shorter edge of the rectangle, the maximum
number of routing wires fabricated underneath the electrodes is mintWs, Hsu. As
the orientation of routing wires can be parallel to either the longer or shorter edge
of the sub-array, we will always align routing wires parallel to the shorter edge of
the rectangle when designing the wire-routing solution for the Ws Hs rectangu-
lar sub-array. Hence, the maximum number of routing wires need to be fabricated
underneath electrodes in the sub-array is mintWs, Hsu.
Therefore, based on the size of the electrode array, as well as the geometric sizes
of electrodes, routing wires, and vias, we can determine whether a pin-limited biochip
has a feasible wire routing solution. For a W H pin-limited biochip, the sufficient
condition for the existence of its wire routing solution can be derived as follows.
The top view of an electrode and the underneath routing wires are shown in
Figure 7.2(d). Here we assume that the diameter of the via is Dvia, the width and
length of each electrode are both D, and the width of a routing wire is Tw. In order to
prevent electrical shorting of the two wires, the gap between them is Tbw. Therefore,
the average “occupied” width of each routing wire can be estimated as pTw   Tbwq.
As shown in Figure 7.1(b) and Figure 7.2(d), there is a via at the center of each
electrode. Since the routing wire cannot overlap with the via, the “effective width”
under each electrode that can be used for aligning routing wires is estimated as
pDDviaq. Therefore, the maximum number of routing wires that can be fabricated
underneath an electrode can be estimated as tDDvia
Tw Tbw
u, where tu represents the largest
integer not greater than “  ”.
As discussed above, a W  H electrode array can be “equally” partitioned into
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Figure 7.3: The design flow for pin-limited cyberphysical biochips.
four sub-arrays, and the size of the maximum sub-array is rW
2
s  rH
2
s, where rs
represents the smallest integer not less than “  ”.
Therefore, a W H two-metal-layer biochip is routable when:
minprW
2
s, r
H
2
sq ¤
YD Dvia
Tw   Tbw
]
.
The typical values for D, Dvia, Tw, Tbw are 1000 µm, 200 µm, 20 µm, and 20 µm,
respectively [24][135]. Therefore, if W ¤ 40 or H ¤ 40, the pin-limited biochip fabri-
cated by two-metal-layer technique is routable. For most of the benchmark bioassays
that are extensively discussed in literature, the sizes of the required electrode arrays
are smaller than 40 40. Hence for the commonly used pin-limited biochips, we can
derive feasible wire routing solutions by Steps 1  4 proposed above.
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7.3 Design flow for pin-limited cyberphysical biochips
For a given W  H electrode array without pin-assignment, the heuristic algo-
rithm proposed in [136][137] can first derive a pin-assignment configuration that
is application-independent. Next, if W ¤ 40 or H ¤ 40, by applying Steps 1  4
proposed in Section 7.2, we always can find a feasible wire routing solution for this
pin-limited biochip.
For any given bioassay, by applying the operation-dependency-aware synthesis
algorithm and the droplet-routing approach described in Section 5.3 and Section 5.4,
the synthesis result of the bioassay on a W  H direct-addressing biochips can be
derived. The synthesis result is defined as the “initial synthesis results”.
Next, the scheduling algorithm proposed in [137] is used to adjust the “ini-
tial synthesis result” (derived on a direct-addressing biochip) according to the pin-
assignment configuration of the layout. Finally, the synthesis results of the bioassay
on the pin-limited biochip can be derived, i.e., the bioassay can now be executed on
the low-cost pin-limited biochip. The flowchart for the complete design flow is shown
in Figure 7.3.
7.4 Simulation results
7.4.1 Results derived by the operation-interdependency-aware synthesis approach
In Section 5.5.3, we have mapped bioassays to direct-addressing biochips with dif-
ferent sizes. The corresponding completion times of bioassays in dilution/mixing
(D/M) phases and transportation (T) phases on the direct-addressing biochips are
shown in Table 5.3.
As discussed in Section 7, we can map bioassays to pin-limited general purpose
biochips proposed in [136][137]. The pin-assignment configurations for 8  8, 9  9,
10  8, and 12  8 electrode arrays are shown in Figure 7.4. Compared with the di-
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Figure 7.4: Pin-assignment configuration for: (a) 8  8 array; (b) 9  9 array; (c)
10  8 array; and (d) 12  8 array.
Table 7.1: Synthesis results derived by the operation-interdependency-aware synthe-
sis approach on pin-limited general-purpose biochips.
Completion time (s)
Size of
D/M phases T phases Total
Bioassay the biochip
8  8 116 181 297
Exponential 9  9 59 163 222
dilution 10  8 67 161 228
bioassay 12  8 54 244 298
8  8 89 162 251
Interpolation 9  9 45 133 178
dilution 10  8 48 165 213
bioassay 12  8 45 189 234
rect-addressing scheme, the design of pin-limited general-purpose biochips can reduce
the pin-counts by 50.0% to 65.8%.
The synthesis results for executing bioassays on direct-addressing biochips are
defined as “initial results”. By applying the scheduling algorithm proposed in [137] on
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Figure 7.5: The relationship between completion time of bioassays and fT on the
8  8 biochip shown in Figure 7.4(a).
the initial results, we derive the synthesis results for bioassays. Hence the bioassays
can be mapped to the general-purpose pin-limited biochips shown in Figure 7.4. The
corresponding completion times of bioassays in D/M phases and T phases on these
pin-limited general-purpose biochips are shown in Table 7.1. Here the completion
time of D/M phases is defined as the sum of time spans for all the D/M phases in
the bioassay. The completion time of T phases is defined as the sum of time spans
for all the T phases in the bioassay. The working frequency of T phase is also set as
1 Hz.
7.4.2 Completion time with multiple clock frequencies
In Section 5.5.6 we present the relationship between the bioassay completion time
and the clock frequency of the droplet transaction phase on a biochip with multiple
working frequencies. If the bioassays are executed on the 8 8 pin-limited electrode
array shown in Figure 7.4(a), the relationship between completion time of bioassays
and the clock frequency of the T phase is shown in Figure 7.5. The execution times for
exponential dilution and interpolation dilution bioassays on the pin-limited biochip
can be greatly reduced by increasing fT. For example, when fT increases from 1 Hz
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to 10 Hz, the execution time for exponential dilution bioassay is reduced from 297
seconds to 134 seconds.
From the simulation results, we find that when the clock frequency of the T phase
increases, the completion time of PCR bioassay on the pin-limited biochip does not
decrease significantly. This is because the time for droplet transportation in the PCR
bioassay is relatively low.
7.5 Chapter summary and conclusions
In this chapter, we discuss the method for metal wire routing on pin-limited biochip.
The proposed method can guarantee that, with two-metal-layer fabrication tech-
nique, all the widely-used pin-limited biochips are routable. In order to reduce the
cost of the cyberphysical biochip, we also propose the design flow for pin-limited
cyberphysical microfluidic biochip. The simulation results show that, the proposed
method can reduce the number of control pins and facilitate the “general-purpose”
use of cyberphysical digital microfluidic biochips for a wide range of applications.
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8Conclusions and Future Work
8.1 Thesis contributions
In this thesis work, we have proposed a set of design techniques for cyberphysical
microfluidic biochips. Contributions include design methods that consider timing
uncertainties in operations, optimization to handle droplets with various volumes,
layout optimization of cyberphysical PCR biochips, and a design flow for cyber-
physical pin-limited microfluidic biochips. Compared to prior design methods, this
thesis has led to a computer-aided design flow that considers physical constraints
and enables the development of cyberphysical biochip systems.
This thesis presents the first step towards physical-aware optimization and control
software design. We have developed an algorithm for droplet tracking based on
pictures captured by CCD cameras, and a reliability-driven error recovery strategy.
Using feedback from sensors, the control software can determine whether there are
errors on the biochip. The control software discards the region where an error has
occurred to ensure reliable chip operation. We have also developed a re-synthesis
method for cyberphysical biochip, which can dynamically alter the schedule of fluid-
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handling operations based on sensors’ feedback.
An important contribution of this thesis includes a dictionary-based error recov-
ery method for low-cost portable cyberphysical microfluidic systems. In order to
derive error dictionaries, a technique has been developed for realistic fault simula-
tion. By utilizing error dictionaries, we can achieve a cost-effective implementation
of cyberphysical systems to recover from errors that occur during chip usage.
In order to mimic the behavior of faulty fluid-handling operations, we have de-
veloped a fault simulation framework that can integrate data collected from real
experiments. In prior work, error recovery and synthesis were based on the assump-
tion that all operations have the same failure probability, but this assumption may
not reflect reality. In order to address this problem, we have developed failure models
of biochips based on real data, and used these models to guide fault simulation.
By considering the physical constraints in cyberphysical microfluidic system, we
have developed a layout optimization technique for cyberphysical PCR biochips. A
statistical model for DNA amplification has been introduced. The module is used
to predict whether the droplet has enough DNA strands to carry out the PCR, and
it helps us to improve the efficiency of PCR on cyberphysical biochips. We have
developed a layout algorithm that considers interference between the on-chip ele-
ments such as reservoirs, sensors and thermal units. An optimization algorithm has
been developed to minimize the area and electrode count of the biochip and satisfy
proximity constraints. Several real-life bioassays have been used to demonstrate that
the proposed design method reduces the overall mixing/dilution/detection time for
a given bioassay.
In order to overcome the inherent variability and randomness of biological/chemical
processes and improve the quality of product droplets, this thesis has also presented a
synthesis algorithm for bioassays that is capable of taking into account uncertainties
inherent in biochemical reactions. An “operation-interdependence-aware” synthesis
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algorithm has been developed — the first on-chip biochemistry synthesis procedure
that does not use the module library as a design guideline. Using this algorithm,
the dependence on characterization can be reduced. The algorithm leads to a de-
sign approach that considers completion-time uncertainties for fluidic operations,
hence the accuracy of fluidic operations is also improved. The proposed approach
explicitly considers the transportation of droplets. Hence it guarantees the feasibil-
ity of droplet-routing, and determines the transportation path for each droplet. In
order to reduce the execution time of the bioassay without additional degradation
of electrodes or hardware cost, the design of microfluidic biochips using multiple
clock frequencies has also been considered. An on-line droplet-routing method with
low computational complexity has been developed. The response time of the result-
ing cyberphysical system is negligible. Therefore, the degeneration of intermediate
products in the bioassay can be avoided.
To minimize the number of control pins and simultaneously maximize the flexibil-
ity of biochips, we have developed design techniques for general-purpose pin-limited
biochips. A graph model for analyzing pin-assignment configurations of a biochip
has been developed. Based on the graph model, we have developed a heuristic al-
gorithm for the design of pin-assignment configuration, devised an acceptance test,
and developed a scheduling algorithm for fluid-handling operations. The manip-
ulation of droplets with various volumes has also been considered, and new design
constraints associated with the processing of large droplets have been discussed. The
metal wire routing method for pin-limited has been investigated. Finally, by combin-
ing the design algorithms for general-purpose pin-limited biochip and cyberphysical
microfluidic biochips, a design flow for cyberphysical pin-limited biochips has been
developed.
In summary, this thesis work has been centered on the design and optimization
of a comprehensive algorithmic infrastructure for a cyberphysical biochip system. A
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series of related design problems for cyberphysical microfluidic systems have been
addressed, including uncertainty-aware synthesis, dynamic error recovery, layout op-
timization, pin-count minimization, and optimization for cyberphysical pin-limited
biochips. This thesis has therefore led to powerful design tools for cyberphysical mi-
crofluidic biochips and can serve as a bridge between theoretical design algorithms
and realistic applications of biochips.
8.2 Future research directions
The contents of this thesis open up a number of exciting directions for research in the
emerging area of automated biochip design. These new directions are summarized
below.
8.2.1 Optimization of droplet monitoring systems on cyberphysical biochips
In a cyberphysical digital microfluidic system, the monitoring of droplets is vitally
important. Researchers often use cameras fixed on the hardware platform to simulta-
neously monitor multiple operations on the biochip [21]. From the captured images,
the volumes and concentrations of the droplets can be determined at each step of
the bioassay, and the time required to complete the dilution/mixing processes on
the biochip can be measured precisely [21]. However, misleading results concerning
the completion of these processes may be derived if only the top view is used for
monitoring the fluid-handling operations. For example, a fluorescein droplet and
a non-fluorescein droplet are merged together for 10 seconds, and cameras capture
images of the mixed droplet from top and side views, as shown in Figure 8.1 [21].
From the top view, it is observed that the fluorescent reagent has been homoge-
neously distributed in the merged droplet, i.e., the mixing procedure may appear to
be complete. However, from the side view, it is apparent that the merged droplet has
multiple layers, i.e., the fluorescein droplet and the non-fluorescein droplet are over-
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  Top view                Side view
Figure 8.1: Top and side views captured after merging a fluorescein droplet with
a non-fluorescein droplet for 10 seconds [21].
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Figure 8.2: (a) Droplets 1 and 2 are invisible from side view if the camera is
fixed at Position 1. Droplets 2 and 3 are invisible from side view if the camera is
fixed at Position 2; (b) set at different initial positions for Droplets 3 and 4; (c) the
movements of Droplets 1 and 2 in the x direction.
lapping each other rather than being well mixed. From this example, we know that
it is essential to monitor cyberphysical microfluidic biochips, using both top and side
views simultaneously. Thus, two cameras must be fixed onto the hardware platform
so that images of the droplets can be acquired from two different perspectives.
When multiple droplets are manipulated concurrently on the biochip, the visibil-
ity of the droplets for the side-view assessment should be considered. An example is
shown in Figure 8.2(a). We assume that droplets 1  4 are being mixed concurrently
in four mixers on the biochip.
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The directions in which droplets 1  4 are moving in the mixing procedure are
indicated by the arrows. We assume that these four mixing operations start at the
same time with the droplets moving in the same direction. The initial positions of
droplets 1 and 3 are in the same row of the electrode array, and the initial positions
of droplets 2 and 4 are in the same row of the electrode array. When we project the
movements of droplets 1 and 3 on the y-axis, they will always overlap each other
during the mixing procedure. Therefore, if the camera is fixed at position 1 and
we acquire side-view images of these four droplets, droplet 1 will always be hidden
behind droplet 3, i.e., droplet 1 is “invisible” to the monitoring system. Similarly,
droplet 2 will always be hidden behind droplet 4, and it is also invisible to the
monitoring system.
If the camera is fixed at position 1 and monitors these four droplets from the side,
droplets 2 and 4 will always be invisible to the monitoring system. This situation
must be avoided in order to monitor the mixing procedures of all of the droplets on
the biochip simultaneously.
To solve this problem, we can set different initial positions for droplets 1 and 2,
as shown in Figure 8.2(b). When projecting the movements of droplets 1 and 2 on
the x-axis, the relationship between time and the positions of these two droplets is
shown in Figure 8.2(c). At times 1, 2, 3, and 4, the positions of droplets 1 and 2 do
not overlap each other, so both of these droplets can be photographed by the camera.
By projecting the movements of droplets onto the x or y axis, the maximum
number of droplets that can be observed from the side view can be calculated. An
example is as follows. Assume there are 1  4 mixers on the biochip, and the pro-
jections of these mixers on the y-axis overlap each other. Then by setting different
initial positions and different initial moving directions, we can determine that the
maximum number of droplets that can be observed in parallel is six. In the synthe-
sis algorithm of a microfluidic biochip, this constraint on the maximum number of
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Figure 8.3: Schematic diagram showing s side-view of the hot-air thermocycler
with optical setup [138].
operations that can be executed in parallel must be considered.
8.2.2 Optimization of 3-dimensional PCR microfluidic biochips
In Chapter 5, we discussed the optimization of the layout design of a PCR biochip.
This thesis has only considered planar digital microfluidic biochips, i.e., we assumed
that all of the components of the biochip, including the electrode array, on-chip reser-
voirs, optical sensors, and the heater, are fabricated on the surface of the substrate.
With the development of an appropriate fabrication technique, the design of “3-
dimensional PCR biochip” has been proposed [138]. For some biochips, the heater
may be placed under the biochip rather than being fabricated on the same layer with
the reservoirs; also, the detectors may be placed above or under the biochip (on the
top or bottom plate of the biochip) rather than being placed on the same flat with
the reservoirs. Figure 8.3 shows the structure of a 3D PCR biochip [138]. Therefore,
optimization of the placement of the modules on PCR biochips must be viewed as a
3-dimensional, module-placement problem.
8.2.3 Synthesis with a decision-tree structure
On a cyberphysical microfluidic biochip, we can potentially implement a bioassay
with a decision-tree architectures. Decision-tree architectures will enable new func-
tions for a biochip, such as biochemical analysis for unknown analytes. This pro-
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cedure can be described as follows. Droplets with an unknown sample can be used
as an input to the biochip. Then, the droplet will be sent to a series of checkpoints
and the droplet’s constituents are checked step by step. Based on the detection re-
sult at each checkpoint, the biochip will determine the next operations that will be
implemented on the droplet.
Before a bioassay is executed, all possible optimized actuation sequences, cor-
responding to different root-to-leaf paths in the decision tree, are generated by the
control software and saved in memory. In a real experiment, the actuation sequences
to be applied to the chip are chosen based on the feedback from on-chip sensors.
8.2.4 Integration of capacitive sensors in pin-limited biochips
In [139], the authors presented the first demonstration of a cyberphysical system on
real biochips. Capacitive sensors are integrated into a direct-addressing biochip to
monitor the movements of droplets. Here we propose the integration of a capaci-
tive sensor into a pin-limited general-purpose biochip (Chapter 6) and discuss the
corresponding algorithm for monitoring droplets.
A schematic diagram of the system used to measure the capacitance of a digital
microfluidic biochip is shown in Figure 8.4(a). Each unit of the digital microfluidic
biochip has a pair of plates; the upper plate is a common ground for all the unit cells
and the lower plates are connected to corresponding control pins.
There is a capacitance associated with a pair of electrodes in each unit cell of
biochips. In order to measure the capacitance, the unit cell of a biochip is connected
to a resistance to establish an resistor-capacitor (RC) circuit. By measuring oscilla-
tion frequency of the RC circuit, we can derive the capacitance of the unit cell on
the biochip. When a droplet is moved to a pair of electrodes, the capacitance corre-
sponding to this pair of electrodes will change. Hence by comparing the calibrated
capacitance of the unit cell with the measured capacitance, we can determine the
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(a) (b)
Figure 8.4: (a) The schematic for the system of capacitance measurement for digital
microfluidic biochips [140]; (b) equivalent circuit for electrodes that are controlled
by the same pin.
presence of a droplet.
Next, we consider capacitive sensors that are integrated with pin-limited biochips.
As shown in Figure 8.4(b), there are four unit cells of EWOD actuators. In order
to use Pin A to apply control signals on unit cells 1 and 4 together, their lower
plates, i.e., electrodes E1 and E4, are connected by a metal wire. Hence the unit
cells of the EWOD actuators 1 and 4 can be modeled as two capacitors C1 and C4
that are connected in parallel, as shown in Figure 8.4(b). The capacitative sensor
can measure the value of the two capacitors together, but it cannot measure the
capacitance values of C1 and C4 separately. In this scenario, the capacitive sensor
for the pin-limited biochip can only detect the absence/presence of droplets on the
electrodes that are connected to Pin A, but it cannot identify the exact position of
the droplet.
Hence the results provided by capacitive sensors in pin-limited biochips may be
misleading. An example is shown in Figure 8.6. Electrodes A and B are both
connected to Pin 1, and Electrode B is a checkpoint for droplet monitoring. At
time t, the expected positions of the droplets are shown in Figure 8.5(a). However,
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Figure 8.5: (a) The expected positions of droplets; (b) wrong positions of droplets
which still can get “correct” sensing result; (c) an example of “capacitance transfer”
from control Pin A to Pin B.
suppose that due to physical defects on the chip, a droplet is stuck at Electrode A,
and another droplet, which is scheduled to be moved to Electrode B, is also stuck
at another electrode, as shown in Figure 8.5(b). Note that Electrodes A and B are
connected in parallel. Therefore, for the case shown in Figure 8.5(a), the capacitance
C1 measured by the sensor can be expressed as: C1  Cabsence   Cpresence, where
Cabsence is the capacitance due to unit cells without any droplet, and Cpresence is the
capacitance due to unit cells with droplets.
For the case shown in Figure 8.5(b), the capacitance measured by the sensor can
also be written as: C2  Cabsence   Cpresence.
Hence the capacitive sensor will provide the same results for the cases shown in
Figure 8.5(a) and Figure 8.5(b). In this situation, even though errors have occurred
on the biochip, these errors cannot be detected by the capacitative sensor. Thus,
this example shows that we may get misleading results from the checkpoints for
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pin-limited biochips.
In this section, we propose a method to solve this problem by assigning a capaci-
tive sensor to each control pin of the biochip. We show that, for the general-purpose
pin-limited biochip described in Chapter 6, we can track the movements of mul-
tiple droplets simultaneously based on the feedback from capacitive sensors. The
theoretical calculation is introduced below.
According to the design constraints of a general-purpose pin-limited biochip,
when a droplet is moved from one electrode to another, the capacitance of the droplet
will be “transferred” from one pin to another pin, as shown in the following example.
Figure 8.5(c) shows that one droplet is moved from E1 to E2 and that E1 and E2
are controlled by Pin A and Pin B, respectively. When there is no droplet on the
electrodes, assume that the capacitances associated with Pin A and Pin B are CA0
and CB0 , respectively; and when there is a droplet on an electrode, assume the capac-
itances associated with Pin A and Pin B are CpresenceA and CpresenceB , respectively.
So at the time point t  t0, the droplet stays on E1, and the capacitance associated
with Pin A and Pin B (CApt0q and CBpt0q) can be written as:
CApt0q  CpresenceA ,
CBpt0q  CB0 .
At the time point t  t0   1, the droplet has moved from E1 to E2, so the
capacitance associated with Pin A and Pin B (CApt0   1q and CBpt0   1q) can be
written as:
CApt0   1q  CA0 ,
CBpt0   1q  CpresenceB .
From the above equations, we find that the movement of a droplet can lead
to changes in the capacitance for a pair of control pins. According to the design
requirements of the general-purpose pin-limited biochip (introduced in Chapter 6),
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each possible combination of control pins appears no more than once in any layout.
Based on the pin-assignment configuration of the biochip and the pairs of pins that
indicate capacitance change, we can identify the position of droplets on the chip. This
approach for droplet localization and monitoring can be examined in more detail in
future work.
8.2.5 Design of microfluidic biochips with on-chip logic circuits
Recent developments in the techniques used to fabricate biochips have enabled the
integration of logic circuits and electrowetting-on-dielectric (EWOD) devices. Fig-
ure 8.6(a) shows an EWOD electrode array (boxed area) controlled by a backplane
complementary metal-oxide-semiconductor (CMOS) circuit [141], and Figure 8.6(b)
shows the logic circuit integrated on an active-matrix electrowetting-on-dielectric
(AM-EWOD) device [54].
The capability of integrating an electrode array and control logic may result
in some exciting improvements in the design of digital microfluidic biochips. For
example, for pin-limited biochips, integrated CMOS multiplexers can be fabricated
on the electrode array to control the pin-assignment configuration of the biochip.
Therefore, a biochip may dynamically change its pin-assignment configuration during
the execution of a bioassay. With this controllability on pin-assignment biochips,
the pin-count of the biochips and the completion time of bioassays may be reduced
further. Thus, more powerful “general-purpose pin-limited biochips” can be achieved.
8.2.6 Design of fluidic-constraint-aware cyberphysical microfluidic biochip
When bioassays are run on digital microfluidic biochips, there are some fluidic con-
straints on the movement of droplets. For example, if two droplets are not scheduled
to be mixed together, then they should never come in contact with each other. In
previous designs, these constraints are set when we generate the synthesis result, i.e.,
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Figure 8.6: (a) EWOD electrode array (boxed area) controlled by backplane com-
plementary metal-oxide-semiconductor (CMOS) circuit [141]; (b) logic circuit on an
active matrix electrowetting on dielectric (AM-EWOD) device [54].
in the ideal case, the synthesis result of a bioassay should guarantee that all of the
fluidic constraints are satisfied.
All synthesis algorithms have an underlying assumption, i.e., that all of the
droplets move at the same speed when the same voltage is applied. However, the
experimental results demonstrate that different kinds of droplets move at different
speeds with the same applied voltage. For example, a droplet of a dilute solution
of Na2CO3 moves at twice the speed a droplet of a dilute solution of CaCl2 when
the same voltage is applied [24]. For droplets that contain the same solution with
different concentrations, their movement speeds can also be different.
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Due to the differences in the speeds at which droplets move, the synthesis results
cannot provide a 100% guarantee that fluidic conflicts will be avoided because some
droplets may move slower or faster than expected. Thus, the undesirable “collisions”
of droplets may occur if the speeds at which the droplets move are different from the
expected speeds.
Two solve this problem, on-chip capacitive sensors can be used to create an
“intelligent” system that can automatically adjust the movements of the droplets
when a violation of the fluidic constraints may occur. As introduced in Chapter 1,
with on-chip capacitive sensors, we can precisely locate droplets and measure their
speeds. If the measurement results indicates that a “collision” of two droplets will
occur, the sensor sends a “stop” signal to one of the droplets. Then, the droplet will
be required to stay at its current position to avoid the unwanted violation of fluidic
constraints.
Another possible application for the intelligent cyberphysical biochip is the de-
velopment of a power-saving biochip. In the biochips described in the literature,
all droplets are driven by the same voltage, and their corresponding charging times
of the electrodes are the same. However, as the “mobility” of droplets vary, a fixed
charging time for driving all the droplets may be unnecessarily long for some droplets.
The excessive charging time for electrodes may increase the degradation of electrodes
[24]. To avoid this problem, a cyberphysical microfluidic biochip may dynamically
adjust the voltage and charging time for driving droplets according to their “mobili-
ties”. In this way, the reliability as well as the lifetime of biochips is improved, while
the power-consumption is reduced.
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